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Abstract 
This thesis empirically explores aspects of the economics of waiting times in the 
mental health context. Waiting times are of persistent policy concern as they risk 
poorer treatment outcomes and threaten the desired principles of timely and equitable 
access. The empirical applications focus on first-episode psychosis patients and early 
intervention in psychosis (EIP) services in the English National Health Service where 
policymakers recently placed new emphasis on reducing waiting times. 
Analyses are based on the nationally representative Mental Health and Learning 
Disabilities Dataset 2011 to 2015. We develop procedures to measure various 
dimensions of waiting times at the patient level – such as duration of untreated 
psychosis, inpatient waiting time, and referral-to-treatment waiting time. We apply 
generalised linear modelling to accommodate the heavy-tailed distribution of waiting 
time and use duration analysis to overcome the challenge of right-censoring. We 
further make use of difference-in-difference and matching techniques to evaluate the 
impact of the newly introduced EIP waiting time target.  
We found significant socioeconomic inequalities in duration of untreated psychosis. 
Also, hallucinations and delusions, as well as previous mental health service use, were 
influencing factors for patients to access services. Waiting for a care coordinator was 
associated with a clinically significant deterioration in patient outcomes independent 
of treatment intensity. The implementation of the EIP waiting time target led to an 
increased probability of waiting below target whereas waiting times along the 
distribution did not improve. However, waiting times improved already in anticipation 
of the policy change with little evidence of unintended effects such as re-prioritisation 
of patients or gaming behaviour of providers. Results of this thesis can help to inform 
the development of strategies to reduce inequalities in access to EIP services, and the 
prospective implementation of waiting time targets in other mental health service areas 
as well as its adaptation to other countries. 
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 “Far too many people of all ages wait too long to get the mental health services they 
need. The longer they wait for support, the more likely it is their condition gets worse. 
This has to change. […]. Simply making services available is not enough. We are also 
looking at ways to overcome inequalities around service usage – and around the 
outcomes those services achieve.” 
Department of Health (2014a), pp.12-13
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1.1 Research objective 
Providing access to services for people in need of care is a key perspective for health 
systems around the world (Willcox et al., 2007). Hence, waiting times are of persistent 
policy concern in countries with publicly funded health care systems and universal 
access such as the United Kingdom, Canada, New Zealand, or Australia (Siciliani, 
Moran and Borowitz, 2014; Cullis, Jones and Propper, 2000). Waiting lists can be used 
to stock available demand and optimise utilisation of the scarce supply of resources 
such as skilled staff and medical equipment (Culyer and Cullis, 1976). However, 
excessively long waiting times do not only risk poorer patient outcomes they also 
create anxiety and disability during waiting (Propper, 1995, 1990; Lindsay and 
Feigenbaum, 1984) and threaten the desired principles of timely and equitable access 
to care (Oudhoff et al., 2007). 
This thesis empirically explores aspects on the economics of waiting times in the 
mental health context. Recently, new policy emphasis has been placed on reducing 
waiting times in mental health services in England. With its strategy “No health 
without mental health” published in February 2011, the Department of Health 
acknowledged the often neglected importance of mental health for individuals, society 
and the economy (Department of Health, 2012, 2011). With its aim to ensure mental 
health having parity of esteem with physical health, some of the key objectives of this 
strategy were to improve access to specialist services, promote early intervention for 
people with severe mental illness, and to reduce inequalities in accessing services. The 
key objectives were later specified by the announcement of the first ever waiting time 
targets in mental health services in January 2014 (Department of Health, 2014a). 
This thesis aims to investigate to what extent the governmental objectives regarding 
shorter waiting times and more equal access to specialist mental health services have 
been met after the first four years of its announcement. The empirical applications 
focus on first-episode psychosis patients within the English National Health Service 
(NHS) which is one of the key areas the waiting time target policy focused on. On the 
demand side, we will analyse inequalities in accessing specialist services and explore 
the impact of waiting on treatment outcomes. On the supply side, we will provide 
answers to whether the increased policy focus on reducing waiting times led to any 
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intended or unintended changes in provider behaviour. We look into provider 
responses to enforced waiting time targets and analyse changes in prioritisation 
patterns, and gaming behaviour. 
 
1.2 Background 
1.2.1 Clinical and institutional background 
Psychotic disorders, including schizophrenia, encompass a group of conditions that are 
considered to be among the most serious mental illnesses (Iyer et al., 2015). A 
psychosis is characterised by disturbances in thinking and perception which manifests 
in positive symptoms such as delusions, hallucinations, and disorganised thoughts and 
behaviour as well as negative symptoms such as monotone speech, lowered levels of 
motivation, lack of interest in social interaction, or inability to feel pleasure (NICE, 
2014; Andreasen, 1984, 1983). In 2016, there were 20.9 million prevalent cases of 
schizophrenia worldwide (Vos et al., 2017). The estimated lifetime median prevalence 
of psychotic disorders is 4.0 per 1,000 persons (McGrath et al., 2008). The pooled 
incidence of all psychosis in England is 31.7 per 100,000 person-years (15.2 for 
schizophrenia) (Kirkbride et al., 2012a). Incidence varies markedly by demographic 
as well as neighbourhood related factors. For example, men have an almost twofold 
greater risk than woman (McGrath et al., 2008; Kirkbride et al., 2006). Also, migrants 
were found to have a more than four-fold higher incidence compared to native-born 
people (McGrath et al., 2008) and incidence is two- to three-fold higher in most 
deprived or socially fragmented neighbourhoods (O'Donoghue et al., 2016). 
The economic and social consequences of psychosis are tremendous. Once a psychosis 
has emerged, the majority of patients suffers from repeating psychotic episodes over 
their lifetime. Only 44% will symptomatically recover within eight years (Revier et 
al., 2015). Psychosis is closely linked to poorer physical health and in consequence 
shorter life expectancy (Naylor et al., 2012; Thornicroft, 2011; McGrath et al., 2008; 
Henderson et al., 2000). It affects people during late adolescent and early adult years 
when they are just about to pursue further education or employment. At the same time, 
patients face lower rates of employment, poorer pay and less secure jobs throughout 
their lifetime (Revier et al., 2015; Marwaha and Johnson, 2004). The often unusual or 
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bizarre behaviour leads to difficulties in managing their own life and social exclusion 
(Revier et al., 2015; Huxley and Thornicroft, 2003). Fear of stigma and reluctance 
prevents patients from seeking help (Dawson, Jordan and Attard, 2013). Worldwide, 
the annual national costs for schizophrenia are estimated to range from US$94 to 
US$102 billion (Chong et al., 2016). In England, schizophrenia causes total cost of 
£8.8 billion per year with service costs contributing 40%, and informal care 13% 
(Kirkbride et al., 2012b). 
The first two to five years following the onset of psychosis are referred to as “first-
episode psychosis” (Breitborde, Srihari and Woods, 2009). Here is where the majority 
of the decline in functioning emerges and treatment response is highest. There is 
compelling scientific evidence that the early phase of a psychosis is critical and delays 
in first treatment are robustly linked to poorer outcomes (Birchwood, Todd and 
Jackson, 1998). Based on this idea, specialised early intervention in psychosis (EIP) 
services have been developed in many countries (Marshall and Rathbone, 2006; Joseph 
and Birchwood, 2005). EIP services provide multidisciplinary care including 
pharmacological, psychological, social, occupational and educational interventions 
(Cheng and Schepp, 2016; NICE, 2014). Treatment is delivered by stand-alone 
services within the community in planned sessions over a period of two to five years 
(Malla et al., 2017). Key components of EIP care should comprise easy and rapid 
access to services, integrated biopsychosocial care plans, a multidisciplinary team 
including a psychiatrist, treatment of comorbidities, and formal evaluation of care 
quality (Addington et al., 2013). Given the multidisciplinary nature, the care 
coordinator plays a key role in the effective delivery of care (Iyer et al., 2015). She 
brings together all involved professionals and is responsible for engaging and 
supporting patients in treatment. Treatment engagement is a particular challenge in 
first-episode psychosis as about 30% of patients disengage from treatment over time 
(Doyle et al., 2014). 
Specialised EIP care during first-episode psychosis effectively improves outcome 
prospects through various channels (Fusar‐Poli, McGorry and Kane, 2017):  (1) 
reduced time from onset of symptoms until first treatment; (2) improved treatment 
response; (3) improved well-being including caring relatives; (4) treatment of 
comorbidities; (5) secondary prevention of illness progression. Furthermore, the cost-
17 
 
effectiveness of EIP care has been demonstrated (Behan et al., 2015; Valmaggia et al., 
2015; Hastrup et al., 2013). In England, specialist mental health services such as EIP 
care are provided by mental health trusts. There are just over 50 mental health care 
trusts within the English NHS. Each trust covers a certain geographical area with a 
number of inpatient wards as well as community-based service teams. In the following, 
we will refer to mental health trusts as providers.  
 
1.2.2 Policy context 
Specialised EIP services have experienced great policy interest in the past two decades. 
But although they are well-established in many countries, availability of services and 
implementation standards are very heterogeneous between countries (Nordentoft and 
Albert, 2017) and access to services is falling behind its expectations (Anderson et al., 
2018). Surveys in countries such as Australia (Catts et al., 2010), Canada (Nolin et al., 
2016), the United States (Breitborde and Moe, 2017), and Italy (Cocchi et al., 2018) 
report insufficient progress in the nationwide implementation of EIP care. Service 
availability is mainly impeded by the lack of governmental funding, and explicit 
standards EIP services will be operating from. EIP provision is highly influenced by 
the local EIP network, including clinicians and front-line staff in mental health services 
that support the EIP idea (Cheng, Dewa and Goering, 2011). 
England is one of the few countries which has had a nationwide EIP implementation 
strategy from the early 2000s onwards. In 1999, the English government issued a 
National Service Framework for Mental Health which initiated the implementation of 
functional community psychiatric services including EIP teams (Joseph and 
Birchwood, 2005). By December 2004, fifty EIP services were expected to be 
implemented nationwide with the aim of providing access to specialist care for every 
young person with first-episode psychosis for the first three years of their illness. The 
strategy was accompanied with a considerable amount of funding and a detailed 
guidance about how EIP services were expected to be specified and operated. 
However, after initial funding, EIP provision began to decline and waiting times were 
increasing (Kirkbride et al., 2017; Marwaha et al., 2016). Against this backdrop, the 
English government introduced the first waiting time target in mental health history 
(Department of Health, 2014a). From April 2015, 50% of patients being referred to an 
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EIP service were expected to wait no longer than 14 days from referral to treatment 
(NHS England, 2015). Referrals may come from any internal or external source (e.g. 
other mental health service, inpatient ward, prison, general practitioner, school, or self-
referral). A £40 million funding package was provided to support its implementation. 
The target is planned to be raised to 60% by 2020/21 and within the following years, 
all mental health services shall be affected by a similar target. Since 2000, England 
continuously focused on setting maximum waiting time targets in order to improve 
access to various areas of health care such as first outpatient appointments, elective 
inpatient treatment or routine cardiac surgery (Willcox et al., 2007). Often combined 
with substantial penalties for failing providers, they have been shown to be effective 
in reducing waiting times (Besley, Bevan and Burchardi, 2009; Propper et al., 2008; 
Bevan and Hood, 2006). To date it is however unknown whether a comparable target 
within the mental health context can be similarly effective. 
 
1.2.3 Theoretical framework 
Queuing theory provides an overall theoretical framework of why waiting times are 
prevalent in publicly funded health systems with zero prices. Queues for health care 
emerge for three main reasons (Culyer and Cullis, 1976): (1) the price of health care is 
below the market clearing level and thus causes an excess in demand; (2) demand for 
health care is stochastic; (3) patients have preferences about when to be treated. 
Queues can serve as a rationing instrument as the price for health care becomes the 
opportunity cost of time spent waiting (Martin and Smith, 1999). However, waiting 
time as discussed in this thesis does not require patients to queue in person. Once 
referred to a specialist service, one is free to use the time of waiting for anything else 
without the costs of wasted time. Lindsay and Feigenbaum (1984) developed the 
theory of queuing by list which explains why waiting times impose costs to patients 
even without wasted time. The model introduces an exponential demand decay rate 
which reflects the fact that a good or service received later is worth less today. When 
waiting for health care, patients may experience pain, anxiety, disability, and 
restrictions in their daily activities. A patient’s health status may deteriorate during the 
time of waiting and will make the awaited treatment less likely to be successful - 
particularly if waiting affects the patient’s ability to benefit from treatment. The 
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negative impact of waiting time can be also long-term as the deteriorated condition of 
the patient due to waiting may take longer to recover or will not be reversed at all after 
a critical waiting time has passed (Koopmanschap et al., 2005). Given the fact that 
waiting time imposes deadweight losses, it can be welfare improving to impose 
different waiting times for different patient groups (Gravelle and Siciliani, 2009; 
Gravelle and Siciliani, 2008). Which groups to prioritise depends on where the total 
cost of waiting will be reduced through the prioritisation.  
A second theoretical foundation for this thesis builds on the principal-agent economic 
model in the presence of asymmetric information. It motivates the analysis of provider 
responses to performance targets. The policymaker (principal) wishes to maximise 
some welfare function that depends on an unobserved health outcome which can be 
influenced by the provider (agent)’s level of effort. Due to asymmetric information, 
the policymaker can only imperfectly observe the provider (agent)’s effort to achieve 
the unknown health outcome (Goddard, Mannion and Smith, 2000). The waiting time 
target serves as a quantifiable measure to approximate the provider’s performance. 
Target performance is linked to some kind of financial or non-financial reward (or 
penalty) which incentivises the provider to achieve a good target performance. 
However, providers act in a complex environment with multiple stakeholders, budgets, 
and objectives that need to be served (Besley and Ghatak, 2003). Being under pressure 
to meet different objectives with limited resources, the provider may also take 
unintended actions to improve target performance at the expense of worse performance 
in non-targeted areas (Smith, 1995). 
1.3 Thesis structure 
The remainder of this thesis is structured into four main chapters and a concluding 
chapter. Chapter 2 investigates whether there exist inequalities in duration of untreated 
psychosis associated with socioeconomic deprivation in a national cohort of first-
episode psychosis patients in England. Chapter 3 contributes to the still ongoing debate 
whether longer waiting time for treatment leads to poorer health outcomes. We explore 
the impact of waiting time for specialist treatment on HoNOS outcomes for EIP 
patients in England. Chapters 4 and 5 focus on provider responses to the newly 
introduced EIP waiting time target. In chapter 4, we explore providers’ changes in 
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behaviour in anticipation of the EIP target policy. Looking at the years prior to the 
policy, we examine whether the public announcement of the policy was associated 
with changes in waiting time as well as unintended changes in prioritisation patterns. 
We further explore whether providers tried to game the target by making performance 
look better than it actually was. Research in chapter 5 aims to measure the causal effect 
of the EIP target policy in reducing referral-to-treatment waiting time after the first six 
months of its implementation using a difference-in-difference design. To validate our 
approach, we also test whether there have been any spill-over effects from the targeted 
EIP services towards the non-targeted standard community mental health teams. 
 
1.4 Data sources, main measures, and methods 
1.4.1 Mental Health and Learning Disabilities Dataset (MHLDDS) 
All research presented in this thesis uses the administrative Mental Health and 
Learning Disabilities Dataset (MHLDDS) as the main data source. The MHLDDS 
contains patient-level data on any mental health related treatment in hospitals and 
community settings within the English NHS (NHS Digital, 2017). Its first version, 
named Mental Health Minimum Dataset, was introduced in 2000 and became 
mandatory in 2003 for all providers of specialist mental health services funded by the 
NHS. From September 2014, the dataset was renamed Mental Health and Learning 
Disabilities Dataset following the inclusion of people in contact with learning 
disability services. Data collection paused in November 2015 in order to introduce a 
new version, the Mental Health Services Dataset, from April 2016. For the purpose of 
this thesis, data were available from April 2011 to November 2015. In the following 
we consistently use the name MHLDDS to refer to any of the corresponding versions. 
A main measure of disease severity within the MHLDDS is the Health of the Nations 
Outcomes Scale (HoNOS) (Wing, Curtis and Beevor, 1999; Wing et al., 1998). We 
will discuss HoNOS in more detail in chapter 3 where we use it as our main outcome 
measure to estimate the effect of waiting time on treatment outcomes. Next to the total 
HoNOS score, the HoNOS item 6 is of particular interest for our analyses as it 
measures problems with hallucinations and delusions. As such it allows us to measure 
symptom severity for psychotic patients. Moreover, the MHLDDS provides rich 
21 
 
information on patient demographics which we use to control for patient case mix in 
all chapters. To enrich information on the patient’s socioeconomic background we use 
the lower super output area (LSOA) of the patient’s place of residence in our data and 
link it to the Index of Multiple Deprivation (IMD) (McLennan et al., 2011). More 
detail will be provided in chapter 2 where the IMD is our main explanatory variable to 
explain socioeconomic inequalities in waiting time. In chapter 5, we further use the 
patient’s LSOA to calculate travel distances from the patient’s place of residence to 
the nearest EIP site postcode. Provider information within the MHLDDS is at the trust-
level with no information about the local community service site the patient was 
receiving care from. Therefore, we create a novel dataset including postcode 
information of all EIP sites within the English NHS. We will present the procedures 
of the data collection in chapter 5 where this information is used. 
 
1.4.2 Measuring and analysing waiting time 
Waiting time can be measured in various ways (Siciliani, Moran and Borowitz, 2014; 
Godden and Pollock, 2009). First, waiting time needs to be distinguished from the 
concept of waiting lists often published in official waiting time statistics. Waiting lists 
represent the number of patients waiting at a given point in time. As such they reflect 
a cross-sectional snapshot rather than the patient’s full waiting experience. Waiting 
time, in contrast, is longitudinal in nature and measures the time the patient spends on 
the list from being added until the start of treatment. It can only be generated 
retrospectively once a patient has finished waiting. 
Second, patients may face several waiting times during their care pathway which is 
illustrated for a first-episode psychosis patient in Figure 1.1. The most comprehensive 
waiting time concept specific to first-episode psychosis is the duration of untreated 
psychosis (DUP). DUP measures the time from the first onset of symptoms (1) to the 
start of treatment (4) thus it includes the period of help-seeking where no service 
contact has happened yet (Norman and Malla, 2001). A large body of literature mainly 
located in psychiatric outlets exists on measuring DUP, its predictors and its impact 
on patient outcomes (Penttilä et al., 2014). DUP is considered to be one of the key 
parameters in managing patients with psychosis. But is has also been criticised as the 
operative measurement varies widely across studies (Register-Brown and Hong, 
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2014). The date of onset needs to be reconstructed retrospectively and relies on the 
self-report of the patients or carers which may in turn be related to the patient’s severity 
of illness. 
 
Figure 1.1: Different waiting times along the patient pathway 
 
In the health economic literature, inpatient waiting time is most commonly used which 
measures the time from the specialist’s decision to treat (3) to the start of (inpatient) 
treatment (4) (Siciliani, Moran and Borowitz, 2014). It has been particularly applied 
in the investigation of the relationship between waiting time and treatment outcomes 
(Moscelli, Siciliani and Tonei, 2016; Nikolova, Harrison and Sutton, 2016). The 
measure’s advantage is that it is quite easy to derive when there are administered 
waiting lists that contain information on when the patient was put on the list and when 
treatment started. However, it may miss important parts of the patient’s waiting 
experience – particularly if the inpatient treatment only follows a range of other 
primary care and outpatient treatments in the community as in the case of first-episode 
psychosis. Referral-to-treatment waiting time, therefore, considers the additional 
waiting time from referral (2) to the first specialist assessment (3) and adds it to the 
inpatient wait. This concept has gained increased attention by policy makers since the 
perception that an emphasis on inpatient waits may come at the cost of longer waits 
for a specialist assessment (Marques et al., 2014; Kelman and Friedman, 2009). Its 
measurement requires, however, to relate a referral to the treatment the referral is 
directed to. This challenges most existing data structures as referrals will be likely to 
happen in a different care sector (e.g. primary care or social care agency) then the 
treatment (e.g. secondary mental health service). 
(1) Onset of 
symptoms
Help-seeking period
(2) First contact
(Referral)
(3) Decision to 
treat
Specialist 
treatment
t
(4) Start of 
treatment
(5) End of 
treatment
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To date there exists no waiting time concept that is superior to all others. Each measure 
comes with its strengths and limitations and has to be chosen in accordance with the 
purpose of the analysis. This research aims to investigate a broad range of different 
waiting time concepts to overcome each single measure’s limitations and provide 
different perspectives of the concept. None of these measures can be observed directly 
in our data. However, we develop methods to estimate waiting times based on the 
procedures outlined below. Table 1.1 provides an overview of how we defined the 
relevant measurement points along the patient pathway based on Figure 1.1 in our data. 
The MHLDDS contains information on a patient’s first-episode psychosis which we 
make use of to calculate DUP in chapter 2. We use the emergent date of the first-
episode psychosis as start point and the start of antipsychotic medication as end point 
of our DUP measure. In chapter 3, we use a variation of inpatient waiting time. We 
refer to it as specialist waiting time as the service to be waited for is a specialist 
treatment (EIP care) within the community rather than inpatient treatment. We 
measure the time from the start of EIP care to the assignment of a care coordinator. As 
outlined before, the care coordinator plays a key role in the delivery of EIP care and is 
responsible for implementing a care plan concordant with the treatment guidelines of 
the National Institute for Health and Care Excellence (NICE). Hence, we assume that 
once a care coordinator is assigned the patient will receive a relevant care package. 
This same endpoint is also used in chapters 4 and 5 were we estimate referral-to-
treatment waiting times in accordance with the EIP waiting time target policy. The 
difference is the start point which requires one to identify the relevant referral. 
Referrals within the MHLDDS cannot be directly linked to the service they were 
directed to. We used a number of measures to identify the referral directed to the 
relevant EIP episode. The MHLDDS defines care spells which are overarching and 
continuous periods of time a patient spent in the care of a single or multiple healthcare 
providers (Monitor, 2015). We considered all care spells that started within the study 
period and where the patient’s first team episode was with an EIP service. We 
identified referrals that initiated the care spell (i.e. happened before the start of the 
spell). Referrals could have been received from multiple sources, including primary 
and secondary care providers, other tertiary mental health or social care providers, 
agencies within the justice system and self-referrals. We considered only referrals that 
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were accepted by the receiving provider. If there were multiple accepted referrals 
before the start of a care spell, we used the referral closest to the start of the care spell. 
We defined acceptance onto the EIP caseload as the start of the EIP team episode 
which initiated the care spell. The first care coordinator the patient was assigned to 
following the EIP acceptance stopped the waiting time clock. 
 
Table 1.1: Measurement point definitions to estimate waiting times in the thesis 
Measurement points Definition in thesis MHLDDS variable used 
(1) Onset of symptoms emergent date of psychosis EMERPSYCHDATE 
(2) Referral date of referral REFRECDATE 
(3) Decision to treat start of EIP care episode STARTDATE if CLINTEAM = 
“A14” 
(4) Start of treatment date of care coordinator assignment STARTDATE if EPITYPE = 
“CCASS” 
Note: A14 is the code for the early intervention in psychosis team. CCASS refers to an episode of an assigned 
care coordinator. 
 
 
Econometric analysis is challenged when using waiting time as variable of interest for 
two reasons. First, waiting time has typical count data properties. It takes only positive 
integer values and is usually skewed heavily to the right as it contains a large 
proportion of zero or very short waiting patients but an extensive right tail of a few 
very long waiters (Jones et al., 2013). One way to solve this is to bin waiting time in 
several categories such as short (< 6 months) and long waiters (> 6 months). 
Thresholds for these categories are, however, often chosen arbitrarily. Another 
common approach is to use transformations of waiting time (e.g. logarithm). In 
consequence, interpretation of results can no longer be made on the original scale. 
More recently, count data models have been used in the economic literature. For 
example, generalised linear models (GLM) have gained increased attention as they 
offer a high degree of flexibility in modelling mean and variance functions (Deb and 
Norton, 2018; Jones et al., 2016; Sinko et al., 2016). At the same time, they allow the 
interpretation of the dependent variable on its natural scale. We use GLM in chapters 
2 and 3 to exploit its advantages for our analysis. Second, waiting time can only be 
measured retrospectively, i.e. once a patient finished waiting (or started treatment). 
This means that patients still waiting at the end of the study period have to be excluded 
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in conventional regression analysis. Duration analysis can help to overcome this 
challenge as it accounts for the time in the study and prevents the need to truncate the 
sample (Rabe-Hesketh and Skrondal, 2012). We make use of duration analysis 
techniques in chapter 4 for these reasons. 
 
1.4.3 Limitations of the available data sources 
There are two limitations of the MHLDDS which shall be discussed here as they are 
relevant to the analyses in all of the following chapters. The first limitation is the 
identification of first-episode psychosis patients relevant to the study. Typically, when 
working with administrative data, relevant patients can be identified by their primary 
diagnosis which is based on the International Statistical Classification of Diseases and 
Related Health Problems code in its 10th version (ICD-10). In the mental health 
context however, diagnosis information is less informative. First, diagnosing a 
psychosis is complex and requires a long process of investigation and mutual exclusion 
of competing conditions (American Psychiatric Association, 2013; Williams and 
Doessel, 2001). Hence, a confirmed diagnosis may only be recorded once treatment 
commenced already. Second, a severe mental health diagnosis is still attached with 
considerable stigmatisation which is why clinicians tend to not diagnose patients to 
prevent them from “being labelled as insane” (Wykes and Callard, 2010). Third, the 
concept of first-episode psychosis is still lacking a precise definition and studies find 
their own ways to operationalise the concept (Breitborde, Srihari and Woods, 2009). 
In consequence, we apply a number of selection criteria used in previous studies to 
identify relevant patients (Kirkbride et al., 2017; Tsiachristas et al., 2016): (1) 
schizophrenia diagnosis (ICD-10 F.20-F.29); (2) received treatment by an EIP team; 
(3) reported problems with hallucinations and delusions (HoNOS item 6 > 0), or (4) 
allocated to the first-episode psychosis mental health care cluster2. The detailed 
methods of the sample selection will be presented in each chapter respectively. 
                                               
2 Mental healthcare clusters are reference groups used to group service users with similar needs and 
problem severities related to their mental health within the English NHS. There are 20 clusters each of 
which describes a particular type, combination and severity of needs. Similarly, to the idea of health 
resource groups (HRGs) in the acute physical health context, mental health care clusters can be 
combined with a fixed price to form a system of prospective payment for mental health services 
(Department of Health, 2013). However, only a handful of providers have adopted this payment system 
to date (Jacobs et al., 2018). 
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The second limitation to be highlighted is related to data completeness and data quality 
in the MHLDDS. Data quality has improved considerably over the first years of data 
collection. However, not all variables of interest for us are mandatory for providers to 
report and hence data missingness is an issue. For categorical explanatory variables in 
our regression models, we used the missing-group method suggested by Cohen and 
Cohen (1975) to deal with missing information. That is, we created a separate group 
for patients with missing values. This approach allows us to use all available 
information and avoids the risk of selection bias by dropping subjects for which 
missing information is not random as well as lower power by the considerable 
reduction in sample size. In cases where information was missing on the main 
explanatory variable of interest, we followed the complete-case approach by dropping 
patients with missing values from the analysis: In chapter 2, we excluded patients with 
missing information regarding the onset of psychosis date variables which were 
required to measure DUP. In chapter 3, patients with a missing HoNOS rating at the 
end of the 12-month follow-up had to be excluded. We discuss the potential impact of 
these procedures on our results in the corresponding chapters. In general, missing data 
may be indicative of the quality of provider coding practices which in turn may be 
associated with the provider’s performance regarding patient waiting times and 
outcomes. Waiting times in return are also known to vary across providers due to 
supply factors such as the availability of staff, infrastructure, and other resources as 
well as regional demand factors such as overall health of the population. We therefore 
control for provider heterogeneity in all our models using either provider fixed effects 
(chapter 2, 3, and 5) or stratification by provider (chapter 4). 
 
1.5 Contribution to research 
This thesis makes substantial contributions to the existing evidence base in a number 
of ways. It provides the first comprehensive and rigorous analysis of waiting times for 
nationally representative first-episode psychosis patient samples in England using 
large administrative data. The policy maker’s neglect of the importance of mental 
health over many years is also mirrored in a lack of empirical evidence in the health 
economic literature. To date the majority of studies analysing aspects of access to care 
for people with mental illnesses have a more clinical or epidemiological focus and 
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often rely on simple correlations without controlling for any confounding. Waiting 
time is mostly just a side aspect rather than the main focus of research.  
The lack of health economic studies in the area of mental health is closely linked to 
the lack of available data. Most studies in the psychotic literature are based on 
observational data derived from epidemiological field cohorts such as the National 
EDEN prospective cohort study (Marshall et al., 2014) or the Aetiology and Ethnicity 
of Schizophrenia and Other Psychoses (AESOP-10) study (Morgan et al., 2014). 
Cohort data rely on small sample sizes in a limited geographical catchment area and a 
limited number of providers. Most cohort studies are correlational only without aiming 
for causal inferences. This research overcomes this problem by using a unique, large, 
administrative dataset. It not only allows us to build a nationally representative patient 
and provider sample, but it also helps us to appropriately risk adjust in regression 
analyses thanks to the rich information of disease-related as well as demographic 
patient variables. Unlike most other administrative datasets, we are able to use 
information on both inpatient care as well as care taking place within the community. 
Since the main focus of EIP care is to keep patients within the community and prevent 
costly inpatient admissions, this is crucial to our analysis. 
This thesis further presents the first attempts to measure waiting times for first-episode 
psychosis patients using the MHLDDS. The dataset in its current version is not 
designed to directly derive waiting times which is one more reason why evidence in 
this area is scarce. We develop procedures to estimate waiting times in a number of 
ways and critically appraise each measure’s advantages and limitations. We move 
beyond the well-established psychosis-specific measure DUP and analyse waiting 
times that are mainly induced by delays within the health care system which is of 
relevance for policy makers. We are also the first to create evidence on the regional 
distribution of EIP care availability and distances patients have to travel to access EIP 
care.  
Moreover, our work extends existing evidence with regard to methodological aspects. 
We use generalised linear modelling to appropriately account for the skewness in 
waiting time and quantile regression to analyse waiting time along the entire 
distribution. Further, we apply duration analysis to overcome the challenge of right 
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censoring in waiting time studies. To evaluate the effectiveness of the EIP waiting time 
target, we make use of quasi-experimental methods. Difference-in-difference designs 
are well established in the analysis of waiting time targets. However, most analyses 
rely on country-level comparisons without appropriately controlling for patient case 
mix and different institutional settings. We add to this evidence by conducting 
difference-in-difference analysis at the patient level. 
The research presented spans across various areas of health policy analysis and is thus 
of potential benefit for policymakers from different angles. We provide insights into 
whether socioeconomic determinants contribute to the unequal distribution of waiting 
times. Policymakers can draw conclusions as to which patients are potentially 
disadvantaged when accessing specialist services and develop strategies to target these 
patient groups before others. We also add to the understanding of whether delayed 
access to mental health services is linked to patient outcomes. In doing this, we are 
one of the first to use the routinely collected HoNOS to measure outcomes. 
Policymakers can more likely justify investments for policies that aim to reduce 
waiting times if outcome prospects can be improved by shorter waiting times. We use 
HoNOS as a non-psychosis specific outcome measure which will further foster 
comparisons across studies of different mental health conditions in the future. Further, 
this research offers evidence on the responsiveness of mental health providers towards 
performance measures. As such it translates well established evidence and experience 
from the physical health area to the mental health context which entails a separate 
group of providers acting in a different incentive system. We provide the first evidence 
on the effectiveness of the newly introduced EIP waiting time target. We do not only 
uncover the intended effects in terms of reduced waiting times but also look at potential 
unintended consequences in non-monitored performance outcomes as well as non-
targeted service areas. Results can aid the prospective development of the waiting time 
targets in other mental health service areas and its adaptation to other countries.  
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2. Chapter: Socioeconomic inequalities in duration 
of untreated psychosis 
____________________________________________________________________ 
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2.1 Introduction 
Equitable access to care is one of the corner stones of modern health care systems with 
universal access. However, the existence of a socioeconomic gradient in accessing 
health care has been proven in many countries and various areas of physical health 
care (Cookson et al., 2016; Siciliani, 2016; Abasolo, Negrin-Hernandez and Pinilla, 
2014; Kaarboe and Carlsen, 2014; Monstad, Engesæter and Espehaug, 2014; Johar et 
al., 2013; Laudicella, Siciliani and Cookson, 2012; Arnesen, Erikssen and Stavem, 
2002). The relationship can differ depending on the type of health care. For example, 
low-income individuals and ethnic minorities have been shown to use secondary care 
to a lower but primary care to a higher extent (Morris, Sutton and Gravelle, 2005). 
Little is known about the extent to which socioeconomic status plays a role in 
accessing specialist mental health care. This chapter aims to empirically investigate 
inequalities in DUP by socioeconomic deprivation for a national first-episode 
psychosis sample in England.  
In its mental health policy strategy the English Department of Health outlined its 
ambitions to not only make services available but also overcome inequalities around 
service usage (Department of Health, 2014a). DUP – measuring the time from the first 
onset of psychotic symptoms to the initiation of treatment (Norman and Malla, 2001) 
– is a key measure of access to care for first-episode psychosis patients. A growing 
body of evidence shows that a long DUP is associated with poorer symptomatic 
outcomes, reduced chances of recovery, poorer social functioning and less treatment 
engagement (Doyle et al., 2014; Penttilä et al., 2014; Tang et al., 2014; Marshall et al., 
2005; Perkins et al., 2005). Since DUP is widely accepted as a modifiable risk factor 
in first-episode psychosis, plenty of studies have focused on investigating the 
determinants contributing to a longer DUP. Mostly studied were factors such as 
migration status, ethnicity, age at onset, gender, and history of substance abuse 
(Apeldoorn et al., 2014; Broussard et al., 2013; Cascio et al., 2012; Morgan et al., 
2006b). Only few studies looked into variables of socioeconomic deprivation and its 
impact on DUP. There is, however, some evidence that suggests the existence of a 
socioeconomic gradient (O'Donoghue et al., 2016). DUP is composed of two 
components: (1) delays due to individual help-seeking; and (2) delays within care 
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services (Birchwood et al., 2013). Both aspects may influence DUP differentially 
depending on the level of socioeconomic deprivation. First, DUP is associated with 
fewer social interactions, limited coping skills, unemployment, and less family 
involvement (O'Donoghue et al., 2016; Poyraz et al., 2015; Morgan et al., 2006a; 
Drake et al., 2000). Relatives and friends play an important role in the help-seeking 
process and in engaging the patient to receive treatment (Fridgen et al., 2013; Hui et 
al., 2013). In more socioeconomically deprived areas this supportive social network 
may be less well established which contributes to longer DUP for those patients. 
Further, it has been shown that a lower degree of education contributes to a longer 
DUP (Hardy et al., 2018). Second, service provision in socioeconomically deprived 
areas may be less developed. Particularly in rural and remote areas, availability of EIP 
care is challenged which may further contribute to longer DUP (Cheng et al., 2014). 
Theoretically, the notion of socioeconomic inequalities in health care is motivated by 
the Grossman model which characterises health care as one input factor into the 
production process of health (Grossman, 1972). Patients need to invest time and other 
inputs such as diet, physical activity, or non-smoking behaviour in order to produce 
better health in future. So even with health care at zero prices, socioeconomically 
disadvantaged people may invest less in health as they are more time constrained due 
to worse living and working conditions and have less income to spend on a healthy 
lifestyle. Second, the ability to produce health even with given inputs depends on the 
individual’s level of education and the environment. People from socioeconomically 
disadvantaged backgrounds will more likely have to face less supportive social 
networks, poorer infrastructures, and reduced ability to navigate through a complex 
health care system in order to seek best quality of care. 
Most previous work in this field is limited to small regionally restricted samples with 
a small number of providers. Also, studies are mainly looking at correlations without 
adequately controlling for confounding factors. The work presented in this chapter will 
contribute to the existing literature in a number of ways. First, this is the first study 
that focuses on the relationship between DUP and socioeconomic deprivation in 
England. We measure deprivation at small area level using the Index of Multiple 
Deprivation which is a widely used and accepted measure in the analysis of 
socioeconomic inequalities in health and in particular with regard to waiting times 
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(Gutacker, Siciliani and Cookson, 2016; Siciliani, 2016; Laudicella, Siciliani and 
Cookson, 2012). Second, this is the first study to use administrative data to measure 
DUP which allows us to analyse a national cohort of first-episode psychosis patients 
and a large number of mental health providers from different regions in England. It 
further allows us to control for a rich set of possible confounding factors. Particularly, 
we control for the severity of hallucinations and delusions, and previous mental health 
service use. Third, we explicitly model non-linearity to account for the skewed nature 
of DUP using generalised linear modelling (Jones et al., 2016). Fourth, we look at the 
effect of socioeconomic deprivation on the whole distribution of DUP using quantile 
regression recently suggested in the literature (Guloksuz et al., 2016). 
 
2.2 Methods 
2.2.1 Data and measures 
This study uses secondary patient-level data from the MHLDDS (see section 1.4.1). 
We identified first-episode patients for our study if they had a record of the emergent 
or manifest date of the psychosis. Patients were included if both, their first-episode 
psychosis and their anti-psychotic treatment, started within the study period April 2012 
to March 2015. 
DUP is defined as the time from the onset of psychosis to the start of treatment 
(Norman and Malla, 2001). The majority of patients with psychotic disorders 
experiences a prodromal phase where the first noticeable change in behaviour takes 
place. First psychotic symptoms may occur during this phase but do not cross the 
diagnostic duration and severity thresholds of a psychosis. The time between the start 
of this prodromal phase and the start of anti-psychotic treatment is sometimes referred 
to as duration of untreated illness (DUI). The onset of psychosis is given once the 
psychotic symptom thresholds have been crossed. In this regard, the emergent date 
marks the start of first psychotic symptoms with required severity and the manifest 
date defines the time when symptoms have lasted for more than a week. These dates 
usually have to be assessed retrospectively by a trained clinician once the patient has 
first contact with a specialist mental health service. Assessment methods can vary 
between providers from clinical interviews, to generic psychosis assessment 
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instruments (e.g. the Positive And Negative Symptoms Scale) or instruments 
specifically used to assess DUP (e.g. the Interview for the Retrospective Assessment 
of the Onset of Schizophrenia). The interrater reliability of these instruments was 
found to be generally good with no substantial differences between the various 
instruments (Register-Brown and Hong, 2014). 
The definition of treatment start varies in previous DUP studies. Most commonly used 
end points were the first psychiatric hospitalisation and the first prescription of anti-
psychotic medication (mostly regardless of dose, duration, and compliance) (Register-
Brown and Hong, 2014; Norman and Malla, 2001). The NICE treatment guideline for 
schizophrenia recommends oral anti-psychotic medication in conjunction with 
psychological interventions as the preferred treatment options for first-episode 
psychosis (NICE, 2014). If patients want to try psychological interventions alone, 
providers are asked to advise that these are more effective when delivered in 
conjunction with antipsychotic medication. Hence, we assume that the majority of 
patients will receive medication. In contrast, not every patient necessarily gets 
hospitalised during the course of the illness. In fact, a shorter DUP may contribute to 
a reduced likelihood of an inpatient admission which is why hospitalisation may not 
be a good measurement end point. 
The MHLDDS provides the following information related to the onset of psychosis 
and treatment: the prodromal date, the emergent date, the manifest date, the date of 
anti-psychotic medication, and the treatment date (defined as medication taken for 
75% of the next month). We have no information on the clinicians that reconstructed 
the dates and which assessment instruments they used. Figure 2.1 compares median 
and mean durations in our data when using the different start and end points as 
introduced above. For the following analysis, we used the emergent date as start and 
the date of anti-psychotic medication as the endpoint to measure DUP. To increase the 
number of patients with observed DUP, we used the manifest as alternative start and 
treatment date as alternative end point if the emergent or medication date were 
missing.3 
                                               
3 This is why our final study sample is larger than the ones displayed in Figure 2.1.  
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Figure 2.1: Median (mean) days for three different definitions of duration of untreated 
psychosis (DUP) 
 
We measured socioeconomic status through the Index of Multiple Deprivation (IMD) 
2010 which captures deprivation at lower super output area (LSOA) level (McLennan 
et al., 2011). The IMD includes seven domains of deprivation (income, employment, 
health and disability, education, barriers to housing, crime, and living environment) 
which are measured by 38 different indicators. Domains are each weighted according 
to their perceived importance to calculate the overall index. Each LSOA is ranked, 
where a rank of 1 equals the most deprived and a rank of 32,482 equals the least 
deprived area. We derived quintiles of the rank based on the distribution in the general 
population to indicate the 20% least deprived to the 20% most deprived small areas in 
England. 
The severity of hallucinations and delusions is likely to impact a patient’s DUP as 
patients may lack insight into their illness, fear of being stigmatised, or not be able to 
attend appointments due to their condition (Compton et al., 2011). We used the 
HoNOS item 6 which focuses on problems with hallucinations and delusions to 
approximate the patient’s severity of condition (see sections 1.4.1 and 3.3). The item 
is evaluated on a scale between 0 (no problem) and 4 (severe to very severe problems). 
Prodrome Date
Emergent Date
(1) 97 (176) days, n = 534
t
(3) 15 (68) days, n = 534 
Manifest Date
(2) 21 (67) days, n = 624
Start of anti-psychotic 
medication 
Treatment date
(1) Duration of untreated illness: Median (mean) in days
(2) Duration of emergent psychosis: Median (mean) in days
(3) Duration of manifest psychosis: Median (mean) in days
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Since symptom severity is an important confounder in the relationship between DUP 
and socioeconomic background, we excluded patients for which HoNOS information 
was missing. For patients with a valid HoNOS score, ratings have been conducted at 
different points in time which vary considerably for patients. Ideally, we are interested 
in the HoNOS score before treatment started as at later stages the severity of symptoms 
is likely to be influenced by the treatment itself. Hence, we used the score closest to 
the psychosis start but within a maximum window of 30 days after the treatment 
started. We allow for this time window in order to reduce the number of patients that 
would be excluded from the analysis due to the HoNOS rating having been conducted 
later. We do not believe that allowing for this time window affects our results for two 
reasons. First, by definition the clinician is supposed to rate the patient’s condition 
over the past two weeks. If a score was taken 30 days after treatment start it gives a 
picture of the patient’s severity two weeks after treatment start. Second, symptom 
remission in psychosis is a long-lasting process taking several months and years. 
Keeping a patient stable is a common outcome at the early stages of treatment. Hence, 
we assume that the symptom severity at 30 days after treatment start is still a good 
indicator for the symptom severity before treatment started. Moreover, the patients’ 
ability to navigate themselves through the health care system might be influenced by 
previous experience of service contacts. Therefore, we considered additional variables 
of previous mental health service use not related to the first-episode psychosis. For 
each patient, we counted the number of mental health related professional contacts, 
outpatient episodes, and ward stays in the twelve months prior to the psychosis start.  
We included a set of patient characteristics: age at onset, gender, ethnicity, marital 
status, accommodation status, employment status, number of physical comorbidities, 
and number of mental comorbidities. Comorbidities were counted as the number of 
ICD-10 codes recorded as secondary diagnoses for each patient. ICD-10 codes starting 
with an “F” where categorised as mental illness comorbidities, while all others as 
physical comorbidities. Each patient characteristic was measured at the time of the 
psychosis start. We additionally controlled for the primary diagnosis group measured 
at the start of the anti-psychotic treatment to distinguish between affective and non-
affective psychoses.  
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2.2.2 Model and statistical methods 
We define DUP as the number of days elapsed between the emergence of the patient’s 
psychosis and the start of the first anti-psychotic prescription. Formally, the model is 
specified in Equation 2.1. 
Equation 2.1:  !"#$%& = ()*+% + (-*.$& + 	(0*1$%& + 2$ + 3& + 4$%& 
 !"#$%& is the DUP for patient 5 = 1,… , 9 living in LSOA : = 1,… , ; and being treated 
at provider < = 1,… , =. The socioeconomic status is represented by the vector +% 
which contains a factor variable for the quintiles of overall deprivation at LSOA-level. 
The vector .$& contains factor variables to account for severity, namely the HoNOS 
subscale and the variables of previous service use. The vector 1$%&  summarises the 
patient demographics. We included year dummies 2$ to eliminate any effects due to 
changes over time not being captured in the control variables and used provider fixed 
effects 3& to control for differences in DUP between providers. Previous literature has 
shown the importance of controlling for provider related differences in waiting times 
(Sharma, Siciliani and Harris, 2013; Laudicella, Siciliani and Cookson, 2012). 
Controlling for variations between providers by introducing provider fixed effects 
allows us to control for the fact that wealthier and better educated people may choose 
providers with shorter waiting times. As a result, all observed variation needs to be 
interpreted as inequalities within providers rather than between. The term 4$%& 
represents the idiosyncratic error. 
Both the Shapiro-Wilk test (Shapiro and Wilk, 1965) and the Shapiro-Francia test 
(Shapiro and Francia, 1972) strongly rejected the null hypothesis of !"#$%& being 
normally distributed. We accounted for the skewness of DUP by using GLM methods 
(Nelder and Wedderburn, 1972). GLM have been shown to be an adequate choice in 
typically skewed data such as waiting times (Deb, Norton and Manning 2017; Jones 
et al., 2016; Sinko et al., 2016; Jones, 2007). GLM allow the expectation of the 
outcome variable to be a function of the linear index of covariates (link function). At 
the same time, heteroskedasticity can be modelled explicitly by choosing a distribution 
family that appropriately defines the functional relationship between the variance of 
the outcome and its predicted value. Further, GLM permit predictions of the outcome 
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on the natural scale which avoids the problem of re-transformation and simplifies 
interpretation of results. 
We chose the link function and distribution family of the GLM estimations based on 
standard procedures suggested in the literature (Deb, Norton and Manning 2017; 
Jones, 2007). First, we compared the Akaike information criterion (AIC) (Akaike, 
1970) and the Bayesian information criterion (BIC) (Schwarz, 1978) after jointly 
choosing the link function and the distribution family. Both criteria favoured the log 
link and gamma distribution. Additionally, we performed a modified Park test (Park, 
1966) which confirmed the gamma distribution to fit the data best. Pregibon’s link test 
(Pregibon, 1980), the modified Hosmer-Lemeshow goodness-of-fit test (Hosmer and 
Lemeshow, 2005) as well as Ramsey’s Regression equation specification error test 
(RESET) (Ramsey, 1969) further confirmed the model specification. 
We used cluster robust standard errors for 31 provider clusters. To extend our results, 
we analysed the heterogeneous effects of socioeconomic status at different quantiles 
of the DUP distribution. Especially in the presence of extreme outliers, it can provide 
more accurate estimates (Guloksuz et al., 2016). Due to small sample sizes we could 
only estimate the effect of socioeconomic deprivation and unemployment on DUP 
without including further covariates.  
2.2.3 Sensitivity analyses 
We conduct a number of sensitivity analyses to test the robustness of our results. First, 
we test to what extent the start and end point definitions of our DUP measure 
influenced the results: (1) we use only the emergent and the prescription date as start 
and end dates (no substitution of manifest and treatment date), (2) we use the same 
DUP definition but include only observations that have a valid treatment date, (3) we 
calculate DUP with the end point being the treatment date only and compare results 
with and without provider fixed effects. Second, we test the results for the impact of 
potential outliers: (1) we restrict the sample to the ages 14 to 35 as the main target 
group for early intervention services, (2) we exclude patients with a DUP of zero as 
this may be an artefact in the data recording, (3) we exclude patients with a DUP longer 
than 2 years and 1.5 years respectively. Third, we use marital, accommodation, and 
employment status as alternative measures of socioeconomic status at the patient-level 
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and look at the differences compared to using our small-area measure or a combination 
of the two. 
 
2.3 Results 
2.3.1 Descriptive statistics 
We identified 1,368 patients with a valid psychosis start and treatment date within the 
study period (full sample). Six observations were dropped due to missing LSOA codes 
and 97 observations due to missing HoNOS scores. We further excluded 365 patients 
from the analysis if the HoNOS rating happened more than thirty days after the 
treatment start.  to account for the level of severity at the early stages of the psychosis. 
16 providers (22 corresponding patients) were dropped as they treated fewer than three 
patients. The final sample comprised 887 patients (65% of full sample) and 31 
providers (60%) (see Appendix A1 for more details). 
Table 2.1 summarises the demographic characteristics of the study sample and 
compares it to the full sample as well as to other recent first-episode psychosis studies. 
The cohort was on average 26 years old, predominantly male (65.6%), of White 
ethnicity (69.8%), and single (66.2%). Most patients lived in mainstream housing 
(70.9%), many were unemployed (31.3%) and diagnosed with schizophrenia (38%). 
There are no significant differences between demographic characteristics of the study 
sample and the full sample implying that there is no selection bias due to the exclusion 
of incomplete observations (see also Appendix A2). Further, our study sample appears 
to be comparable to other recent first-episode psychosis studies by Tsiachristas et al. 
(2016), O'Donoghue et al. (2016), Kirkbride, Stubbins and Jones (2012), Morgan et al. 
(2006a). 
 
 
39 
 
Table 2.1: Demographic characteristics of the study sample compared to the full sample and other first-episode psychosis (FEP) studies 
  Study sample Full sample Other FEP studies References 
Total number of observations (n) 887 1,368 831, 292, 357, 495 1,2,3,4 
Duration of untreated psychosis in days, median (mean, SD) 22 (73.8, 125.8) 21 (65.9, 115.5) 36 (406, 1036) 4 
Duration of untreated psychosis = 0, n (%) 112 (12.6) 192 (14.0) - - 
Total HoNOS score (range 0-48), mean (SD) 15.3 (6.7) 14.39 (7.1) - - 
Hallucinations and delusions (HoNOS 6, range 0-4), mean (SD) 2.33 (1.3) 2.11 (1.4) - - 
Patient age, mean (SD) 26.7 (10.09) 26.12 (10.54) 24.7 (4.62)* 1 
Gender - Male (%) 65.6 65.4 65.5, 66.2, 57.8 1,3,4 
Ethnicity - British White (%) 69.7 69.8 56.7, 79.1, 43.8 1,3,4 
Marital status - Single (%) 66.2 66.7 68.5, 72.5 2,4 
Employment         
Unemployed (%) 31.3 30.3 29.16, 50.0 1,3 
Employed (%) 21.8 19.7 12.24, 25.0 1,3 
Students (%) 17.3 18.7 9.96, 19.0 1,3 
Not known (%) 14.2 14.8 48.62, 2.0 1,3 
Accommodation         
Mainstream housing (%) 70.9 69.9 45.6 1 
Homeless (%) 9.4 8.8 4.4 1 
Institutionalised (%) 5.1 5.2 - - 
Not known (%) 13.6 15.0 42.3 1 
Diagnosis         
Schizophrenia (%) 38.0 37.0 44.9 2 
Affective disorders (%) 12.2 10.4 11.0 2 
Not known (%) 34.2 37.9 - - 
Note: Full sample includes all patients with a valid psychosis start date and a valid prescription date in the financial year 2012/13 - 2014/15. The study sample is 
based on the full sample and excludes observations with missing LSOA, missing HoNOS score (or HoNOS more than 30 days after treatment start), and providers 
where fewer than 3 patients were treated. "Institutionalised" includes accommodation with mental health or other care support or criminal justice, acute or long-stay 
healthcare facility, or sheltered housing. References: 1 = Tsiachristas et al. (2016), 2 = O'Donoghue et al. (2016), 3 = Kirkbride, Stubbins and Jones (2012), 4 = 
Morgan et al. (2006a). * Study sample was restricted to 16 to 35-year-old patients. 
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Figure 2.2 demonstrates the typically skewed distribution of our DUP measure. Most 
patients had a DUP smaller than 200 days. For a small proportion of patients DUP was 
between 200 and 400 days and very few patients waited longer than 400 days from 
onset of symptoms until start of medication. 
 
Figure 2.2: Distribution of duration of untreated psychosis 
In Table 2.2, all covariates included in the model are presented for the study sample in 
total and by socioeconomic deprivation quintile. There is an increase in first-episode 
psychosis patients as the level of deprivation increases. At least 71% of all providers 
in our sample treated patients from all five socioeconomic quintiles. We note that 
providers are counted multiple times if they treated patients from more than one 
socioeconomic quintile. The median DUP overall was 22 days (mean = 73.8 days). 
Patients from the least deprived quintile waited shortest followed by a clear increase 
in DUP with every deprivation quintile – with the exception of the most deprived 
quintile. On average, patients had mild to moderately severe problems with 
hallucinations and delusions according to their HoNOS score (mean = 2.33). We note 
that patients from the most deprived quintiles differ in a number of characteristics from 
the rest of the sample. Compared to the study sample, they are more likely to be single, 
unemployed, homeless, and in contact with mental health services before the 
psychosis. The sample is distributed across all nine English regions with the largest 
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proportion of patients from the South East (25.7%) and the smallest proportion from 
the North East (0.3%) (see Appendix A3).4 
                                               
4 Please note that variations across regions may also be due to different incidence rates or age 
distributions in the general population. 
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Table 2.2: Distribution of patients, providers, and patient characteristics by socioeconomic status 
  Study sample Least deprived 2nd least deprived 3rd least deprived 4th least deprived Most deprived 
Number of patients, n (%) 887 (100) 145 (16.3) 142 (16.0) 180 (20.3) 191 (21.5) 229 (25.8) 
Number of providers, n (%) 31 (100) 22 (71) 23 (74) 29 (94) 24 (77) 25 (81) 
Duration of untreated psychosis,        
median (mean) 
22 (73.8) 14 (46.3) 21 (75.2) 25.5 (80.5) 34 (100.3) 20 (62.8) 
Disease severity, mean (SD):       
Total HoNOS score (range 0-48)      15.4 (6.7) 15.0 (6.5) 15.2 (6.9) 15.0 (6.5) 15.9 (6.8) 15.6 (6.8) 
Hallucinations and delusions (HoNOS 6, 
range 0-4) 
2.3 (1.3) 2.2 (1.4) 2.3 (1.3) 2.4 (1.3) 2.3 (1.3) 2.5 (1.3) 
Mental health service use, mean (SD): 
      
Number of service contacts 2.8 (8.6) 2.8 (8.1) 2.3 (9.4) 2.3 (6.9) 2.8 (9.5) 3.3 (8.9) 
Number of outpatient episodes 0.09 (0.4) 0.14 (0.5) 0.05 (0.3) 0.7 (0.3) 0.07 (0.3) 0.10 (0.6) 
Number of ward stays 0.09 (0.4) 0.06 (0.3) 0.08 (0.5) 0.09 (0.4) 0.09 (0.5) 0.14 (0.5) 
Number of physical comorbidities 0.01 (0.1) 0.01 (0.1) 0.02 (0.2) 0.01 (0.1) 0.01 (0.1) 0.2 (0.1) 
Number of mental comorbidities 0.02 (0.2) 0.01 (0.1) 0.01 (0.1) 0.01 (0.1) 0.04 (0.3) 0.01 (0.1) 
Patient characteristics:       
Patient age, mean (SD) 26.7 (10.1) 28.0 (14.1) 28.8 (13.4) 25.5 (9.0) 26.5 (11.1) 25.8 (7.4) 
Male (%) 65.6 65.5 59.9 67.8 62.3 70.3 
British White (%) 69.7 78.6 78.9 68.3 68.1 61.1 
Single (%) 66.2 56.6 57.8 63.9 71.2 75.1 
Employed (%) 21.8 26.9 30.3 20.6 23.0 13.1 
Unemployed (%) 31.3 21.4 30.3 28.3 27.2 44.1 
Students (%) 17.3 25.5 16.2 14.4 18.6 13.5 
Long-term disabled (%) 8.1 6.2 4.9 8.9 8.9 10.0 
Other employment (%) 7.3 9.0 5.6 8.9 7.3 6.1 
Mainstream housing (%) 70.9 84.8 74.7 69.4 71.7 60.3 
Homeless (%) 9.4 3.5 7.0 11.1 6.3 15.7 
Institutionalised (%) 5.1 2.8 5.6 1.1 7.3 7.4 
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  Study sample Least deprived 2nd least deprived 3rd least deprived 4th least deprived Most deprived 
Schizophrenia diagnosis (%) 38.0 31.1 26.8 41.7 41.4 43.7 
Affective disorder diagnosis (%) 12.2 13.8 17.6 6.7 12.6 11.8 
Substance abuse (%) 7.9 5.5 9.2 6.7 6.8 8.3 
Financial year 2012/13 (%) 33.2 34.5 33.1 34.4 36.7 28.4 
Financial year 2013/14 (%) 40.0 40.7 41.6 34.4 42.4 41.1 
Financial year 2014/15 (%) 26.8 24.8 25.4 31.1 20.9 30.6 
Note: Categorical variables may not sum up to 100% as categories of missing values are not presented. The number of providers refers to those that treated at least one 
patient from the given socioeconomic quintile, providers can be counted more than once if they treated patients from more than one socioeconomic quintile. Service contacts, 
outpatient episodes and ward stays refer to mental health related service use in the twelve months prior to the psychosis start. 
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2.3.2 Estimation results 
Estimation results from Table 2.3 confirm significant variations in DUP by 
socioeconomic deprivation for the first four deprivation quintiles (least to fourth least 
deprived). Patients in the second least deprived quintile have a 35.5 day longer DUP 
than patients from the least deprived quintile. Patients from the third and fourth least 
deprived quintiles face a DUP that is 24 and 31 days longer than the patients’ DUP 
from least deprived neighbourhoods. The most deprived quintile has a negative 
coefficient indicating a slightly shorter DUP for patients from most deprived areas 
compared to the least deprived quintile. However, the result is not statistically 
significant. Experiencing very severe problems with hallucinations and delusions has 
a significant impact on DUP. But different to what would be expected, patients 
suffering from severe hallucinations and delusions wait 21 days shorter than patients 
having no problems at all. Negative coefficients for moderately severe problems and 
minor problems indicate the same severity gradient in DUP, however the estimates are 
not statistically significant. This may indicate some effective prioritisation as patients 
being most severely affected receive treatment first. However, if this is the case then 
prioritisation is only effective for the very severely affected but not the patients with 
moderately and mildly severe problems. The observed effect may also be explained by 
the fact that the severe symptoms led to a quicker identification of the psychotic 
condition and motivated patients or carers to seek specialist help earlier.  Mental health 
professional contacts in the twelve months prior to the psychosis start, significantly 
reduce DUP by 36 days for one to ten contacts, and by 53 days for more than ten 
contacts compared to no contact at all. Having had an outpatient mental health 
consultant episode before the psychosis, did not show a significant effect on DUP. 
However, for patients with more than three previous ward stays related to a mental 
health condition, DUP was 60 days shorter. Patient numbers in the latter case were low 
which might have affected their statistical significance. Regarding other patient 
characteristics, we find a small effect of age on DUP. Further, there is a strong 
relationship between employment status and DUP. Patients being unemployed have a 
40 day longer DUP than employed patients. Also, students have a 30 day longer DUP 
compared to patients in employment. We could not find any significant inequalities in 
DUP with regard to gender, ethnicity, marital status, or accommodation status. 
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Table 2.3: Generalised linear model regression results 
                               Coeff. Std. Err. [95% Conf. Int.] dy/dx 
Socioeconomic status (ref.cat.: least deprived quintile)  
2nd least deprived quintile   0.459*** (0.131) [0.204 0.715] 35.5 
3rd least deprived quintile   0.331*** (0.099) [0.137 0.525] 23.86 
4th least deprived quintile   0.410* (0.183) [0.051 0.770] 30.89 
Most deprived quintile   -0.012 (0.155) [-0.315 0.291] -0.73 
Severity of hallucinations and delusions (ref.cat.: no problems)  
Minor problems   -0.147 (0.256) [-0.648 0.354] -11.95 
Mild problems   0.011 (0.193) [-0.367 0.389] 0.94 
Moderately problems   -0.169 (0.200) [-0.562 0.223] -13.61 
Severe problems   -0.271* (0.118) [-0.502 -0.040] -20.77 
Previous mental health service use (ref.cat.: zero service contacts, outpatient episodes, and ward stays)  
1-10 Service contacts   -0.526** (0.163) [-0.845 -0.206] -35.79 
>10 Service contacts   -0.929** (0.297) [-1.512 -0.347] -52.96 
1-3 Outpatient episodes   -0.713 (0.547) [-1.786 0.359] -40.10 
> 3 Outpatient episodes   -0.211 (0.635) [-1.456 1.034] -14.95 
1-3 Ward stays   -0.726 (0.435) [-1.578 0.127] -40.76 
> 3 Ward stays   -1.417** (0.519) [-2.434 -0.399] -59.83 
Patient demographics             
Age   -0.017* (0.009) [-0.034 -0.000] -1.34 
Female   0.059 (0.139) [-0.214 0.332] 4.63 
Ethnicity (ref.cat.: White or White British)             
Mixed ethnic group   0.326 (0.291) [-0.244 0.896] 28.71 
Asian or Asian British    -0.474 (0.244) [-0.952 0.004] -28.11 
Black or Black British   0.198 (0.201) [-0.196 0.592] 16.32 
Other ethnic group   -0.024 (0.277) [-0.566 0.519] -1.74 
Marital status (ref.cat.: single)             
Married/civil partner   -0.060 (0.136) [-0.326 0.207] -4.32 
Divorced/separated   -0.012 (0.314) [-0.628 0.603] -0.92 
Accommodation (ref.cat.: mainstream housing)          
Homeless    0.011 (0.217) [-0.414 0.435] 0.82 
Institutionalised   0.077 (0.247) [-0.408 0.562] 6.14 
Other accommodation   -1.081*** (0.223) [-1.518 -0.644] -50.89 
Employment (ref.cat.: employed)             
Unemployed   0.572*** (0.147) [0.283 0.860] 39.98 
Student   0.456* (0.203) [0.060 0.853] 29.98 
Long-term disabled   0.270 (0.244) [-0.209 0.749] 16.07 
Other employment   0.193 (0.415) [-0.621 1.006] 11.01 
Diagnosis (ref.cat.: schizophrenia)             
Substance abuse   -0.096 (0.223) [-0.5323 0.341] 13.12 
Affective disorders   -0.431 (0.246) [-0.913 0.050] -10.72 
Other diagnosis   -0.349 (0.276) [-0.891 0.192] -0.62 
Number of physical comorbidities   -2.137 (1.179) [-4.448 0.174] -75.00 
Number of mental comorbidities   -0.966 (0.517) [-1.980 0.048] -166.00 
Note: * p<0.05, ** p<0.01, *** p<0.001. Dependent variable is duration of untreated psychosis in days (DUP). 
Included are year dummies for 3 financial years and provider dummies for 31 providers. Marginal effects 
(dy/dx) are average marginal effects in days. For factor levels they present the discrete change from the 
reference category. Cluster robust standard errors in parentheses. 
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The graphical analysis in Figure 2.3 confirms that the effect of socioeconomic 
deprivation increases towards the higher quantiles of the DUP distribution. The 
coefficients for all deprivation quintiles – except the most deprived quintile - are 
smaller for the lower quantiles and increase along the DUP distribution. However, 
confidence intervals increase towards the end of the DUP distribution. Also, the effect 
of unemployment on DUP increases along the DUP distribution. 
 
Figure 2.3: Differential effects of socioeconomic deprivation and unemployment by quantile 
 
2.3.3 Sensitivity analyses 
Estimation results for the sensitivity analyses can be found in Appendices A4 to A7. 
Results were shown to be robust against different definitions of the DUP measure 
(Appendix A4). Using only the emergent and prescription date as start and end point 
did not seem to influence the results in a significant way. Also, using only observations 
with a valid treatment date did not change the gradient we observed. Appendix A5 
shows the results when using the treatment date as an alternative end point to calculate 
DUP. Again, the gradient remained similar with and without provider fixed effects. 
Restricting the sample to the ages 14 to 35 revealed an even stronger socioeconomic 
gradient compared to the full sample (Appendix A6). The socioeconomic gradient 
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decreased in magnitude and the second least deprived quintile lost significance as we 
exclude DUP that exceeds 1.5 years. This suggests that the socioeconomic gradient is 
stronger for patients with very long waits which was further confirmed when we 
excluded patients with a zero DUP. In the subsample of non-zero DUP patients, we 
observed a clear socioeconomic gradient. Excluding marital, accommodation, and 
employment status as patient-level measures of socioeconomic status from the 
regression, did not change the observed gradient (Appendix A7). Among the patient-
level variables, only employment had a significant effect which was similar to what 
we observed in the main model. The IMD quintiles seem to capture aspects of 
deprivation which are not included as separate covariates in the model. The most 
deprived quintile remained insignificant regardless of the specification.  
 
2.4 Discussion 
Since the prevalence of first-episode psychosis in more deprived neighbourhoods is 
found to be higher compared to less deprived areas (O'Donoghue et al., 2016), we 
asked whether the level of socioeconomic deprivation determines the patient’s help-
seeking behaviour and access to care. As well as being the first to investigate the 
relationship between DUP and socioeconomic deprivation in England, we were able 
to use a large sample from administrative data including a large number of mental 
health providers. Compared to other literature in the field we controlled for a rich set 
of covariates and applied statistical methods that adequately account for non-linearity 
in DUP. The results were robust in a number of sensitivity analyses. 
Our findings revealed significant inequalities regarding the level of socioeconomic 
deprivation. However, the effect was not linear across deprivation quintiles. Patients 
from the second least deprived quintiles had the longest DUP followed by patients 
from the fourth, and the third least deprived quintiles. For the most deprived quintile, 
differences were not statistically significant. Severe hallucinations and delusions and 
previous mental health service contacts not related to the psychosis significantly 
reduced the DUP. We did not find any significant inequalities in DUP with regard to 
age, gender, or ethnicity, which also confirms findings from previous studies (Ghali et 
al., 2013; Cascio et al., 2012; Large et al., 2008; Morgan et al., 2006a). We used a 
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comprehensive measure of socioeconomic status which captures various aspects of 
deprivation and is widely used in other literature on health inequalities. It should be 
noted that our measure is relative – not every person living in a highly deprived area 
will themselves be deprived and vice versa. At a patient level, marital, accommodation, 
and employment status could serve as proxies for the patient’s socioeconomic status. 
Results consistently indicate that employment status plays an important role in the 
length of DUP as has been found by other studies (Morgan et al., 2006a). Marital and 
accommodation status, however, did not explain any differences in DUP. Since we 
control for provider fixed effects and patient-level socioeconomic status in our model, 
the observed socioeconomic gradient in DUP is independent of provider 
characteristics and of the patient’s marital, accommodation, and employment status. 
 
2.4.1 Limitations 
It remains to be explained why the most deprived neighbourhoods have a shorter DUP 
than the other deprivation quintiles which contradicts findings of a clear 
socioeconomic gradient within the physical health literature (Siciliani, 2016). It may 
be that patients from most deprived neighbourhoods enter the system more often 
through the criminal justice system which may shorten their DUP, or they are more 
likely to be in contact with a general practitioner due to a poorer general health. 
Comparing most deprived patients with the rest of the sample revealed that they are 
more likely to be single, unemployed, and homeless. They were also more likely to 
have been in contact with mental health services before the psychosis which seems to 
support our theory. Further, this could represent a recall bias by the patient. The 
information on the emergence of the psychosis relies on self-report. Patients from more 
deprived neighbourhoods may systematically report their symptom history differently 
from others due to different educational levels or insight into the disease. Future work 
could aim to split DUP into two constituent parts in order to analyse the help-seeking 
period (from onset of symptoms to first referral) separately to see whether the effect 
of deprivation is different for this period. However, this requires the identification of 
the relevant referral which will lead to further restrictions in the selection of patients 
for the study with the given data. It is also unclear whether the interpretation of results 
would change considerably. 
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Our study focuses on DUP as one of the key parameters in managing first-episode 
psychosis patients. The importance of the DUP concept lies in its strong relationship 
to improved clinical outcomes while at the same time being a modifiable risk factor. 
The median DUP in our study was 22 days which is close to figures in some studies 
(Apeldoorn et al., 2014) but shorter compared to other studies reporting a median DUP 
of 50 to 120 days (O'Donoghue et al., 2016; Behan et al., 2015; Birchwood et al., 
2013). On the one hand, differences may be caused by our study period being limited 
to three years. Thus, we possibly exclude a number of DUP observations exceeding 
the study period. As we can only observe patients that finished waiting by the end of 
the study period, long waiting patients were also more likely to be truncated at the end. 
This may explain the significant decline in DUP across the three years of study. 
However, this may as well reflect that the increasing international awareness of early 
intervention contributed to an overall reduction in DUP. In this case, our study 
provides a much more recent measure of DUP as previous studies used data from 1995 
to 2011. If we are underestimating the DUP and it holds true that the socioeconomic 
gradient increases as the DUP increases, then we are likely to further underestimate 
socioeconomic inequalities. On the other hand, differences may be rooted in the 
measurement of DUP. Despite its strengths, the DUP concept has been criticised in the 
literature as its definition varies across studies (Register-Brown and Hong, 2014; Large 
et al., 2008; Singh, 2007). From our data, we are not able to provide information on 
the methods being applied to define the emergent date and what training the clinical 
teams received with regard to this. It is also very likely that methods varied between 
the providers in our sample. By applying provider fixed effects, we controlled for any 
measurement differences between providers. However, we were not able to capture 
any variation if clinicians within the same provider were recording dates differently. 
This would have influenced results if clinicians within a provider would record dates 
for patients from socioeconomically more deprived areas differently to those from less 
deprived areas. We defined the first antipsychotic prescription as the treatment start as 
it can be consistently defined within our dataset. But we appreciate that the prescription 
of medication does not necessarily imply that a patient has received effective treatment 
(Breitborde, Srihari and Woods, 2009). Using this approach introduces the problem of 
reliably defining effective treatment. To date, there is no agreed best way of measuring 
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DUP (Register-Brown and Hong, 2014). Assuming that effective treatment will be put 
in place from the first antipsychotic prescription, we are likely to underestimate the 
actual DUP and look at just a part of its full duration. We do, however, cover the period 
of help-seeking which is expected to be much more influenced by the patient’s 
socioeconomic background than the aspect of receiving effective treatment after the 
first service contact. Our results were also robust against changing the DUP endpoint. 
Nevertheless, future research should aim to address this limitation by establishing a 
DUP measure that goes beyond the traditional definition using for example the 
acceptance onto the caseload of an EIP service as the endpoint. This approach will 
allow the inclusion of patients who never received any anti-psychotic medication. 
Despite the policy relevance of DUP, the reporting of relevant data is not mandatory 
for providers. Hence, we cannot rule out that there is a bias in the composition of our 
sample as we may miss out first-episode psychosis patients not being reported by 
providers. We further had to exclude patients with missing HoNOS scores in a 
maximum 30-day window after treatment start in order to measure symptom severity 
as an important confounder. However, we see no reason to believe that patients with 
HoNOS ratings at later stages during treatment (which we excluded) are systematically 
different to our study sample in terms of their relationship between DUP and 
socioeconomic background. Overall, our sample proved to be comparable with first-
episode psychosis patient cohorts from other recent studies.  
Finally, any unobserved heterogeneity cannot be ruled out due to factors such as drug 
abuse, family history in psychosis, or patients’ social network. For example, there is 
evidence of interactions between age, gender, and cannabis use (Donoghue et al., 2014; 
Broussard et al., 2013). Also stigma-related processes have been found to influence 
help-seeking and service contact at early stages of psychotic disorders (Gronholm et 
al., 2017). Although HoNOS is a validated tool in the application of psychoses it might 
not capture all aspects of disease related severity. This could lead to an over- as well 
as underestimation of the effects of socioeconomic deprivation on DUP depending on 
whether hallucinations or delusions are more prevalent in certain deprivation quintiles. 
 
51 
 
2.4.2 Implications for EIP services 
DUP captures the complete waiting experience of the patient including time from first 
symptom to help-seeking, from referral to assessment, and from assessment to 
treatment. Therefore, we cannot distinguish between the patient’s and the care 
system’s contribution to the delay and factors are likely to interact with each other. 
However, socioeconomic deprivation is a contributing factor to a prolonged DUP 
independent of severity of hallucinations, previous service contacts, and patient 
demographics. Inequalities arise predominantly at the higher end of the DUP 
distribution. Policies to improve equitable access to care should therefore focus on 
preventing very long delays in treatment and target unemployed patients and students. 
Being known to mental health services for reasons other than psychosis seems to make 
it easier to access the system a second time regardless of the severity of the condition. 
Efforts aimed at shortening DUP should particularly target people that have not been 
in contact with any mental health professional in the past. For example, general 
practitioners or other health professional education campaigns could improve 
awareness of the signs of early psychosis and encourage them to refer patients 
promptly to specialist services (Lloyd-Evans et al., 2011). Also, information 
campaigns for young people and their families in schools or in mainstream media may 
contribute to a reduced stigmatising image of psychosis and will promote early help-
seeking (Connor et al., 2016). The decrease in DUP over the past years indicates that 
the awareness of its importance has increased. However, significant variations within 
providers remain and should be addressed further to reduce inequalities. 
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3. Chapter: The impact of waiting time on patient 
outcomes 
____________________________________________________________________ 
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3.1 Introduction 
Concerns about waiting times arise when cases are affected in which waiting time 
impedes the patient’s utility gain from treatment. But to date, little is known about 
delays within the mental health service system and their impact on outcomes. This 
chapter seeks to improve the understanding of the relationship between waiting times 
and patient outcomes in the context of EIP services in England. We investigate whether 
the time from acceptance onto the EIP caseload to the assignment of a care coordinator, 
not only leads to a deterioration in the patient’s condition while waiting but also 
impedes the patient’s ability to benefit from treatment up to twelve months after the 
start of treatment.  
The theoretical foundation builds the model of queuing by list (Lindsay and 
Feigenbaum, 1984) introduced in section 1.2.3. As waiting for a care coordinator does 
not require patients to queue in person, there are no opportunity costs in terms of time 
spent waiting in order to clear markets. But still, waiting times impose costs. The 
treatment received tomorrow is worth less today since the patient (and caring relatives) 
have to experience suffering and inconvenience of living with a disease. This negative 
impact can also be long-term if the deteriorated condition of the patient due to waiting 
increases time of recovery or will not be reversed at all after a critical waiting time has 
passed (Koopmanschap et al., 2005). In case of first-episode psychosis, the suffering 
can be significant and intervening early is critical to successful treatment as has been 
demonstrated in section 1.2.1. 
The distinct feature of EIP services is that treatment is delivered over several months 
or years and treatment intensity can vary from patient to patient. Further, recovery in 
psychosis is a long lasting process where keeping patients in a stable condition is 
considered a good outcome (Revier et al., 2015). Rather than looking at the outcomes 
immediately after a single treatment event as in previous literature, we look at patient 
outcomes after twelve months, incorporating treatment intensity during this time 
period. Our outcome measure, HoNOS, comes with a number of advantages for our 
analysis. Being clinician-reported, it provides a measure of patient outcome, 
independent of the patient’s subjectivity, which on the one hand is a desired dimension 
in patient-reported measures (Fitzpatrick et al., 1998) but may be challenging for 
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people with severe mental illness (Reininghaus and Priebe, 2012; McCabe, Saidi and 
Priebe, 2007). Previous work on waiting times using other outcome measures 
consistently found low to moderate effect sizes. It is however questionable whether 
effects that are statistically significant but small are also clinically relevant. We 
advance the analysis by estimating the impact of waiting time on a clinically reliable 
and significant change in HoNOS. While HoNOS is not specific to psychosis, it is 
routinely collected in administrative data which offers the potential to expand future 
analysis to other samples and mental health conditions in a comparable manner. As 
such, our work contributes to the literature discussing the feasibility and usefulness of 
routine outcome measures in general (Boswell et al., 2015) and for mental health 
conditions in particular (Tasma et al., 2017; Gilbody, House and Sheldon, 2003). 
 
3.2 Related literature 
Two strands of literature can be distinguished in the discussion of waiting times and 
outcomes. The first strand focuses on physical health conditions with most studies in 
the area of non-urgent surgical procedures such as hip and knee replacement 
(Nikolova, Harrison and Sutton, 2016; Quintana et al., 2011; Tuominen et al., 2010; 
Hirvonen et al., 2009; Tuominen et al., 2009; Braybrooke et al., 2007; Hirvonen et al., 
2007; Ho, Hamilton and Roos, 2000; Hamilton and Bramley-Harker, 1999; Hamilton, 
Hamilton and Mayo, 1996), or more urgent surgical procedures such as organ 
transplantation (Rauchfuss et al., 2013; Meier-Kriesche et al., 2000), and coronary 
artery bypass surgery (Moscelli, Siciliani and Tonei, 2016; Manji et al., 2013; Sari et 
al., 2007). Fewer studies investigate the relationship of waiting time with non-surgical 
treatments such as rehabilitation (Pedersen, Bogh and Lauritsen, 2017; Collins et al., 
2015), radiotherapy (Gupta et al., 2016; Seidlitz et al., 2015; Noel et al., 2012), or HIV 
treatment (Su et al., 2016). Results are inconsistent as to whether longer waiting causes 
worse chances of functional remission, recurrence, treatment adherence, quality of life, 
and mortality. Most of these studies use field data which are limited in sample size, 
number of providers, and covariates to control for confounders. More recently, studies 
have used administrative data to overcome some of these limitations. Moscelli, 
Siciliani and Tonei (2016) found that waiting for coronary bypass surgery did increase 
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the number of emergency readmissions but not in-hospital mortality. Nikolova, 
Harrison and Sutton (2016) analysed the impact of waiting for elective surgery on 
patient-reported outcomes. They found that a longer waiting time reduced health-
related quality of life for hip and knee replacement, but not for varicose veins and 
inguinal hernia. 
The second strand of literature focuses on the impact of treatment delays on outcomes 
regarding first-episode psychosis patients. The key measure of waiting time in this 
context is the DUP (see section 1.4.2). Penttilä et al. (2014) recently published a 
comprehensive review of 33 studies. Longer DUP was associated with more severe 
symptomatic outcomes and reduced remission rates with small to moderate effect 
sizes. Also, longer DUP correlated with poorer social functioning but not with 
employment or quality of life. Some recent studies looked at long-term effects of DUP 
on outcomes. In a 20-year follow-up, Cechnicki et al. (2014) found significantly 
deteriorated outcomes for the long DUP group (> 6 months) in terms of symptom 
recovery, social functioning, and employment. Tang et al. (2014) reported 
significantly higher symptom remission rates for the shorter DUP group after 
accounting for confounding factors in a 13-year follow-up period. Despite the quantity 
of studies, evidence remains limited, since studies tend to be small-scale with sample 
sizes between 23 and 776 patients using only a single or a few providers. Attrition rates 
ranged from 4 to 71% which could be a source of significant selection bias. Most 
studies are based on purely correlational methods or do not account adequately for the 
typically skewed nature of DUP (Marshall et al., 2005; Norman and Malla, 2001).  
Our work aims to bridge the gap between these two distinct strands of literature. We 
advance the literature on psychotic patients by using well established methods from 
physical health care and a large, nationally representative sample. Our waiting time 
measure moves beyond the traditional concept of DUP to overcome some of its 
limitations. At the same time, we advance the literature in the physical health context 
by looking at a different treatment regime characterised by multiple treatment events 
over a period of several months. This stresses the importance of treatment intensity 
which we include in the analysis. 
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3.3 Data and key measures 
We analyse a cohort of patients having a first EIP episode within the study period April 
2012 to March 2014 from the MHLDDS (see section 1.4.1). Patients were followed 
up for a period of twelve months. Figure 3.1 summarises the study timeline and 
measurement points. 
 
 
Figure 3.1: Study timeline with measurement points 
 
We choose a twelve-month follow-up period to investigate both whether waiting itself 
is associated with a worsening of the patient’s condition and whether the waiting 
impedes the patient’s ability to benefit from treatment. In both cases, waiting time may 
be endogenous. First, a deteriorated patient condition after waiting may not only be 
caused by the waiting itself but will also depend on the patient’s condition at the 
beginning of the waiting time. For example, if effective prioritisation is in place less 
severely affected patients may have longer waiting times but better outcomes as the 
initial severity level was lower. Second, the ability to benefit from treatment will not 
only depend on how long the patient waited for treatment but also on the treatment 
intensity during the twelve months of follow-up. Our strategy to encounter this 
endogeneity is to control for the initial level of severity at baseline as well as for 
treatment intensity during the follow-up period in our regression model.  
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Our outcome measure, HoNOS, is routinely collected by providers in our dataset 
(Wing, Curtis and Beevor, 1999; Wing et al., 1998). HoNOS is composed of twelve 
items covering the four sub-domains behaviour, impairment, symptoms, and social 
functioning (see Appendix A8). Each item is evaluated by a trained clinician on a scale 
from 0 (no problem) to 4 (severe to very severe problems) and contributes equally to 
the total score ranging from 0 to 48. HoNOS measurements are conducted at treatment 
start and during the course of treatment. This allows us to observe a baseline HoNOS 
score at the start of the EIP episode and a score at follow-up at the end of the twelve 
months (or at the end of the EIP episode if treatment ended before the follow-up). We 
use the baseline measurement to condition on pre-treatment severity. Further, we 
determine whether patients improved reliably and in a clinically meaningful way using 
the concept of reliable and clinically significant change introduced by Jacobson and 
Truax (1991) and applied to HoNOS by Parabiaghi et al. (2005).  
Inpatient waiting time, as commonly used in physical health papers, measures the time 
from the specialist’s decision to treat until the start of the inpatient treatment (Siciliani, 
Moran and Borowitz, 2014). We translate this concept to the context of psychosis by 
measuring the time from the patient’s acceptance onto the EIP caseload (decision to 
treat) to the assignment of a care coordinator (start of treatment). The care coordinator 
is the key requirement for effective treatment to be initiated (NHS England and NICE, 
2015). Previous papers found the relationship between waiting time and outcomes to 
be non-linear with outcomes deteriorating significantly at a waiting time longer than 
one month (Tang et al., 2014) or three months (Cechnicki et al., 2014). Therefore, we 
employ three different transformations of waiting time: (1) a log transformation of 
waiting time in days, (2) waiting time quintiles with an equal number of patients in 
each group, (3) waiting time intervals based on the thresholds typically used in the 
previous literature (0.5 to 3 months, 3 to 6 months, and 6 to 12 months). 
 
 
3.4 Methods 
3.4.1 The model 
We denote hijkl as the mental health status of the !th-patient, ! = 1,… ,&, who lives in 
small area 	(, ( = 1,… , ),  and receives treatment at provider *, * = 1,… , +, in the 
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financial year ,, , = 1,… , -. The health status is measured prior to treatment (ℎ/0123 ) 
and twelve months after treatment start (ℎ/0124 ) as the total HoNOS score. Formally, the 
model is specified in Equation 3.1.  
Equation 3.1: ℎ/0124 = 	56/012 + 8ℎ/0123 + 9:/012 + ;</012 + =>/012 + ?2 + @1 + A/012 
 6/012 represents the patient’s waiting time. The patient’s outcome prospects are likely 
to depend on the severity of the condition at baseline. We therefore condition on the 
baseline HoNOS score	ℎ/0123 . :/012	encompasses measures of treatment intensity. Over 
the 12-month follow-up period, treatment intensity will vary between patients but may 
also impact on the patient’s outcomes. We approximate treatment intensity by the 
following variables: (1) the number of days in EIP care, (2) the number of days in 
inpatient care, and (3) the number of mental health professional contacts until the end 
of follow-up (or end of EIP if earlier than follow-up). We further control for whether 
a patient was being detained under the Mental Health Care Act in that period since 
additional legislative requirements impose a higher level of treatment intensity. Since 
the degree to which each of the variables contributes to the patient’s recovery process 
is unknown, we include each of them with equal weight into the model. 
Patient characteristics that could impact both waiting time and outcomes are captured 
in </012. Alongside a range of demographic characteristics, we consider the patient’s 
socioeconomic background. At patient-level, we include accommodation and 
employment status. Further, we used socioeconomic deprivation based on the IMD 
measured at LSOA level (see section 1.4.1). Previous mental health service use 
represented by >/012	may be indicative of the patient’s ability to navigate through the 
system and take advantage of treatment options (and thus impact waiting times as well 
as outcomes). The vector includes the number of inpatient stays (in intervals 0, 1-2, 
>2), outpatient episodes (in intervals 0, 1-2, >2), mental health professional contacts 
(in intervals 0, 1-10, >10), and primary as well as secondary diagnoses within the 
twelve months prior to the EIP start. There are - unobservable year effects ?2 and + 
unobservable provider-level effects @1 for the 48 mental health trusts in our sample. 
The term A/012 represents the idiosyncratic error.  
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Our main coefficient of interest is 5 which measures the effect of waiting time on 
follow-up HoNOS outcomes conditional on the included covariates. We expect 
follow-up outcomes to deteriorate if waiting time increases both because the waiting 
itself causes a worsening in the patient’s condition and because the waiting impedes 
the patient’s ability to benefit from treatment. Therefore, we expect a positive 5 
indicating an increased (worse) follow-up HoNOS score. By the application of 
provider and time fixed effects, any variation has to be interpreted as within provider 
variation for a given year. 
Both the Shapiro-Wilk test (Shapiro and Wilk, 1965) and the Shapiro-Francia test 
(Shapiro and Francia, 1972) strongly rejected the null hypothesis of  ℎ/0124  being 
normally distributed. We used GLM regression methods (Nelder and Wedderburn, 
1972) to accommodate the skewness of the HoNOS distribution (see section 2.2.2 for 
a detailed discussion of GLM). GLM has been shown to be an adequate choice in 
typically skewed data. The modified Park test confirmed the Poisson distribution to fit 
the data best. Both the Pregibon link test (Pregibon, 1980) and the modified Hosmer-
Lemeshow goodness-of-fit test (Hosmer and Lemeshow, 2005) accepted the square 
root link function. The Ramsey RESET test (Ramsey, 1969) further confirmed the 
model specification. We used cluster robust standard errors for the 48 mental health 
trusts. 
3.4.2 Robustness checks 
We applied the same model from Equation 3.1 to each sub-domain of HoNOS resulting 
in four separate models for behaviour, impairment, symptoms and social outcomes. 
We estimated this system of linear equations as a Seemingly Unrelated Regression 
model without constraints to account for cross-model covariance which was supported 
by the Breusch-Pagan Lagrange multiplier test for error independence (Zellner, 1962). 
Further, we used the concept of a clinically significant and reliable change (see 
Appendix A9 for more details) to test whether the effect size we measure is of clinical 
relevance. We employed an ordered probit model to predict the impact of waiting time 
on the probability of a clinically significant and reliable change in the HoNOS score 
conditional on the same set of covariates as introduced above. 
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3.5 Results 
3.5.1 Descriptive statistics 
We identified 14,912 patients (full sample) having a first EIP episode and a care 
coordinator within the study period. We excluded 5,874 patients (39.4%) for which we 
could not observe two complete HoNOS records. Another 89 patients (0.01%) were 
excluded which were from providers treating fewer than 30 patients in the sample. The 
remaining study sample included 8,949 patients being treated within 48 mental health 
trusts. Table 3.1 compares key characteristics of the study sample with those from the 
full and the excluded sample. Our study sample was on average 25.8 years old, 
predominantly male, of White ethnicity, single, and diagnosed with schizophrenia. 
Most lived in mainstream housing within the most deprived neighbourhoods and were 
unemployed. The mean HoNOS score at baseline was 14.1. During the twelve months 
follow-up, patients in the study sample spent on average 18.8 days in inpatient care 
and experienced 42.5 contacts with any kind of mental health professional. 23.9% were 
sectioned under the Mental Health Care Act at least once during the time of follow-
up. Our study sample was on average two years older than the excluded patients and 
more likely unemployed. Most evident is that patients in the study sample were more 
likely to have been in contact with mental health services in the previous twelve 
months. Also, treatment intensity during the EIP care was higher for the study sample. 
Mean HoNOS scores at baseline were, however, very similar on all dimensions. 
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Table 3.1: Descriptive statistics 
  Full sample 
Study 
sample 
Excluded 
sample 
Number of patients 14,912 8,949 5,963 
Number of providers 55 48 55 
Patient demographics       
Patient age (mean) 24.9 25.8 23.6 
Male (%) 63.7 63.6 64.0 
White ethnicity (%) 73.4 72.1 75.6 
Marital status: Single (%) 88.5 87.1 90.9 
Schizophrenia diagnosis (%) 53.6 52.9 55.2 
Socioeconomic background       
Mainstream housing (%) 83.5 83.6 83.3 
Unemployed (%) 45.2 47.4 41.1 
Least deprived quintile (%) 9.9 9.3 10.8 
Most deprived quintile (%) 37.8 38.1 37.3 
Mental health service use (before start of EIP care)       
Zero health professional contacts (%) 31.7 18.3 52.0 
Zero outpatient episodes (%) 73.7 68.0 82.3 
Zero inpatient admissions (%) 69.2 60.2 82.8 
Zero Mental Health Care Act sections (%) 77.5 71.6 86.5 
HoNOS score at baseline (mean)       
Total (min 0, max 48) 14.0 14.1 13.5 
Behaviour score (min 0, max 12) 2.8 2.8 2.9 
Impairment score (min 0, max 8) 1.4 1.2 1.0 
Symptoms score (min 0, max 12) 5.7 5.7 5.5 
Social score (min 0, max 16) 4.4 4.4 4.1 
Treatment intensity (during EIP care)       
Days in EIP care (mean) 291.5 306.6 268.9 
Days in inpatient care (mean) 15.2 18.8 9.9 
Mental health professional contacts (mean) 36.6 42.5 27.7 
Mental Health Care Act sectioned (%) 20.5 23.9 15.3 
Note: HoNOS observations are reported for the total study sample and for n = 10,012 in the full sample 
and n = 1,063 in the excluded sample. 
 
Figure 3.2 visualises the distributional shift of HoNOS scores towards zero from 
baseline to follow-up. 
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Figure 3.2: Histogram of HoNOS scores at baseline and follow-up 
 
We note that not all patients spent the total follow-up time in EIP care. We therefore 
stratified the study sample by whether a patient finished EIP care before the end of 
follow-up (“short EIP” group, 31.4%) or not (“long EIP” group, 68.6%) and run 
analyses for the two subsamples separately. Table 3.2 shows that in all three samples, 
HoNOS decreased (improved) from baseline to follow-up by about 2 to 4 points. The 
short EIP group improved less in HoNOS but waited almost 15 days longer than the 
long EIP group. 
 
Table 3.2: Summary statistics of waiting time and HoNOS 
  Study sample Long EIP Short EIP 
  Mean SD Mean SD Mean SD 
Baseline HoNOS 14.1 6.8 14.1 6.8 14.0 6.8 
Follow-up HoNOS 10.6 7.0 10.1 6.9 11.7 7.2 
Waiting time 50.1 74.1 42.1 64.1 67.4 89.8 
Observations 8,949   6,135   2,814   
 
Figure 3.3 summarises several descriptive statistics of our main explanatory variable, 
waiting time. As expected, we find waiting time to be heavily left skewed with a 
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median of 20 and a mean of 50 days. Consequently, the largest proportion of patients 
was allocated to the waiting time interval of less than 0.5 months (panel (b)). We also 
see that taking the logarithm of waiting time helps to reduce a large amount of the 
skewness (panels (c) and (d)). 
 
Note: Dashed vertical lines in (a) indicate boundaries of each corresponding waiting time quintile. 
Figure 3.3: Descriptive statistics on waiting time 
 
Figure 3.4 visualises the distribution of HoNOS scores across the different waiting 
time intervals. Baseline HoNOS scores in panel (a) varied very little across intervals 
of waiting particularly for the first three intervals. While patients from the longest 
waiting interval had the lowest median HoNOS at baseline, they improved least at 
follow-up. Panel (b) shows that median follow-up scores decreased (improved) most 
at follow-up for the shorter waiting time intervals. 
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Note: Dashed horizontal line indicates the median HoNOS in the longest waiting times interval. 
Figure 3.4: Box plots for HoNOS scores by waiting time intervals 
 
3.5.2 Estimation results 
Table 3.3 displays the estimation results from the regression of Equation 3.1 including 
marginal effects (dy/dx). The estimates for the three different waiting time measures 
result from three independent regressions. Model (1) includes the whole study sample 
whereas models (2) and (3) look at long and short EIP patients respectively. We 
observe a significant but small effect of log waiting time on the HoNOS score twelve 
months after the EIP start for the total sample and the long EIP group. A 1% longer 
waiting time translates into an increase (worsening) in HoNOS by 0.20 to 0.27 points. 
The association between longer waiting and worse outcomes is only significant for the 
longest waiting quintile – however with a larger effect than the overall. Being in the 
longest waiting quintile is associated with a 0.78 to 1.27 points higher (worse) HoNOS 
compared to the shortest waiting time quintile. For long EIP patients, we observe a 
clear gradient looking at the waiting time intervals. Patients waiting between 0.5 and 
3 months (3 to 6 months; 6 to 12 months) had a 0.34 (1.15; 1.61) higher HoNOS score 
than patients waiting less than 0.5 months. Patients with an EIP episode shorter than 
the follow-up time seem to be not significantly affected by the length of waiting.  
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Table 3.3: Generalised linear model results with follow-up HoNOS as dependent variable 
  (1) Study sample (2) Long EIP (3) Short EIP 
  Coeff. Std. Err dy/dx Coeff. Std. Err. dy/dx Coeff. Std. Err. dy/dx 
Log waiting time (continuous) 0.032*** (0.009) 0.20 0.043*** (0.010) 0.27 0.022 (0.015) 0.15 
Waiting time quintiles (ref.cat.: shortest quintile)  
2nd shortest quintile -0.050 (0.036) -0.32 -0.015 (0.049) -0.09 -0.109 (0.064) -0.73 
3rd shortest quintile -0.057 (0.041) -0.36 0.004 (0.051) 0.02 -0.186** (0.060) -1.24 
4th shortest quintile 0.031 (0.033) 0.20 0.050 (0.039) 0.31 0.036 (0.081) 0.25 
Longest quintile 0.119** (0.045) 0.78 0.199*** (0.053) 1.27 0.021 (0.072) 0.14 
Waiting time intervals (ref.cat.: less than 0.5 months)  
Waiting time 0.5 to 3 months 0.040 (0.023) 0.25 0.054* (0.027) 0.34 0.034 (0.045) 0.23 
Waiting time 3 to 6 months 0.120*** (0.034) 0.78 0.181*** (0.048) 1.15 0.076 (0.052) 0.52 
Waiting time 6 to 12 months 0.215*** (0.059) 1.41 0.250*** (0.065) 1.61 0.189 (0.098) 1.30 
Observations 8,949     6,135     2,814     
Provider and year fixed effects yes     yes     yes     
Covariates yes     yes     yes     
Note: * p<0.05, ** p<0.01, *** p<0.001. Model (1) includes the complete study sample. Model (2) includes only patients with an EIP episode 
longer than the follow-up. Model (3) includes only patients with an EIP episode shorter than the follow-up. "dy/dx" represents average marginal 
effects in days. For factor levels they present the discrete change from reference category. All models use cluster robust standard errors (Std. Err.) 
for 48 provider clusters. 
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Table 3.4 reports the estimated coefficients and marginal changes of the baseline 
HoNOS as well as the treatment intensity variables based on Equation 3.1. As 
expected, we observe a strong positive relationship between baseline and follow-up 
HoNOS scores. A worse baseline condition strongly predicts worse outcomes twelve 
months after treatment start. Most severely affected patients had an up to 5 points 
worse outcome at follow-up. Overall, treatment intensity does not seem to impact 
outcomes much. Although significant, effect sizes are small.  
 
Table 3.4: Generalised linear model results of baseline HoNOS and treatment intensity on 
follow-up HoNOS 
  (1) Study sample (2) Long EIP (3) Short EIP 
  Coeff. dy/dx Coeff. dy/dx Coeff. dy/dx 
Baseline HoNOS (ref.cat.: least 
severe)             
2nd least severe quintile 0.220*** 1.34 0.154*** 0.92 0.347*** 2.18 
3rd least severe quintile 0.310*** 1.92 0.268*** 1.63 0.404*** 2.57 
4th least severe quintile 0.400*** 2.51 0.297*** 1.82 0.620*** 4.08 
Most severe quintile 0.544*** 3.49 0.449*** 2.82 0.759*** 5.09 
Treatment intensity             
Number days in EIP care -0.001*** -0.01 - - - - 
Number of days in inpatient care 0.001* 0.00 0.001** 0.01 0.000 0.00 
Number of mental health 
professional contacts 
0.005*** 0.03 0.005*** 0.03 0.004*** 0.03 
Mental Health Care Act sectioned 
within follow-up 
0.023 0.15 -0.023 -0.15 0.153** 1.04 
Observations 8,949   6,135   2,814   
Provider and year fixed effects yes   yes   yes   
Covariates yes   yes   yes   
Note: * p<0.05, ** p<0.01, *** p<0.001.  All models include log waiting time as regressor. 
 
Regarding treatment intensity, more days spent in EIP care seem to improve outcome 
prospects. Interestingly, more days of inpatient care and more mental health 
professional contacts are associated with a deterioration in follow-up outcomes. This 
may be explained by the fact that the two variables also capture some level of baseline 
severity of the patient that is not captured in the other control variables. In this case, 
more severe patients would need more inpatient care and service contacts but at the 
same time have worse outcome prospects regardless of treatment intensity. For the 
short EIP group, we observe patients who were sectioned under the Mental Health 
Care Act to have significantly worse outcomes. This again may be explained by the 
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variable capturing some different dimension of baseline severity, but it may also be an 
indication that involuntary treatment worsens outcome prospects. 
3.5.3 Robustness of results 
Results from the effects of waiting time on the different HoNOS sub dimensions are 
provided in Appendix A11. In line with previous findings, we find the strongest 
negative impact of waiting time on the symptoms dimension. But also, all other sub 
dimensions are negatively affected by a longer waiting time. As before, patients 
waiting longer than three months are affected most by a deterioration in outcomes on 
each sub-domain. We note that the marginal effects of waiting time on HoNOS scores 
are small (less than 2 score points). After applying the concept of clinically significant 
and reliable change to our study sample, a change of at least 10 score points would 
mean a reliable and a change of at least 13 score points a clinically meaningful change 
(see Appendix A9). Hence, our estimated effect of waiting time is likely to be clinically 
meaningless. However, we find evidence of a significant increase in the probability of 
a reliable and clinically significant deterioration for the study sample and the long EIP 
group. The likelihood of a clinically relevant deterioration is again highest for the 
longest waiting patients (see Appendix A12). 
 
3.6 Discussion 
Waiting times for mental health services in general and for EIP services in particular 
have recently gained considerable policy interest. But little is known about the 
detrimental effect of delays within the care system on outcomes for patients with 
psychosis. We document a moderate decline in patient outcomes twelve months after 
treatment acceptance for additional days of waiting. However, we believe that this 
decline of less than two score points may not be of clinical relevance. Although a 
general agreed threshold on what defines a clinically meaningful change in HoNOS is 
missing, we find a change of at least 10 to 13 points for our study sample to be 
necessary to define a reliable and clinically relevant change. At the same time, we do 
find the risk of a clinically significant and reliable deterioration which is based on the 
above-mentioned thresholds to be elevated by longer waiting time. Effects are 
significant in the waiting time range from three to twelve months which supports the 
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threshold theory discussed in previous papers. Also consistent with previous literature, 
all outcome dimensions are affected with the largest impact on symptomatic and social 
outcomes. 
Our study contributes a number of aspects to existing evidence. First, we developed a 
strategy to measure a system-related waiting time measure in contrast to the commonly 
used DUP. DUP has been criticised in its suitability to measure service effectiveness 
as definitions vary considerably across studies and are prone to a self-report bias by 
patients (Register-Brown and Hong, 2014; Singh, 2007; Norman and Malla, 2001). 
Our waiting time measure allows us to investigate the impact of delays within the care 
system rather than the help-seeking behaviour of patients (Gronholm et al., 2017). 
Second, we consider treatment intensity during the time of follow-up. It allows us to 
reflect recovery in psychosis as a long-lasting process and patient outcomes as a result 
of repeated service contacts over a period of several months. Finally, we are the first 
to study a routine outcome measure (HoNOS) to look at psychosis outcomes. HoNOS 
has been found to have adequate or good validity, reliability, sensitivity to change, and 
feasibility (Pirkis et al., 2005; McClelland et al., 2000; Amin et al., 1999; Wing et al., 
1998). Given its generic nature, it may lack clinical precision. But our findings are 
consistent with studies that use specific but heterogeneous outcome measures. 
We note some limitations of our work. First, we may have underestimated waiting 
time as we excluded any waiting time that occurred between the first service contact 
(e.g. general practitioner) or self-referral and the specialist’s decision to treat. If longer 
waiting time does indeed have negative effects on outcomes, we would have estimated 
a lower bound of the effect. Second, we restricted our follow-up period and thus 
treatment intensity to twelve months given the boundaries of data availability. Longer 
follow-up has, however, been shown to increase the impact of waiting time on 
outcomes (Penttilä et al., 2014). If this is the case, then again, our results are a lower 
bound estimation. Third, our outcome measure demonstrates the clinician’s judgement 
of the patient’s condition which may not necessarily match the patient’s perception 
(Kramer et al., 2003). Fourth, this work is limited by the relatively high number of 
missing HoNOS records which is common when working with clinician-reported 
measures (Jacobs, 2009). The remaining study sample had substantially higher 
proportions of mental health service contacts prior to the EIP treatment than excluded 
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patients. This would have limited the external validity of our results if the relationship 
between waiting for treatment and outcomes of the same treatment would be different 
dependent on past service experience. On the one hand, patients may have learned 
coping strategies during previous service contacts which help them to deteriorate less 
during the time of waiting. On the other hand, patients with more service contacts in 
the past may be in a more severe condition overall which will worsen even more during 
waiting. Whereas in the first case we would have underestimated the negative impact 
of waiting time, we would have overestimated it if the latter case is true. Without 
further knowledge about the role of previous service use in the interplay of waiting 
time and outcomes, our results have to be interpreted as representative for a patient 
cohort with relatively high mental health service use in the past. If there were 
systematic differences in HoNOS coding quality between providers which in turn may 
be associated with the provider’s performance regarding patient waiting times and 
outcomes, we have controlled for these through the use of provider fixed effects.  
Finally, the estimated effect is based on the assumption that the baseline health 
outcome conditional on other individual characteristics, including previous service use 
and treatment intensity, is sufficient to account for the individual’s unobserved pre-
treatment severity. We find the baseline outcome to be a strong predictor for the 
follow-up outcome. Also, accounting for previous service use and treatment intensity 
may have captured some remaining severity not observed by the baseline HoNOS. 
However, there may still have remained unobserved severity that explains both longer 
waiting times and worse outcomes. Future research should aim to consider either a 
valid instrument or a suitable comparison group to deal with this challenge. 
Our results have direct implications for the recently introduced waiting time target 
policy for EIP services. As has been the case in many previous target policies in other 
health areas, the 14-day target appears to have been chosen arbitrarily rather than based 
on evidence. A comprehensive discussion on the optimal targeted waiting time needs 
to consider the effects on patient outcomes but also implications for the supply side. 
Our paper sheds some light on the demand dimension. According to our results, the 
target policy can only be effective in improving patient outcomes if it leads to a 
reduction in excessive waits longer than three months. 
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4. Chapter: Clinical priorities and gaming 
behaviour in the light of waiting time targets 
____________________________________________________________________ 
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4.1 Introduction 
Waiting time targets are well established performance measures in systems with excess 
demand and rationing of care such as the NHS in England (Willcox et al., 2007). They 
guarantee patients’ access to care within a defined window of time though the 
definition of this window varies widely across countries and areas of health care. In 
the market for physical health care, waiting time targets have been shown to be 
effective in reducing waiting time (Woodcock, Alan and Bell, 2013; Besley, Bevan 
and Burchardi, 2009; Dimakou et al., 2009; Propper et al., 2008). Whereas most of 
these targets in the past have been accompanied by substantial financial penalties with 
hospital managers in fear of losing their position (Propper et al., 2008), implicit 
mechanisms such as the public disclosure of performance information can have similar 
effects on provider behaviour (Marshall et al., 2000). Performance benchmarks may 
indirectly affect budgets, bonuses, job security, staff morale and recruitment (Goddard, 
Mannion and Smith, 2000), and the publishing of performance measures could result 
in reputational damage (Bevan and Hamblin, 2009; Hibbard, Stockard and Tusler, 
2005). At the same time, there is an ongoing debate on whether the focus of providers 
on meeting arbitrary targets may lead to unintended consequences in non-targeted 
performance areas (Smith, 1995). 
Since April 2015, the English NHS operates a waiting time target for EIP services as 
one of the first of its kind in the mental health context. Before the target came into 
effect, a number of policy initiatives contributed to a growing awareness about the 
importance of early access for patients seeking EIP care (see Figure 4.1). The strategy 
“No health without mental health” published in February 2011 initiated a sequence of 
activities aimed at improving access to evidence-based treatments at the early stages 
of a mental illness or crisis (Department of Health, 2012, 2011). In January 2014, the 
government announced the intention to introduce waiting time targets for mental 
health services from April 2015 onwards without specifying the services to be affected 
(Department of Health, 2014a). In October 2014, the EIP target was defined for the 
first time: “More than 50% of people experiencing a first episode of psychosis will be 
treated with a NICE approved care package within two weeks of referral” (Department 
of Health, 2014b). The target was supposed to be implemented from April 2015 
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onwards. However, providers were expected to reduce waiting times long before the 
target comes into effect. A detailed guideline on how the EIP target was to be 
implemented was published in February 2015 (NHS England and NICE, 2015). This 
guideline for the first time, introduced the assignment of a care coordinator as the key 
requirement to stop the waiting time clock. 
 
 
Figure 4.1: Timeline of announcements related to the mental health service reform in England 
2011 to 2016 
 
This chapter aims to explore whether referral-to-treatment waiting time changed over 
the years leading towards the EIP target implementation. If providers adapted 
behaviour in anticipation of the policy change, we expect referral-to-treatment waiting 
time for EIP patients to decrease from October 2014 after the first announcement the 
EIP target. We then focus on two different types of unintended effects that may have 
accompanied the change in waiting times: re-prioritisation and gaming. First, 
providers may change the order of treating patients and prioritise those that are most 
likely to breach the target regardless of the clinical urgency of treatment as a form of 
re-prioritisation (Appleby et al., 2005). Hence, we investigate whether changes in 
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waiting time varied by the patient’s referral priority and disease severity as a form of 
re-prioritisation. Second, providers may focus on a reduction of the targeted part of the 
patient’s total waiting time by prolonging non-targeted parts resulting in an unchanged 
or even longer waiting time in total (Kelman and Friedman, 2009). We investigate this 
form of gaming behaviour by differentiating two different waiting times: (1) time from 
referral to EIP caseload acceptance (time-to-EIP); and (2) time from EIP caseload 
acceptance to the assignment of a care coordinator (time-to-CCASS). We exploit the 
fact that in October 2014 little detail was given about what constitutes “NICE approved 
treatment” that is required to stop the waiting time clock. Assuming that providers 
expected the acceptance onto the EIP caseload to be sufficient to stop the waiting time 
clock, gaming behaviour would be present if time-to-EIP improved from October 2014 
whereas time-to-CCASS increased at the same time. Only from February 2015 after 
detailed information revealed that time-to-CCASS will be monitored, we expect time-
to-CCASS to have improved as well. Waiting time can only be measured 
retrospectively, i.e. once a patient finished waiting (or started treatment). We use 
duration analysis techniques to overcome the challenge of right-censoring as it allows 
us to account for a patient’s time in the study (Rabe-Hesketh and Skrondal, 2012). 
Our work is motivated by a principal-agent economic model in the presence of 
asymmetric information as introduced in section 1.2.3. As the policymaker can only 
observe the provider’s effort by monitoring his target performance, providers – being 
under pressure to meet different objectives with limited resources – may take actions 
to make the target performance seem better than it actually is (Smith, 1995). These 
unintended consequences can occur in various ways and evidence is mixed. Appleby 
et al. (2005) found that additional admissions to meet the 15-month waiting time target 
in trauma and orthopaedics did not result in a distortion of clinical priorities. 
Januleviciute et al. (2013) compared the effects of waiting time targets with explicit 
prioritisation rules (Norway) to those without (Scotland). In both cases, waiting times 
did not change for high priority patients. However, explicit prioritisation led to a 
reduction in waiting times for low priority patients. Propper et al. (2010) could not 
identify any re-prioritisation of patients to meet the waiting time target for elective 
hospital admissions in England. In contrast, Nikolova, Sinko and Sutton (2015) found 
some evidence for re-ordering of patients as a consequence of the waiting time target 
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for elective surgery in Scotland. Fewer papers investigated gaming behaviour. Kelman 
and Friedman (2009) as well as Propper et al. (2010) provide evidence that improved 
target performance was neither associated with lower quality of care, nor with effort 
reduction in non-targeted activity such as waiting time or length of stay in other 
departments. Robinson et al. (2003) showed that time from referral to first hospital 
appointment improved as response to the 2-week waiting time target for women 
referred urgently with suspected breast cancer in England. However, waiting time from 
first appointment to treatment increased and consequently total waiting times changed 
very little. Similarly, Marques et al. (2014) showed that although the targeted inpatient 
waiting time in elective surgery in England decreased, total waiting time  did not 
improve. Patients with shorter inpatient waits spent a longer time waiting prior to the 
inclusion in the waiting list.  
We add to this evidence by making a number of important contributions. First, we 
extend existing evidence on the response of providers to waiting time targets to the 
mental health context where providers act in different market structures (e.g. payment 
systems) which may lead to different responses to targets. At the same time, we 
contribute to the still ongoing debate about the extent of unintended effects of enforced 
performance targets – particularly in the context where targets are not accompanied 
with direct penalties for providers. Second, we use duration analysis methods which 
allow us to overcome the challenge of right-censoring which typically occurs in 
waiting time studies. Finally, this chapter provides important evidence for the future 
evaluation of the EIP target policy itself. If providers adapted behaviour in anticipation 
of the policy change, the evaluation of the actual policy has to account for this 
anticipation. 
 
4.2 Methods 
4.2.1 Dataset and sampling 
The analysis in this chapter uses secondary patient-level data from the MHLDDS (see 
section 1.4.1). We identified 10,744 patients aged 16 to 64 that had an EIP episode and 
a related referral between April 2011 and November 2015. We aimed to look at first-
episode psychosis patients as treatment patterns may change for repeated episodes. 
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Hence, we excluded patients that were in contact with psychosis related services in the 
previous six months. Among those excluded, 336 (3%) had a previous EIP episode 
and 1,356 (13%) had a psychosis related care cluster episode. We further excluded 70 
(1%) patients that were treated at independent providers as their care pathways may 
be different from NHS providers. To ensure that patient groups per provider are large 
enough, we excluded 16 (0.2%) patients that were with providers treating less than ten 
patients in our sample. Out of the remaining 8,966 patients, we excluded 2,800 (31%) 
with missing HoNOS information which we needed as a measure of priority. The final 
study sample consisted of 6,166 patients treated at 42 mental health providers. 
 
4.2.2 Outcomes, covariates and empirical analysis 
We use duration analysis to investigate changes in referral-to-treatment waiting time 
over the five-year study period. Referral-to-treatment time measures the time a patient 
waited from referral to the assignment of a care coordinator or censoring (see section 
1.4.2 for more details). We included only referrals that have been accepted for action 
by the receiving provider. To analyse potential gaming behaviour, we differentiate two 
components of the referral-to-treatment time: (1) time from referral to acceptance onto 
EIP caseload (time-to-EIP); and (2) time from acceptance onto EIP caseload to the 
assignment of a care coordinator (time-to-CCASS). Censoring can occur because 
patients drop out of the study due to death (after acceptance of referral), because they 
are no longer in need of treatment, or because the care coordinator was assigned after 
the end of the study period. We interpret the number of days patients waited, as 
continuous time-to-event data. The start point, where analysis time	" = 0, is defined 
by the patient’s date of referral. We assume that the process by which patients entered 
the study is random at patient level. 
First, we apply non-parametric methods to estimate survivor, hazard, and cumulative 
hazard functions of time-to-treatment (Aalen, 1978; Nelson, 1972; Kaplan and Meier, 
1958). Second, we employ a stratified Cox regression model (Cox, 1972) to estimate 
the effect of the patient’s referral year, referral priority and severity of condition on 
the probability (or hazard) of getting treated, conditional on a number of possible 
confounders. We parameterise the conditional hazard function, ℎ("|()*), for patient 
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, = 1,… , 0, living in small area 1 = 1,… , 2 as defined in Equation 4.1 and Equation 
4.2. 
Equation 4.1: ℎ3"|()*4 = ℎ56(")exp	(:;<)*;+	:>?)*+	:@(<)*; × ?)*) + :BC)*) 
Equation 4.2: ℎ3"|()*4 = ℎ56(")exp	(D;<)*>+	D>?)*+	D@(<)*> × ?)*) + DBC)*) 
 
Time to treatment is indicated by " for which we distinguish time-to-EIP, time-to-
CCASS and referral-to-treatment. We define a variable <)*;  which equals 1 if a patient 
was referred to EIP after the first announcement of the EIP target policy and before 
the second announcement of the care coordinator assignment (October 2014 to January 
2015). <)*>  equals 1 if the patient was referred to EIP after the second announcement 
(February 2015 to November 2015). ?)* indicates the patient’s priority status which we measure in two different ways. First, 
we use the patient’s referral status which indicates the urgency of the referral. Patients 
are defined as high priority (?)*=1) if the receiving mental health provider accepted 
the referral for immediate action and as low priority (?)*=0) if the patient was placed 
on the appointment waiting list. Waiting time in this context may be related to both, 
the time until the acceptance onto the EIP caseload (i.e. start of the EIP episode) and 
the assignment of the care coordinator. Second, we use the HoNOS item 6 as a measure 
of severity of psychotic symptoms (see sections 1.4.1 and 3.3). We defined patients as 
high severity (?)*=1) if the HoNOS 6 score was 3 or 4 and low severity (?)*=0) if the 
HoNOS 6 score was below 3. HoNOS measurements must have taken place within a 
maximum window of 30 days before or after the start of the EIP treatment. 
We control for patient characteristics C)* that have been found to be related with patient 
waiting times (O'Donoghue et al., 2016; Apeldoorn et al., 2014). We consider general 
demographic factors such as age, gender, ethnicity, and marital status as well as 
socioeconomic variables. For the latter, we used accommodation and employment 
status at a patient-level and socioeconomic deprivation at LSOA level based on the 
IMD (see section 1.4.1). Furthermore, we controlled for the primary diagnosis during 
the EIP care and the source of referral (e.g. general practitioner, self-referral, or justice 
system). 
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We estimate Equation 4.1 and Equation 4.2 separately for time-to-EIP, time-to-
CCASS and referral-to-treatment time. 	:; and 	D; measure the estimated probability 
(hazard) of getting treated when being referred between October 2014 and January 
2015 and between February and November 2015 respectively. We expect 	:; and 	D; 
to be positive for referral-to-treatment if providers respond to the target policy by 
reducing waiting time. Potential gaming behaviour would be observed if :; for time-
to-EIP i.e. the hazard of getting accepted onto the EIP caseload increased between 
October 2014 and January 2015 whereas :; for time-to-CCASS i.e. the hazard of 
getting assigned a care coordinator decreased at the same time. Only between February 
2015 and November 2015, we expect time-to-CCASS to improve which would be 
indicated by a positive D;. 
The interaction of <)*;  (and <)*>) and ?)* identifies high priority/severity patients being 
referred after the first (and second) policy announcement. Hence, the coefficients :@ 
and D@ measure to what extent the hazard of getting treated changed for high priority 
patients after the first and second policy announcement respectively. We do not have 
an a priori assumption about the extent of prioritisation pre-policy. Any change in 
prioritisation over time (“good” or “bad”) and hence a significant :@	or D@ would 
indicate the presence of re-prioritisation. 
The Cox model identifies the effect of each covariate on time to treatment in terms of 
hazard ratios EFG = exp	(:H) which we will present in the result section alongside the 
estimated coefficients. The stratum-specific baseline hazard, ℎ56("), indicates the 
probability of being treated when all covariates are zero. We assume there are I =1,2, … , K strata with K = 42 corresponding to the number of mental health providers 
in our sample. Stratification by provider allows us to control for any unobserved 
provider heterogeneity.  At the same time, it is coherent with our study objective as we 
are not interested in provider effects per se but want to control for them. Estimated 
hazard ratios must be interpreted as the within-provider ratio of hazards (Rabe-Hesketh 
and Skrondal, 2012). 
The strength of the Cox model is that is does not require the parameterisation of the 
baseline hazard function. However, this only allows estimating the probability of 
survivorship rather than absolute survival time in days. To predict adjusted variations 
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in median waiting times, we additionally model waiting time variation using 
accelerated failure time (ACF) models. ACF models use a parametric approach to 
estimate baseline survivorship over time which is assumed to follow a known 
distribution. We use the Akaike’s information criterion (AIC) (Akaike, 1970) and the 
Bayesian information criterion (BIC) (Schwarz, 1978) to choose the best fitting 
distribution among the most commonly used exponential, Weibull, normal, logistic 
distribution. 
4.2.3 Validation checks and assessing proportional hazards 
We used Efron’s method (Efron, 1977) to handle ties which was found to gain closer 
results to the exact partial likelihood (Hosmer, 2008). We evaluated the overall fit of 
the final models by plotting the Cox-Snell residuals against the Nelson-Aalen 
cumulative hazard function. The Cox model assumes that ratio of the hazards for any 
two individuals is constant over time (proportional). We assessed the proportional 
hazards assumption by performing overall as well as covariate specific score tests 
based on the (scaled) Schoenfeld residuals (Hosmer, 2008). We examined the 
magnitude of time dependencies by visually analysing scatterplots of the scaled 
Schoenfeld residuals as well as log-log plots. If the hazards are proportional, residuals 
should be scattered randomly around zero and log-log plots should be approximately 
parallel. Further, we investigated time varying interactions in an extended Cox model. 
Violations of the assumption are, however, only critical if (1) time dependencies are 
strong, or (2) there is a theoretical interest in analysing the time dependencies (Allison, 
2010). Case (2) can be ignored given our study objective. In case of weak time 
dependencies, results can be interpreted as average effects over the range of times 
observed in the data (Allison, 2014).  
 
4.3 Results 
4.3.1 Descriptive statistics  
Descriptive sample characteristics are summarised in Table 4.1 separately for the three 
time periods before, after first and after second policy announcement. For all 6,166 
patients being referred to an EIP service within the study period, we observe the 
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complete time-to-EIP (100%).5 The median time-to-EIP was one day in all three time 
periods with the mean decreasing from 29 to 8 days over time. 2,042 patients (33%) 
were right censored in their time-to-CCASS. The median time-to-CCASS was 52 days 
before the first announcement, increased to 64 days after the first announcement and 
decreased to 38 days after the second announcement. A similar pattern can be observed 
for the referral-to-treatment time.  
 
Table 4.1: Summary statistics 
Sample characteristics Apr11-Sept14 Oct14-Jan15 Feb15-Nov15 
n 5,178 321 667 
Time-to-EIP, median (mean, SD) 1 (29, 98) 1 (12, 35) 1 (8, 21) 
Time-to-CCASS, median (mean, SD) 52 (369, 501) 64 (161, 160) 38 (79, 88) 
Referral-to-treatment, median (mean, SD) 71 (397, 514) 82 (172, 162) 44 (85, 89) 
        
High priority, n (%) 3,184 (61.5) 178 (55.5) 381 (57.1) 
High severity, n (%) 1,301 (25.1) 115 (35.8) 251 (37.6) 
        
HoNOS score, range 0-48       
for low severity, mean (SD) 10.7 (5.4) 11.2 (5.5) 11.3 (5.4) 
for high severity, mean (SD) 16.9 (6.0) 16.8 (5.4) 16.7 (5.9) 
HoNOS 6 score, range 0-4       
for low severity, mean (SD) 0.9 (0.9) 1.0 (0.9) 1.1 (0.9) 
for high severity, mean (SD) 3.2 (0.4) 3.2 (0.4) 3.2 (0.4) 
        
Age 16 to 35, n (%) 5,023 (97.0) 315 (98.1) 649 (97.3) 
Male, n (%) 3,275 (63.3) 192 (59.8) 423 (63.4) 
Single, n (%) 3,883 (75.0) 205 (63.9) 383 (57.4) 
White ethnicity, n (%) 3,628 (70.1) 216 (67.3) 409 (61.3) 
Unemployed, n (%) 1,616 (31.2) 71 (22.1) 150 (22.5) 
Least deprived quintile, n (%) 581 (11.2) 42 (13.1) 67 (10.0) 
Most deprived quintile, n (%) 1,829 (35.3) 100 (31.2) 233 (34.9) 
No fixed accommodation, n (%) 751 (14.5) 34 (10.6) 56 (8.4) 
 
55.5 to 61.5% of patients were referred with high priority and 25.1 to 37.6% were 
classified as high severity. The average HoNOS score was 10.7 to 11.3 for low severity 
patients and 16.7 to 16.9 for high severity patients. The demographic and 
socioeconomic composition of our sample is comparable to other first-episode 
psychosis cohorts studied in the past (Kirkbride et al., 2017; Tsiachristas et al., 2016). 
The majority of our sample (97.0-98.1%) was aged 16 to 35 at time of referral, of male 
                                               
5 We were only able to identify patients relevant to our study if they had an EIP episode within the study 
period. Hence, right censoring of time-to-EIP was not possible by definition as for all patients we 
observed the start of the EIP episode. 
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gender (59.8-63.4%), and single (57.4-75.0%). Compared to the general population, 
we observe a relatively high proportion of people being unemployed (22.1-31.2%), 
living in the most deprived neighbourhoods (31.2-35.3%), and having no fixed 
accommodation (8.4-14.5%). 
 
4.3.2 Graphical analysis of non-parametric functions 
Figure 4.2 presents non-parametric functions for time-to-EIP, time-to-CCASS and 
referral-to-treatment time. The survival for time-to-EIP, panel 1(a), descends sharply 
for approximately the first 100 days and then slowly towards the end of the 
distribution. The descent is approximately constant from 400 days. The initial steep 
descent is a result of a relatively higher probability to be treated in the first days 
following referral. The treatment rate then decreases and remains at about the same 
level for the remainder of the follow-up period. The survival function based on time-
to-CCASS in panel 2(a) shows a similar pattern. Survival diminishes fast, though not 
as fast as in the former case, within the first 100 days and then less than proportionally. 
The survival function finishes at about 46% reflecting the fact that 46% of the sample 
had a time-to-CCASS that was censored as they were still waiting for a care 
coordinator assignment at the end of the study period. The hazard of being treated is 
highest at the beginning of the duration and decreases sharply after. Both the hazard 
of EIP acceptance and of care coordinator assignment are at their minimum at around 
400 days. After this point, the hazard of care coordinator assignment continues to 
decrease at a smaller rate whereas the hazard of EIP acceptance appears to rise again. 
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Figure 4.2: Non-parametric functions for time-to-EIP (1a-c), time-to-CCASS (2a-c) and 
referral-to-treatment time (3a-c) 
 
Figure 4.3 compares the Kaplan-Meier survival curves for time-to-EIP and time-to-
CCASS in the three different time periods. A steeper survival curve indicates a higher 
hazard of getting treated and thus a shorter time to treatment. For a time-to-EIP below 
35 days, there were no apparent differences in survival between the pre-announcement 
period (Apr11-Sept14) and the period after the first announcement (Oct14-Jan15). 
However, for time-to-EIP above 35 days survival was steeper for the first 
announcement period and remained almost as steep in the second announcement 
period (Feb15-Nov15). Time-to-CCASS at the lower end of the distribution was 
shortest for the pre-announcement period (Apr11-Sept14). At the higher end of the 
distribution (50 days and above) time-to-CCASS for pre-announcement and first 
announcement period almost overlapped. However, there was a clear decrease in time-
to-CCASS after the second policy announcement particularly for time-to-CCASS of 
40 days and above.  
The graphical analysis indicates that providers responded to both of the policy 
announcements. Time-to-EIP seems to have improved after the first announcement 
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and time-to-CCASS improved after the second announcement. At the same time, we 
find no evidence of gaming. Time-to-CCASS did not seem to be affected negatively 
by the improvement in time-to-EIP after the first announcement. 
 
Note: Graph truncated at time >1 and <180 days. 
Figure 4.3: Kaplan-Meier survival curves for time-to-EIP and time-to-CCASS for different 
time periods 
 
Figure 4.4 plots the survival curves for time-to-EIP and time-to-CCASS for low and 
high priority patients. Whereas the upper panel compares time-to-EIP pre-
announcement (solid line) and after the first announcement (dashed line), the lower 
panel compares time-to-CCASS before and after the second announcement. We 
observe that time-to-EIP for low priority patients improved after the first 
announcement as the survival curve got steeper – particularly for time-to-EIP above 
25 days. The same effect cannot be observed for high priority patients as both survival 
curves mostly overlap. Hence, providers seem to have improved time-to-EIP in 
response to the policy announcement but to the benefit of low priority rather than high 
priority patients. For time-to-CCASS we find the opposite. Time-to-CASS increased 
after the second policy-announcement for both low and high priority patients. The 
increase seems to have been larger for high priority patients. 
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Note: Graph truncated at time >1 and <180 days. 
Figure 4.4: Kaplan-Meier survival curves for time-to-EIP and time-to-CCASS by priority 
 
A very similar picture can be seen in Figure 4.5 here we compare survival curves for 
time-to-EIP and time-to-CCASS by severity. Again, we observe improvements in 
time-to-EIP for low severity patients after the first announcement but not for high 
severity ones. At the same time, time-to-CASS increased after the second policy-
announcement for both low and high severity patients.  But in contrast to before, this 
increase seems to have been larger for low severity patients compared to high severity 
ones. 
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Note: Graph truncated at time >1 and <180 days. 
Figure 4.5: Kaplan-Meier survival curves for time-to-EIP and time-to-CCASS by severity 
 
4.3.3 Regression results 
Table 4.2 and Table 4.3 report the results from the stratified Cox models which control 
for patient characteristics and provider heterogeneity. The dependent variable is time-
to-EIP for model (1), time-to-CCASS for model (2) and referral-to-treatment time for 
model (3). In panel (a) the policy announcement indicator was interacted with the 
referral priority indicator and in panel (b) with the severity dummy. Positive 
coefficients indicate an increase in the hazard of getting treated and hence a reduction 
in waiting time.  
Results in Table 4.2 are based on Equation 4.1 which compares the pre-announcement 
period (Apr11-Sept14) with the period after the first announcement (Oct14-Jan15). 
Low priority patients significantly improved in time-to-EIP after the first 
announcement (hazard ratio (HR)=1.19). A similar but slightly smaller effect can be 
observed when using severity as measure (HR=1.15). At the same time, time-to-
CCASS and referral-to-treatment time were not negatively affected by the first policy 
announcement which indicates no evidence of gaming. In fact, referral-to-treatment 
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time seemed to even have improved for high priority patients in the first post-
announcement period (HR=1.35).  
High priority patients had a longer time-to-EIP in the pre-announcement period 
(HR=0.87) compared to low priority patients. Improvements in time-to-EIP can only 
be observed for low priority and low severity patients whereas there was no significant 
change for high priority/severity ones. By severity, we observe some effective 
prioritisation in the pre-announcement period as high severity patients had a shorter 
time-to-CCASS (HR=1.17) and referral-to-treatment time (HR=1.19) than low 
severity ones. This prioritisation cannot be observed after the first policy 
announcement. Overall, there is no evidence of re-prioritisation associated with the 
first policy announcement as no patient group improved to the expenses of another 
patient group.  
Table 4.3 presents results based on Equation 4.2 which compares the period before the 
second announcement (Apr11-Jan15) with the one after (Feb15-Nov15). Time -to-EIP 
continued to improve for low priority and low severity patients after the second 
announcement (HR=1.19 and 1.15 respectively). But this time, also time-to-CCASS 
and referral-to-treatment time improved significantly for low priority patients 
(HR=1.38). High priority patients did not improve in a similar way. When looking at 
prioritisation effects by severity the picture is the opposite around. High severity 
patients had a shorter time-to-CCASS (HR=1.18) and referral-to-treatment time 
(HR=1.21) before the second policy announcement compared to low severity patients. 
Both time measures decreased after the second announcement (HR=1.42/HR=1.41) 
without any effects on low severity patients. 
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Table 4.2: Stratified Cox regression results comparing Apr11-Sep14 and Oct14-Jan15 
  
(1) Time-to-EIP   (2) Time-to-CCASS   (3) Referral-to-treatment 
Coeff. Std. Err. HR Coeff. Std. Err. HR Coeff. Std. Err. HR 
a) Priority                   
Low priority from Apr11-Sept14 ref. cat.   1.00 ref. cat.   1.00 ref. cat.   1.00 
Low priority from Oct14-Jan15 0.178** (0.065) 1.19 -0.139 (0.110) 0.86 -0.158 (0.114) 0.85 
High priority from Apr11-Sept14 -0.141* (0.063) 0.87 -0.046 (0.085) 0.95 -0.069 (0.083) 0.93 
High priority from Oct14-Jan15 -0.073 (0.090) 0.93 0.234 (0.150) 1.27 0.300* (0.152) 1.35 
b) Severity                   
Low severity from Apr11-Sept14 ref. cat.   1.00 ref. cat.   1.00 ref. cat.   1.00 
Low severity from Oct14-Jan15 0.141* (0.058) 1.15 -0.061 (0.099) 0.94 -0.059 (0.100) 0.94 
High severity from Apr11-Sept14 0.029 (0.029) 1.03 0.156*** (0.037) 1.17 0.174*** (0.038) 1.19 
High severity from Oct14-Jan15 -0.012 (0.092) 0.99 0.137 (0.150) 1.15 0.170 (0.151) 1.19 
Note: * p<0.05, ** p<0.01, *** p<0.001. Regression based on Equation 4.1. Reported are standard errors (Std. Err.) and hazard ratios (HR). 
 
Table 4.3: Stratified Cox regression results comparing Apr11-Jan15 and Feb15-Nov15 
  
(1) Time-to-EIP   (2) Time-to-CCASS   (3) Referral-to-treatment 
Coeff. Std. Err. HR Coeff. Std. Err. HR Coeff. Std. Err. HR 
a) Priority                   
Low priority from Apr11-Jan15 ref. cat.   1.00 ref. cat.   1.00 ref. cat.   1.00 
Low priority from Feb15-Nov15 0.156*** (0.044) 1.16 0.324*** (0.088) 1.38 0.327*** (0.087) 1.38 
High priority from Apr11-Jan15 -0.154** (0.058) 0.86 -0.001 (0.079) 1.00 -0.029 (0.078) 0.97 
High priority from Feb15-Nov15 -0.045 (0.062) 1.05 -0.154 (0.114) 0.86 -0.109 (0.114) 0.90 
b) Severity                   
Low severity from Apr11-Sept14 ref. cat.   1.00 ref. cat.   1.00 ref. cat.   1.00 
Low severity from Oct14-Jan15 0.218*** (0.041) 1.24 0.078 (0.081) 1.08 0.111 (0.080) 1.12 
High severity from Apr11-Sept14 0.035 (0.028) 1.04 0.169*** (0.036) 1.18 0.190*** (0.036) 1.21 
High severity from Oct14-Jan15 -0.096 (0.062) 0.91 0.347** (0.110) 1.42 0.341** (0.112) 1.41 
Note: * p<0.05, ** p<0.01, *** p<0.001. Regression based on Equation 4.2. Reported are standard errors (Std. Err.) and hazard ratios (HR).  
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In Table 4.4, we report the predicted median waiting times when comparing the pre-
announcement period with the period after the first announcement. The results are 
based on the ACF models for which we assumed a log-logistic distribution for time-
to-EIP and a log-normal distribution for time-to-CCASS and referral-to-treatment 
time. Differences in median time-to-EIP are very small between the groups ranging 
between 2.5 and 2.8 days. The shortest median time-to-EIP of 2.5 days is observed for 
high severity patients from October 2014 to January 2015. Differences in predicted 
median time-to-CCASS are larger although we note that the predictions are generally 
quite large compared to the observed data. Median time-to-CCASS ranges between 
129.0 days for high severity patients from October 2014 to January 2015 and 416.7 
days for low priority patients from April 2011 to September 2014. Overall, median 
time to treatment for all three measures decreased after the first policy announcement. 
Hence, we find no evidence of gaming behaviour. Also, high priority/severity patients 
had consistently shorter time to treatment (except a slightly higher time-to-EIP for high 
priority patients) not only before but also after the first policy announcement which 
implies that there is no evidence of re-prioritisation. 
We observe a very similar picture when looking at the difference in predicted median 
time to treatment before and after the second policy announcement as shown in Table 
4.5. Median time-to-EIP decreased after the second policy announcement from 2.8 to 
2.7 days, median time-to-CCASS from 345.6 to 216.9 days and referral-to-treatment 
time from 327.7 to 253.3 days when interacting priority with the announcement 
indicator. Overall, high priority as well as high severity had shorter time to treatment. 
However, we find some evidence of re-prioritisation by referral priority. Whereas time 
to treatment decreased after the second policy announcement for low priority patients 
it increased at the same time for high priority patients. We observe a similar re-
prioritisation effect when using severity as priority measure for time-to-EIP but not for 
time-to-CCASS and referral-to-treatment time. 
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Table 4.4: Predicted median waiting times based on Accelerated Failure Models for Apr11-Sept14 compared to Oct14-Jan15 
  
(1) Time-to-EIP (2) Time-to-CCASS (3) Referral-to-treatment 
Median 95% Conf. Int. Median 95% Conf. Int. Median 95% Conf. Int. 
(a) Priority             
Apr11-Sept14 2.8 [2.6-2.9] 345.7 [267.3-424.0] 372.7 [301.1-444.5] 
Oct14-Jan15 2.7 [2.3-3.2] 216.9 [124.5-309.4] 253.3 [159.3-347.3] 
Low priority 2.7 [2.5-3.0] 401.4 [302.4-500.4] 424.7 [335.4-514.0] 
High priority 2.8 [2.6-3.0] 280.7 [213.2-348.3] 311.7 [247.6-375.8] 
              
Low priority from Apr11-Sept14 2.7 [2.5-3.0] 416.7 [311.8-521.6] 437.0 [342.9-531.0] 
Low priority from Oct14-Jan15 2.8 [2.6-3.0] 291.7 [220.3-327.0] 322.4 [254.9-390.0] 
High priority from Apr11-Sept14 2.6 [2.0-3.2] 263.1 [102.4-423.7] 308.6 [146.1-471.1] 
High priority from Oct14-Jan15 2.8 [2.2-3.4] 181.8 [84.5-279.1] 210.0 [110.8-309.2] 
              
(b) Severity             
Apr11-Sept14 2.8 [2.6-2.9] 346.2 [268.2-424.2] 374.1 [302.4-445.8] 
Oct14-Jan15 2.7 [2.3-3.2] 255.7 [130.5-380.9] 306.2 [175.2-437.1] 
Low severity 2.8 [2.6-3.0] 360.7 [280.3-441.1] 394.0 [319.0-469.1] 
High severity 2.6 [2.4-2.9] 232.9 [171.7-294.1] 252.2 [194.9-309.5] 
              
Low severity from Apr11-Sept14 2.8 [2.6-3.0] 369.3 [285.6-453.1] 399.4 [322.1-476.6] 
Low severity from Oct14-Jan15 2.6 [2.4-2.9] 244.6 [178.8-310.4] 264.0 [202.5-325.5] 
High severity from Apr11-Sept14 2.8 [2.2-3.4] 284.5 [133.8-435.2] 344.0 [185.8-502.3] 
High severity from Oct14-Jan15 2.5 [1.9-3.1] 129.0 [51.4-206.7] 141.1 [66.3-215.9] 
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Table 4.5: Predicted median waiting times based on Accelerated Failure Models for Apr11-Jan15 compared to Feb15-Nov15 
  
(1) Time-to-EIP (2) Time-to-CCASS (3) Referral-to-treatment 
Median 95% Conf. Int. Median 95% Conf. Int. Median 95% Conf. Int. 
(a) Priority             
Apr11-Jan15 2.7 [2.5-2.9] 330.9 [253.1-408.7] 353.3 [288.7-417.8] 
Feb15-Nov15 2.0 [1.8-2.2] 127.5 [86.8-168.2] 140.0 [103.5-176.5] 
Low priority 2.6 [2.4-2.8] 339.5 [260.2-418.7] 359.1 [290.8-427.4] 
High priority 2.6 [2.5-2.8] 246.7 [189.1-304.3] 273.6 [222.5-324.6] 
              
Low priority from Apr11-Jan15 2.7 [2.5-2.9] 339.5 [295.1-512.3] 419.5 [332.2-506.9] 
Low priority from Feb15-Nov15 2.7 [2.5-2.9] 246.7 [205.8-351.9] 303.2 [242.0-364.4] 
High priority from Apr11-Jan15 1.8 [1.6-2.0] 116.6 [68.3-164.9] 118.9 [77.1-160.6] 
High priority from Feb15-Nov15 2.6 [1.9-2.4] 135.3 [83.4-187.1] 156.0 [105.3-206.7] 
              
(b) Severity             
Apr11-Jan15 2.7 [2.5-2.9] 326.5 [250.4-402.6] 349.9 [286.3-413.4] 
Feb15-Nov15 2.0 [1.8-2.2] 161.6 [102.2-221.0] 174.0 [119.7-228.3] 
Low severity 2.7 [2.5-2.8] 315.5 [249.6-381.4] 342.7 [284.7-400.7] 
High severity 2.5 [2.3-2.8] 188.1 [143.0-233.2] 205.3 [163.8-246.8] 
              
Low severity from Apr11-Jan15 2.7 [2.6-2.9] 352.1 [270.9-433.2] 378.3 [309.3-447.4] 
Low severity from Feb15-Nov15 2.6 [2.3-2.8] 221.0 [161.9-280.1] 236.2 [184.5-287.8] 
High severity from Apr11-Jan15 1.9 [1.7-2.2] 183.8 [112.7-254.9] 197.6 [131.3-263.9] 
High severity from Feb15-Nov15 2.2 [1.8-2.5] 69.8 [44.1-95.6] 79.7 [54.3-105.0] 
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4.3.4 Validation of the approach 
In the following we discuss the results from the validation checks detailed in section 
4.2.3. In Appendix A13, we show that results are consistent independent of the choice 
of method to handle ties. The results of the global score tests – reported in Appendix 
A14 – indicate some evidence of non-proportional hazards. Particularly, in the models 
with time-to-CCASS as dependent variable the test showed significant p-values for all 
four functions of time. Hence, we visually assessed the magnitude of the non-
proportionality in our two main explanatory variables, the post-announcement 
indicators. In Appendix A15, we plotted the scaled Schoenfeld residuals against each 
of the four functions of time. Residuals mostly appear to be randomly scattered around 
zero with the lowess smooth being roughly flat and horizontal. The log-log plots in 
Appendix A16 show that plots are mainly parallel and close to each other, except for 
some overlap for the second announcement period indicator based on the model of 
time-to-CCASS. The observed effect on both, time-to-EIP and time-to-CCASS, 
remained similar once we interact the main regressors with time in an extended Cox 
regression (see Appendix A17). Time interactions were partly significant but 
comparably small in magnitude. However, effects partly disappear after interacting the 
main regressors with log of time (see Appendix A18). 
 
4.4 Discussion 
The EIP waiting time target is the first of its kind in mental health service provision in 
England. We investigated whether waiting times changed already in anticipation of the 
policy change and to what extent this may have led to unintended consequences for 
patients. 
Our findings showed that the first announcement of the EIP target in October 2014 
was associated with a significant reduction in time-to-EIP. Furthermore, the second 
announcement of the care coordinator requirement in order to stop the waiting time 
clock in February 2015 was associated with a significant decrease in time-to-CCASS 
and also in total referral-to-treatment time. Hence, providers seem to have responded 
to the policy announcements and adapted behaviour in anticipation of the policy 
change. The absolute effect on median time-to-EIP was, however, very small (less than 
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a day). In contrast, the absolute effects on time-to-CCASS and referral-to-treatment 
time were quite substantial.  
We found no evidence that this anticipation led to gaming behaviour as time-to-
CCASS and referral-to-treatment time were not negatively affected by the 
improvements in time-to-EIP after the first announcement. We also find only little 
evidence of re-prioritisation and results from the non-parametric, semi-parametric and 
parametric analyses were partly contradictive and inconsistent. Although we observed 
differences in time to treatment by priority as well severity in the semi-parametric Cox 
regressions, there was no clear pattern apparent and no patient group benefitted at the 
expense of another. Overall, low priority/severity patients seemed to have benefitted 
from the improvements in time-to-EIP but without disadvantaging high 
priority/severity patients at the same time. For time-to-CCASS, we observed effective 
prioritisation by severity that did not change after the policy announcements. High 
severity patients had a shorter time-to-CCASS not only before but also after the second 
announcement. The parametric analyses indicated some re-prioritisation after the 
second policy-announcement as time-to-EIP decreased for low priority/severity 
patients but increased at the same time for high priority/severity patients. For time-to-
CCASS and referral-to-treatment time, this re-prioritisation could only be observed for 
the priority but not the severity measure. 
Three aspects may have contributed to the fact that patients seemed to be effectively 
prioritised by severity when assigning a care coordinator rather than accepting patients 
onto the caseload. First, time-to-CCASS was only focused on after the announcement 
of the care coordinator requirement in February 2015. Hence, a similar re-ordering of 
patients as for time-to-EIP may be observed in future data. Second, the patient’s 
severity of condition is mostly unknown at the point of referral. Only after a period of 
assessment, clinicians can actually judge the patient’s severity and hence prioritise 
patients accordingly. Consequently, we observe effective prioritisation by severity for 
time-to-CCASS that seems to not be affected by the efforts of providers to meet 
targets. In contrast, the observed discrimination of more severe patients facing a longer 
time-to-EIP may not only be due to provider’s ambitions to meet targets but also an 
unintentional consequence of providers having insufficient information about the 
patient’s severity at time of referral. Third, the patients themselves may cause the 
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longer time-to-EIP. We found that particularly problems with hallucinations and 
delusions are associated with longer time-to-EIP rather than any other dimensions of 
severity. The lack of insight into the illness or the fear of being stigmatised due to 
hallucinations and delusions may cause patients to not being able to take advantage of 
the referral and delaying follow-up appointments with EIP services. Hence, their time-
to-EIP is longer than for other patients. It is, however, clearly stated in the EIP target 
guideline that it is the responsibility of the provider to actively encourage patients’ 
attendance as this will not be taken into consideration when evaluating the providers 
performance against the EIP target.  
Our methodological approach has a number of strengths in addressing our research 
question. A key issue in the analysis of waiting times is censoring. Since some patients 
are still waiting at the end of the study period, they would need to be excluded from 
conventional regression analyses. This is likely to produce a selection bias if the 
probability of waiting longer is not random. Duration analysis allows us to account for 
a patient’s time in the study and it further offers the advantage of adequately modelling 
the skewed distribution of waiting time. As we use non- and semi-parametric survival 
methods, we do not impose any assumptions on the statistical distributions of the 
baseline hazard. We take care of systematic differences between providers by the 
stratification of the model. 
We note some potential limitations to our results. First, the observed changes in 
waiting time over time may be caused by other factors rather than providers 
anticipating the policy change. We do however control for a large number of potential 
confounders. Second, our measures of priority and severity may be imperfect. Some 
unobserved component may also be captured in the other control variables. In this case, 
we would have underestimated the impact of priority and/or severity on time to 
treatment. Moreover, HoNOS measures for different patients were taken at different 
times during the patient’s complete waiting experience. This may have overestimated 
the severity of patients for which we measure severity later if the patient’s condition 
deteriorates while waiting and vice versa. However, this will have influenced our 
results only if there was a systematic difference in the timing of HoNOS measurements 
over the five years of study. Finally, our findings on the impact of severity on time to 
treatment may not be generalizable to patients with missing HoNOS. Although 
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differences in observed characteristics between the subsamples with and without 
HoNOS were very small, some unobserved factors may be related to both the fact of 
not having received a HoNOS measurement and the time-to-treatment. 
 
4.5 Conclusions 
Our study entails a number of important policy implications. First, the growing public 
awareness about the importance of early access to treatment for patients seeking EIP 
care was associated with improvements in patient waiting times. However, the 
growing political emphasis on waiting times may have put implicit clinical priorities 
at stake. Particularly at the early stages of the total waiting time, when providers are 
not yet able to judge the patient’s severity of condition, more severely affected patients 
are in danger of being disadvantaged. Future work should aim to analyse other 
potential sources of undesired behavioural changes such as redistribution of resources 
across different services within a provider in order to meet targets.  
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5. Chapter: The effects of the EIP waiting time 
target 
____________________________________________________________________ 
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5.1 Introduction 
As introduced in section 1.2.2, England has had a nationwide EIP implementation 
strategy from the early 2000s onwards (Joseph and Birchwood, 2005). However, EIP 
provision began to decline after initial funding (Marwaha et al., 2016) and first 
evidence of referral-to-treatment waiting times recently showed an increase in waiting 
between 2009 and 2013 (Kirkbride et al., 2017). In this context, the English 
government introduced the first waiting time target in mental health history 
(Department of Health, 2014a). From April 2015, 50% of patients being referred to an 
EIP service were expected to wait no longer than 14 days from referral to treatment. 
Waiting time targets are a common strategy to tackle excessive waiting times in a 
number of countries and areas of health care (Willcox et al., 2007). To date it is 
however unknown whether a comparable target within the mental health context can 
be similarly effective.  
This chapter investigates the effects of the EIP target after the first six months of its 
implementation. We exploit the fact that patients with first-episode psychosis may 
receive care from two different service models: EIP care or standard community 
mental health care (standard care in the following). Whereas EIP patients are affected 
by the target policy, standard care patients are not and hence serve as our control group. 
Assuming that on average both groups would have common trends in the absence of 
the policy, the control group provides an estimate for the post-policy outcome of the 
treatment group had they not been affected by the target policy (Dimick and Ryan, 
2014; Abadie, 2005). We use controls that had no access to EIP services within 15 
kilometres travel distance. Travel time can be interpreted as a nonmonetary price for 
obtaining care and it has been found to be strongly associated with health care 
utilisation (Fortney et al., 2005). Psychotic care requires the patient to travel to services 
several times a week over a period of up to three years in order to receive various 
interventions. We assume that a patient who is actually eligible for EIP care but would 
have to face a long travel distance to receive it, would rather be treated by a comparable 
standard care service nearby. We assume this patient would not necessarily be different 
in terms of severity of condition and need of treatment. However, to ensure 
comparability between groups, we employ matching methods to control for observed 
characteristics (Heckman et al., 1998) with a difference-in-difference regression model 
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which further accounts for unobserved time-invariant components (Jones and Rice, 
2011; Angrist and Pischke, 2009). We use coarsened exact matching (Blackwell, Iacus 
and King, 2009) and propensity score matching (Rosenbaum and Rubin, 1983) to show 
that results are robust against the choice of the matching method.  
To our knowledge, we are the first to evaluate the impact of a waiting time target in 
the mental health care context. Evidence has shown that providers do respond to 
waiting time targets in line with its intended objective (Propper et al., 2010; Besley, 
Bevan and Burchardi, 2009; Propper et al., 2008). Studies are however limited to state-
level analyses in the area of physical health care. We contribute to the existing 
literature in a number of ways. First, our study moves beyond the state-level by 
analysing patient individual waiting times. This allows us to control for potential 
changes in case mix over time and further assures that both groups have been exposed 
to the same institutional setting. We analyse the probability of waiting below target at 
patient level and aggregate waiting times at provider level to analyse changes at 
different percentiles of the waiting time distribution. Data at provider level further 
allow us to test for some unintended provider responses to the target policies which 
have been investigated in the past (Propper et al., 2010; Kelman and Friedman, 2009). 
Second, we choose a control group with no access to EIP services in a certain travel 
distance. For this, we create a novel dataset on the regional distribution of EIP and 
standard care services across England and calculate travel distances for patients. Third, 
we combine our difference-in-difference approach with non-parametric matching. Pre-
processing the data through matching leads to less model dependence and reduced 
statistical bias in the regression analysis (Ho et al., 2007). Finally, the EIP target 
operates in a different institutional setting which may lead to different responses to 
performance targets. In contrast to single-event surgical procedures provided in 
hospitals, we focus on services which are provided by stand-alone multidisciplinary 
teams within the community that deliver treatment in regular sessions over a period of 
up to three years (NICE, 2015). Also, the need for treatment in the case of psychosis 
is urgent rather than elective. Unlike target policies in the past, the EIP target is not 
accompanied with aggressive penalties but relies on the response of providers to the 
publication of performance data. Hence, we provide evidence on provider’s responses 
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to performance targets without direct financial penalties (Smith et al., 2009; Propper 
and Wilson, 2003).  
Our work will be of relevance to policymakers as it informs the future development of 
the English target policy and its potential international adaptation. We do not only 
provide novel information about EIP service availability and travel distances within 
the English NHS but also reveal and compare waiting times for both EIP and standard 
care patients for a large national cohort of first-episode psychosis patients. Hence, this 
study contributes to a still ongoing discussion whether specialised EIP services are 
superior to standard care in providing early access to care (Marwaha et al., 2016). 
 
5.2 Methods 
5.2.1 Difference-in-difference model 
We use a difference-in-difference approach at the patient level to extract the effect of 
the EIP target on the probability of waiting below target (Y). For patient ! in provider " at time	$, we estimate the model detailed in Equation 5.1. 
Equation 5.1: %&'( = * + ,-./0( + 102340&' + 5602340&' × -./0(8 + 9:&'( + ;' + <&'( 02340&'	is a dummy variable indicating whether the patient received EIP care, and -./0(	is a dummy variable for whether the patient was referred in the post-policy 
period. :&'(	is a set of patient-level characteristics to account for time-varying 
differences in patient severity across the treatment and control groups and mitigate the 
effects of compositional changes over time. It contains the variables age, male, single, 
non-white, unemployed, no fixed accommodation, neighbourhood deprivation 
quintile, overall disease severity, severity of psychotic symptoms, schizophrenia 
diagnosis, first-episode psychosis cluster, referral priority and referral source. Fixed 
effects ;' for 58 mental health providers control for any time-invariant differences. <&'( represents the idiosyncratic error.  
The coefficient 5̂ yields the difference-in-difference estimate of the policy effect. It 
can be interpreted as the population average treatment effect which represents the 
expected gain from the target policy for an individual randomly selected from the 
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treated population (Jones and Rice, 2011). We expect the probability of EIP patients 
to wait below the target to increase in the post-policy period (5̂ > 0). We estimate 
Equation 5.1 as a linear probability model using ordinary least squares regression. For 
the linear probability model, the regression is inherently heteroscedastic which is why 
we use robust standard errors that are clustered at the provider level. 
In a second step, we aggregate our data at the provider level with one observation per 
provider, per quarter and per treatment. We weighed each observation of provider p in 
quarter t and treatment by a weight equal to each provider’s number of EIP and 
standard care patients in a given quarter as a share of all EIP and standard care patients 
in that quarter. We analyse the policy effect at different percentiles of the waiting time 
distribution using ordinary least squares regression. Further, we look at some 
potentially unintended effort substitution of providers due to the increased target 
pressure. Providers could, for example, decrease the length of treatment of existing 
patients or accept fewer patients onto the caseload in order to free up resources and 
use the additional resources to improve target performance. Therefore, we analyse 
changes in length of treatment and in the number of newly accepted patients onto the 
caseload. 
 
5.2.2 Pre-processing the data through matching 
The credibility of the difference-in-difference approach in identifying the policy effect 
depends on the comparability of the treatment and control group in terms of observed 
as well as unobserved characteristics. In our case the assignment to EIP and standard 
care is not random. Patients access services through various routes (Singh and Grange, 
2006). Most commonly they will be referred by a health professional, or patients may 
self-refer. Whereas EIP services are exclusive to first-episode psychosis patients 
between the ages of 16 and 35, standard care is not limited to psychotic conditions and 
patients may enter services at all ages. Hence, we expect patients in the treatment group 
to be younger and having a more severe or further developed psychotic condition than 
standard care patients.  
We use matching as a non-parametric method to balance the treatment and control 
group in terms of potentially confounding pre-treatment control variables before 
applying our regression model. We perform two different well-established matching 
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methods: coarsened exact matching (CEM) and propensity score matching (PSM). The 
CEM algorithm performs exact matching on coarsened data to determine matches. 
Coarsening means that substantively indistinguishable values are grouped together and 
get assigned the same numerical value. CEM then sorts all observations that have 
identical values for all the coarsened pre-treatment covariates into strata and discards 
all observations within any stratum that do not have at least one observation for each 
unique value of the treatment variable (Blackwell, Iacus and King, 2009). However, 
the more covariates there are to be matched, the less likely it is to find a suitable control 
unit. As a consequence, unmatched treatment units have to be excluded from the 
analysis and the estimated treatment effect is redefined to the area of common support 
(Jones and Rice, 2011). In contrast, PSM is an approximate matching method that 
identifies control units which are close to the treated unit in terms of the propensity 
score, i.e. the probability of being treated conditional on the covariates (Rosenbaum 
and Rubin, 1983). This less restrictive method allows for more treatment units to 
remain in the final estimation sample. We conduct a nearest-neighbour propensity 
score matching with replacement and enforcing common support (without caliper). 
Controls with identical (tied) propensity scores were also matched to the nearest 
neighbour. 
In both approaches, we match on patient demographic factors (age, male, single, non-
white, neighbourhood deprivation quintile) as well as on variables related to the 
patient’s psychotic condition (severity of psychotic symptoms, schizophrenia 
diagnosis, first-episode psychosis cluster). For the two continuous variables (age and 
HoNOS score as severity measure), we use the automated coarsening to perform CEM. 
That is that the bin size was chosen automatically since we do not have a theory about 
meaningful breaks within the data. Matched units were assigned a weight which was 
entered as an inverse probability weight to the regression based on Equation 5.1. Any 
residual difference in the groups after matching was accounted for by the patient 
characteristics vector in the model. We assessed balance by t-tests of mean differences 
for individual covariates, and the reduction in standardized percentage bias 
(Rosenbaum and Rubin, 1985). 
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5.2.3 Validation of the difference-in-difference approach 
The difference-in-difference method assumes common time trends for both the treated 
and the control group (Jones and Rice, 2011). This means that in the absence of 
treatment, the average change in the outcomes would be the same for treated as for 
untreated individuals. If the assumption is violated, the estimated treatment effect 
would be confounded with a natural time trend. We examine the assumption by testing 
whether linear pre-policy trends are statistically different between the treatment and 
the control group. If both groups have common trends prior to the policy, then there is 
a reasonable expectation that outcomes would also change post-policy at similar rates 
in the absence of the intervention (Ryan, Burgess and Dimick, 2015; Dimick and Ryan, 
2014). Hence, we re-run the regression based in Equation 5.1 including a full set of 
quarter dummies and an interaction of the dummies with the treatment indicator to 
model differential trends for treatment and control groups.  
The assumption would further be violated if waiting times already changed prior to the 
policy implementation, in anticipation of the policy change. In chapter 4, we showed 
that anticipatory effects were likely to have happened. In October 2014, EIP services 
were officially announced to be affected by a target. We therefore omit the two quarters 
from October 2014 to the start of implementation in April 2015 from the analysis. 
Another requirement for our difference-in-difference approach to be valid is that the 
comparison group is not affected by the intervention. That is, the target policy does 
not spill-over from EIP services to standard care services (Ryan, Burgess and Dimick, 
2015). Since mental health providers may offer both, EIP and standard care, there is a 
possibility of spill-over effects in two directions. First, providers may re-allocate 
resources to enhance EIP target performance at the expense of poorer standard care 
performance. Second, the increased effort to improve access for EIP patients will lead 
to improvements in access for standard care patients as well. To investigate the 
possibility of any spill-over effects we make use of the fact that some providers in our 
sample offer standard care only. Whereas providers offering both service models and 
thus experiencing target pressure for their EIP patients may spill-over resources, 
providers offering standard care only are less likely to be affected by the EIP target 
policy. Hence, we repeat our main analysis with a control group that is limited to 
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patients being with providers that only offer standard care, to see whether we observe 
the same policy effect as for the full sample.  
Additionally, we compare standard care outcomes pre- and post-policy for providers 
that offer both service types (treatment) with those that offer standard care only 
(control). The model is identical to Equation 5.1 with the only difference being the 
treatment indicator. We use the same matching procedure, outcome variables and 
estimation methods as introduced above. 
5.3 Data and measures 
5.3.1 Sample 
We use patient-level data from the MHLDDS introduced in section 1.4.1. We define 
the pre-policy period from April 2011 to September 2014 (14 quarters), and post-
policy from April 2015 to November 2015 (3 quarters). The period of anticipation 
from October 2014 to March 2015 was omitted. 
In accordance with the policy guideline, our treatment group includes patients aged 16 
to 35 years and being referred to an EIP service (NHS England, 2015). Standard care 
patients are identified by having had a community mental health care episode within 
the study period. To select EIP-eligible patients from this group, we combined a 
number of criteria which have been used in previous literature (Kirkbride et al., 2017; 
Tsiachristas et al., 2016). Standard care patients must have had either a diagnosis of 
schizophrenia, been classified into the first-episode psychosis cluster, or reported 
problems associated with hallucinations and delusions. Further, we limit our control 
group to EIP-eligible patients that had no access to EIP services within 15 kilometres 
travel distance. We assume that a patient who is actually eligible for EIP care but 
would have to face a long travel distance to receive it would rather be treated by a 
comparable standard care service nearby. This patient would, however, not necessarily 
be different from an EIP patient in terms of severity of condition and need of treatment. 
We use item 6 of the HoNOS which was introduced in section 1.4.1 and discussed 
more detailed in chapter 3 as our main measure of psychotic symptom severity. Since 
the measure was important to ensure comparability between groups in terms of 
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symptom severity, we excluded patients with missing HoNOS records from the 
analysis.  
 
5.3.2 Outcome measures 
The policy guideline monitors the time from referral to treatment (NHS England, 
2015). Treatment is defined as the patient’s acceptance onto the caseload and the 
assignment of a care coordinator. Thus, we measure referral-to-treatment waiting time 
as the days from referral to care coordinator assignment (see section 1.4.2 for more 
details). Based on this, we created a dummy that equals 1 if the waiting time was 14 
days or less, and 0 otherwise. Length of treatment is measured as the number of days 
from start to end of the first EIP or standard care episode (recurrent episodes not 
included). We use the logarithm of waiting time and length of treatment to account for 
the right-sided skewness. 
 
5.3.3 Service availability and travel distances 
The MHLDDS provides information on the mental health provider the patient was 
receiving care from and the type of care (EIP or standard care). However, no 
information is available on how many EIP and standard care teams a provider has and 
which of the teams the patient received care from. In order to identify providers that 
offer both or only one of the service models as well as to calculate travel distances for 
patients, we generated a novel dataset on the number and location of EIP and standard 
care teams per provider across England. We manually researched all provider websites 
to collect address information of all relevant service teams and double-checked 
whether the identified teams were registered as a site with an NHS (or care) provider 
based on information published online by NHS Digital. Based on this list, we 
calculated travel distances from the patient’s place of residence to the nearest EIP team 
(which is not necessarily the one a patient was receiving care from). We measured 
distance in a straight line from the geographical centroids of the 2001 LSOA to the 
grid reference of the service’s postcode using Stata 14 MATA. 
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5.4 Results 
5.4.1 Descriptive statistics 
In total, we identified 17,472 EIP and 23,554 EIP-eligible standard care patients. We 
included 5,625 (32%) EIP patients with valid HoNOS records. From the 12,404 (53%) 
standard care patients with a valid HoNOS record, we selected 3,702 (30%) that had 
no access to EIP care. In Appendices A19 and A20 we compare characteristics of the 
included and excluded patients. Patients excluded with missing HoNOS had a longer 
waiting time but also showed fewer other indicators of a psychosis such as a 
schizophrenia diagnosis or a first-episode psychosis cluster episode which may 
indicate that these patients are not clearly psychotic patients and are better excluded. 
Standard care patients with access to EIP (excluded) were more likely to live in the 
most deprived neighbourhoods. 
Table 5.1 compares sample characteristics of both groups before and after matching. 
Before matching, t-tests indicate the groups to be highly imbalanced on all observed 
characteristics. The EIP group was on average three years younger and more likely to 
be male, single, non-white, and from more deprived neighbourhoods. EIP patients also 
had more severe problems with hallucinations and delusions (HoNOS 6 score) and 
were more likely to be diagnosed with schizophrenia or allocated to the first-episode 
psychosis care cluster. Although some differences in group means remain after 
matching, the observed mean bias between the two groups reduced substantially from 
39.1 to 17.1 after CEM and 4.9 after PSM, respectively. PSM seems to have performed 
better particularly in balancing the psychosis related characteristics. 
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Table 5.1: Sample characteristics before and after matching 
  Unmatched Matched controls 
Patient characteristic Treated Controls CEM PSM 
Age (mean) 22.7 26.0*** 22.4* 22.5* 
Male (%) 0.66 0.48*** 0.66 0.64 
Single (%) 0.95 0.89*** 0.98*** 0.96 
Non-White ethnicity (%) 0.32 0.20*** 0.19*** 0.33 
Least deprived quintile (%) 0.11 0.17*** 0.13** 0.14*** 
Second least deprived quintile (%) 0.14 0.19*** 0.14 0.14 
Third least deprived quintile (%) 0.18 0.23*** 0.17 0.20** 
Fourth least deprived quintile (%) 0.23 0.22 0.23 0.20*** 
Most deprived quintile (%) 0.34 0.19*** 0.32 0.32 
HoNOS 6 score (range 0-4, mean) 1.99 1.51*** 1.66*** 1.78*** 
Schizophrenia diagnosis (%) 0.20 0.06*** 0.03*** 0.18 
First-episode psychosis cluster (%) 0.72 0.11*** 0.47*** 0.72 
Note: CEM = Coarsened exact matching; PSM = Propensity score matching.   
 
Table 5.2 summarises the proportion below target and mean waiting times by treatment 
status. Independent of the matching approach, EIP patients had a significantly higher 
chance of waiting below target during the whole study period. Also, mean waiting 
times are considerably shorter for EIP patients compared to EIP-eligible standard care 
patients. 
Table 5.2: Proportion below target and mean waiting times by treatment status 
  Proportion below target Waiting time in days 
  Treated Control Treated Control 
Unmatched 0.289 0.209*** 48.6 81.7*** 
Coarsened exact matching 0.289 0.202*** 48.6 106.8*** 
Propensity score matching 0.289 0.205*** 48.1 105.0*** 
Note: * p<0.05, ** p<0.01, *** p<0.001 for p-values of t-tests of mean differences between groups. 
 
There are 58 providers in the sample with an average of 3 EIP teams and 13 standard 
care teams. 13 providers offered standard care only. Figure 5.1 maps the distribution 
of EIP and standard care (CMH for community mental health) services across England. 
The average travel distance of EIP patients to their nearest EIP service was 11 
kilometres with a minimum of 0.9 and a maximum of 87 kilometres. 50% lived no 
more than 7 kilometres, 75% no more than 15 kilometres, and 90% no more than 25 
kilometres away from the nearest EIP service. Travel distance to the nearest EIP 
service is shorter for patients in most deprived neighbourhoods (8 kilometres) 
compared to 12 to 13 kilometres for EIP patients from the least deprived 
neighbourhoods. 
105 
 
 
Figure 5.1: Regional distribution of EIP and standard care (CMH for community mental 
health) service availability in England 
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Figure 5.2 visualises pre- and post-policy trends of the probability of waiting below 
target for EIP and standard care patients before and after matching. Trends are quite 
stable and parallel between the groups between 2011 and 2013. We observe a slight 
downward trend in outcomes for both groups starting around the second quarter of 
2014. Whereas this downward trend continued for the control group post-policy, the 
probability of waiting below target increased for EIP patients after the policy 
implementation. 
 
  
Note: Vertical dashed lines indicate start of anticipation period (Oct14) and policy implementation (Apr15). 
Figure 5.2: Pre- and post-policy trends by treatment group before and after matching 
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In Figure 5.3, we present pre- and post-policy trends of outcomes aggregated at the 
provider level (based on the propensity score matched sample). We observe a similar 
downward trend in the proportion of patients waiting below target shortly before the 
start of the anticipation period and a strong increase post-policy for both groups as in 
the patient-level case. Again, the EIP group exceeded its pre-policy levels whereas the 
standard care group recovered to their pre-policy levels before the downward trend. 
For median waiting time (logarithm) and median length of treatment (logarithm), we 
see a constant downward pre-policy trend for both groups which continued during the 
period of anticipation and increased post-policy. There is no clearly identifiable trend 
in pre-policy numbers of new patients accepted onto the caseload for both groups. It 
appears that numbers dropped slightly after the anticipation of the policy change. 
 
 
Notes: Vertical dashed lines indicate start of anticipation period (Oct14) and policy implementation (Apr15). Based 
on propensity score matched sample. 
Figure 5.3: Provider-level pre- and post-policy trends in outcomes by treatment group 
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5.4.2 Estimation results 
Table 5.3 reports the patient-level estimation results from Equation 5.1. We find a 
significant positive post-policy effect for EIP patients on the probability of waiting 
below target independent of the matching method. EIP patients had a 12.2 to 19.5 
percentage point higher chance of waiting below target post-policy compared to 
standard care patients. 
Table 5.3: Patient-level difference-in-difference results of the EIP target policy effect on the 
probability to wait below target 
  (1) Unmatched 
sample 
(2) Coarsened exact 
matching 
(3) Propensity score 
matching 
Post-policy -0.50 (0.036) -0.115 (0.051) -0.121 (0.069) 
EIP patient 0.02 (0.040) 0.032 (0.042) 0.016 (0.051) 
Post-policy for EIP 0.122* (0.049) 0.172** (0.059) 0.195** (0.073) 
Observations 8,393   3,712   6,873   
Note: * p<0.05, ** p<0.01, *** p<0.001. Regression based on Equation 5.1. Pre-policy: Apr11 to 
Mar15; post-policy: Apr15-Nov15. Oct14-Mar15 omitted. Cluster robust standard errors in 
parentheses.  
 
The linear predictions of the probability of waiting below target based on the 
difference-in-difference estimation are presented in Table 5.4. In the unmatched 
sample, the probability of waiting below target for EIP patients increased from 27% 
prior to the EIP target implementation to 34% after the policy implementation. In 
contrast, the probability of standard care patients decreased from 25% pre-policy to 
20% post-policy. Probabilities are similar after coarsened exact matching and 
propensity score matching.  
Table 5.4: Linear predictions of the probability of waiting below target 
Unmatched sample Pre-policy   Post-policy   
  Mean 95% Conf. Int. Mean 95% Conf. Int. 
EIP care 0.27 [0.23-0.30] 0.34 [0.29-0.38] 
Standard care 0.25 [0.20-0.29] 0.20 [0.12-0.27] 
CEM sample Pre-policy   Post-policy   
  Mean 95% Conf. Int. Mean 95% Conf. Int. 
EIP care 0.24 [0.20-0.29] 0.30 [0.24-0.36] 
Standard care 0.21 [0.17-0.25] 0.10 [-0.01-0.21] 
PSM sample Pre-policy   Post-policy   
  Mean 95% Conf. Int. Mean 95% Conf. Int. 
EIP care 0.26 [0.21-0.32] 0.34 [0.28-0.40] 
Standard care 0.25 [0.20-0.30] 0.13 [-0.01-0.26] 
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A main limitation of the linear probability model is that the fitted values of our 
difference-in-difference estimate will not necessarily be in the [0,1] interval (Cameron 
and Trivedi, 2010). Appendix A21 shows that the predicted probabilities are below 
zero at the lower end of the distribution. 
We observe a similarly consistent effect on the proportion of waiting below target at 
the provider-level, independent of the matching method (see Table 5.5, panel 1). The 
proportion of EIP patients waiting below target increased by 12.0 to 15.4 percentage 
points per provider post-policy. However, there was no policy effect on the median 
waiting time (panel 2). The CEM-matched estimates indicate that median waiting 
times were significantly lower for EIP patients compared to standard care patients. 
 
Table 5.5: Provider-level difference-in-difference results of the EIP target policy effect on 
various outcomes 
(1) Proportion below target (1) Unmatched  
sample 
(2) Coarsened exact 
matching 
(3) Propensity score 
matching 
Post-policy -0.036 (0.024) -0.051 (0.026) -0.051 (0.028) 
EIP patient 0.019 (0.122) 0.064* (0.032) 0.071 (0.054) 
Post-policy for EIP 0.120* (0.048) 0.154** (0.048) 0.131* (0.051) 
Observations 1527   1400   1468   
(2) Median waiting time 
(logarithm) 
(1) Unmatched  
sample 
(2) Coarsened exact 
matching 
(3) Propensity score 
matching 
Post-policy -0.522* (0.203) -0.610** (0.215) -0.391* (0.188) 
EIP patient -0.324 (0.630) -0.518* (0.195) -0.431 (0.240) 
Post-policy for EIP -0.094 (0.226) 0.118 (0.248) -0.047 (0.229) 
Observations 1392   1214   1303   
(3) Median length of 
treatment (logarithm) 
(1) Unmatched  
sample 
(2) Coarsened exact 
matching 
(3) Propensity score 
matching 
Post-policy -0.964*** (0.112) -0.888*** (0.131) -0.927*** (0.131) 
EIP patient 0.354 (0.756) 0.411 (0.212) 0.658* (0.270) 
Post-policy for EIP -0.278 (0.154) -0.121 (0.164) -0.329 (0.173) 
Observations 1527   1400   1468   
(4) New patients on 
caseload (logarithm) 
(1) Unmatched  
sample 
(2) Coarsened exact 
matching 
(3) Propensity score 
matching 
Post-policy -0.541** (0.156) -0.484*** (0.139) -0.490*** (0.116) 
EIP patient -0.357 (0.708) -0.540** (0.202) -0.121 (0.205) 
Post-policy for EIP 0.151 (0.181) 0.137 (0.159) 0.143 (0.153) 
Observations 1527   1400   1468   
Note: * p<0.05, ** p<0.01, *** p<0.001. Regression based on Equation 5.1. Pre-policy: Apr11 to Mar15; post-
policy: Apr15-Nov15. Oct14 to Mar15 omitted. Cluster robust standard errors in parentheses.  
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But for all samples, median waiting times significantly decreased for standard care 
patients post-policy. We also could not find any policy effect for other parts of the 
waiting time distribution such as the 25th and 75th percentile or the mean (results not 
reported). We find evidence that median length of treatment decreased post-policy for 
standard care patients but not for EIP patients (panel 3). We observe the same effect 
for the 75th but not for the 25th percentile of the distribution (results not reported). 
Similarly, we find that standard care providers accepted fewer patients onto their 
caseloads after the EIP target introduction compared to before without any effect on 
the number of new EIP patients accepted onto the caseload (panel 4). 
5.4.3 Validation checks 
In the following we discuss the results from the validation checks detailed in section 
5.2.3. The analysis of pre-policy trends showed no significant difference between the 
two comparison groups. Appendix A22 presents the treatment specific referral quarter 
estimates for both the CEM and the PSM matched samples. From the non-significant 
pre-policy trends, we conclude that the common trends assumption is likely to hold. 
We do, however, observe significantly different trends during the time of anticipation 
which confirms our approach to exclude the quarters of anticipation from the main 
analysis. 
Results from the test of potential spill-overs from EIP to standard care services are 
presented in Appendix A23. We observe the same positive policy effect on the 
probability of waiting below target when limiting the control group to patients that 
were with providers offering standard care only for both matching approaches (panel 
1). It needs to be noted, that the number of controls is very small due to the additional 
exclusion criterion (683/776 controls after CEM/PSM). Comparing standard care 
outcomes of providers offering both service models to those offering standard care 
only, did not show any significant differences in post-policy trends (see Appendix 
A23, panel 2). Overall, we conclude that the impact of any spill-over effects if any was 
small. 
5.5 Discussion 
Access to specialist services at the early stages of psychosis is critical to successful 
treatment and recovery. EIP services are internationally recognised as supporting 
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timely provision of evidence-based care to psychotic patients. However, in times of 
financial constraints EIP services may not always be able to meet the desired standards 
of providing rapid access for patients in need. To tackle increasing waiting times, the 
English government pioneered the introduction of a waiting time target for EIP 
services. This chapter examined the effectiveness of this target policy in improving 
access for first-episode psychosis patients. We make use of a difference-in-difference 
design which is a well-established method to evaluate the impact of health policy 
interventions in the absence of randomized controlled trial data. We find the EIP target 
to be effective in increasing the number of patients waiting below target in the first six 
months of its implementation. However, waiting times across the whole distribution 
have not changed differently compared to standard care patients. We find no evidence 
that providers freed up resources by shortening treatment for existing EIP patients or 
accepted fewer EIP patients onto the caseload due to the target pressure. 
Our research moves beyond previous work on the effectiveness of waiting time targets 
which is limited to country level comparisons as we are able to compare two patient 
groups being treated within the same institutional setting. This allows us to measure 
and compare waiting times at the patient level and thus adequately control for changes 
in case mix over time and between groups. The challenge lies in ensuring 
comparability between the groups in terms of variables that may also be associated 
with waiting time. We select control patients with no access to EIP services within a 
certain travel distance to improve comparability of groups. Furthermore, the 
combination of matching and the difference-in-difference design allows us to balance 
the groups on observed as well as unobserved confounders. Whereas the regression 
model accounted for any remaining imbalances after matching through adding 
additional covariates, the non-parametric matching helped to reduce model 
dependence and statistical bias. We found our matching approach to reduce bias in 
observed characteristics between the two groups substantially. Validation checks 
further indicated that the common trends assumption was likely to hold and potential 
spill-overs between EIP and standard care patients was negligible. 
There are some limitations to our research. First, our post-policy period is relatively 
short due to the fact that the collection for MHLDDS temporarily stopped in November 
2018 in order to introduce a revised dataset version from April 2016 onwards which is 
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not yet available for research. Hence, we are only able to look at the first six months 
of the implementation process. Over time, effects may either become larger once more 
providers respond to the target policy at later stages, or effects may disappear over 
time as providers only temporarily focus on the newly introduced target. In future, as 
more service types are expected to be affected by similar waiting time targets, the 
interplay between the response to the different targets by a provider will be important 
to investigate. Second, the t-statistic for our difference-in-difference estimate and in 
consequence its significance level may be overestimated due to the 13 pre-policy 
quarters being serially correlated as discussed by Bertrand, Duflo and Mullainathan 
(2004). To solve the potential problem of serial correlation, future work could 
aggregate the time series into two periods – pre-policy and post-policy. The difference-
in-difference analysis is then performed on the averaged outcome in a panel of two 
time periods. Alternatively, one could use the variation across providers to estimate 
the variance-covariance matrix and compute standard errors from this estimated 
matrix. This method will produce consistent estimates of the standard error as the 
number of providers goes to infinity. Third, despite various measures to improve 
comparability between the groups, our results may still be driven by group differences 
that we were not able to account for but had an impact on patient waiting times. 
Nevertheless, there is no other potential control group to our knowledge which would 
be better suited to analyse our research question. Since the policy was introduced 
nationwide, we cannot exploit regional variation in policy implementation. At the 
same time, England is to date the only country collecting data which allow the 
measurement of EIP waiting times. Hence, a comparison at country level, for example 
using Scotland as control group, as performed in previous literature (Propper et al., 
2010, 2008) would not be possible in our case. Having said this, our measured 
treatment effect is defined for patients under common support – so for patients that 
were comparable in terms of observed characteristics. We cannot conclude from our 
results to what extent the estimated effect is generalisable to the whole population of 
EIP patients. However, using the national administrative database allowed us to draw 
our estimation sample from a nationally representative patient cohort including a large 
number of mental health providers across England. This is an advantage compared to 
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existing literature in the area of psychosis which usually relies on much smaller, 
regionally limited patient cohorts from only one or two providers. 
Our research will be of great relevance to policymakers not only in England but 
internationally. Waiting times are a persistent policy concern in many countries and 
its importance is growing, particularly in the area of mental health. We provide novel 
evidence on the responsiveness of mental health providers towards waiting time 
targets. As such, our work translates well established knowledge and experience from 
the physical health area to the mental health context which entails a separate group of 
providers acting in different incentive systems and providing different treatment 
concepts. We show that targets can be an effective means to improve access to mental 
health care. Our research can help inform the future development of the EIP target and 
its expansion to other areas of mental health in England, as well as informing 
policymakers in other countries considering the introduction of a similar policy.  
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6. Conclusion 
____________________________________________________________________ 
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6.1 Research overview 
This thesis analysed various concepts of waiting times for first-episode psychosis 
patients in the context of the implementation of a waiting time target for EIP services 
in the English NHS. Waiting times are a persistent concern of policy makers in 
publicly funded health care systems such as the English NHS. On the one hand, waiting 
lists can serve to stock available demand and optimise utilisation of the scarce supply 
of resources such as skilled staff and medical equipment. But on the other hand, a 
patient’s health status may deteriorate during the time of waiting and will make the 
awaited treatment less likely to be successful. For patients, the time of waiting matters, 
as they may experience pain, anxiety, disability, and restrictions in their job and family 
commitments. In the case of psychosis, patients usually experience a significant 
amount of suffering as symptoms lead to a high degree of disability, and social 
isolation. Timely access to specialised care is considered a key priority in successful 
treatment of psychosis. Despite this, little evidence exists about waiting times for 
people with psychosis at various stages of their care pathway. 
We analysed a number of different well-established waiting time measures and 
discussed each measure’s strengths and limitations in the context of the analysis. We 
made use of econometric methods that allowed us to adequately account for the count 
data properties of waiting time (generalised linear models and quantile regression) as 
well as the problem of right censoring of samples in waiting time studies (duration 
analysis). We applied quasi-experimental methods to solve the evaluation problem 
when analysing policy effects using observational data (matching and difference-in-
difference). 
In chapter 2, we investigated inequalities in DUP associated with socioeconomic 
deprivation in a national cohort of first-episode psychosis patients in England based 
on the MHLDDS. We used a generalised linear model to account for non-linearity in 
DUP and looked at inequalities across the whole distribution of DUP using quantile 
regression. Although there is a large body of literature on DUP in England, we were 
the first to use administrative data to build a nationally representative patient and 
provider sample. This is particularly important when looking at socioeconomic 
deprivation as it allows one to include patients and providers from all levels of 
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deprivation. Further, we advanced the existing literature methodologically. We moved 
beyond the common analysis of correlations in this area as our regression model 
accounted for a large number of potential confounders such as demographic factors, 
disease history, and service use variables. We were also the first to use count data 
model techniques and quantile regression in this context. We found evidence of 
significant inequalities in DUP regarding the level of socioeconomic deprivation with 
considerable variations between and within mental health care providers. Patients 
living in the second, third, and fourth deprived neighbourhood quintiles faced a longer 
DUP than patients from the least deprived neighbourhoods. Inequalities were more 
prevalent in higher quantiles of the DUP distribution. Also, unemployment – as a 
patient-level measure of socioeconomic status – showed to be a significant 
contributing factor to a longer DUP. At the same time, having been in contact with 
mental health care services prior to the psychosis start significantly reduced DUP. 
Chapter 3 contributed to the still ongoing discussion of whether waiting time is 
associated with worse treatment outcomes. We explored the impact of waiting times 
on patient outcomes in the context of EIP services in England using a national cohort 
of EIP patients from the MHLDDS. Whereas a large body of literature investigated the 
relationship between waiting time and outcomes in the physical health care context, 
little is known about delays in accessing specialist care and treatment outcomes in the 
case of psychosis. The distinct feature of EIP services is that treatment is delivered 
over several months or years and treatment intensity can vary from patient to patient. 
In contrast to previous studies that looked at outcomes immediately after a single 
treatment event, we looked at patient outcomes after twelve months adjusting for 
treatment intensity during this time period. As an outcome measure, we used the 
routinely collected HoNOS. The methodological challenge in this context is the 
potential endogeneity of waiting time as the patient’s outcome twelve months after 
treatment will not only depend on her waiting time but also her level of severity before 
the waiting started. We controlled for baseline HoNOS at treatment start, previous 
service use, and treatment intensity to account for this potential endogeneity. Using 
HoNOS further allowed us to advance the analysis by estimating the impact of waiting 
time on a clinically reliable and significant change in HoNOS. Our results showed that 
longer waiting time was significantly associated with a deterioration in patient 
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outcomes twelve months after acceptance for treatment for patients that are still in EIP 
care. Effects were strongest for waiting times longer than three months. Although 
effect sizes were small to moderate, we found the change in HoNOS to be reliable and 
clinically significant. Patients with shorter EIP treatment periods were not affected.  
Chapters 4 and 5 focused on the recently introduced EIP waiting time target and 
providers’ potential responses to it. Performance measures such as waiting time targets 
incentivise providers to improve the targeted outcome dimension. Even without direct 
financial penalties, providers may expect reputational damage from poor performance 
which makes them work towards an improved target performance. At the same time, 
being under pressure to serve a number of objectives, providers may also take 
unintended actions to make target performance look better than it actually is. For acute 
health care trusts, it has been shown that providers indeed respond to enforced waiting 
time targets in both intended and unintended ways. Mental health care trusts, however, 
comprise a different group of providers acting in different market structures and 
incentive systems (e.g. payment systems). Therefore, it is important to investigate 
whether the same changes in behaviour can be observed for mental health trusts 
compared to acute physical health trusts. We looked at both, intended as well as 
unintended, effects of the EIP target policy. Since this is the first waiting time target 
that has ever been introduced for mental health services, we provide novel evidence in 
this context. 
In chapter 4, we analysed potential anticipatory effects of the EIP target policy in a 
sense that providers may have changed behaviour before the actual implementation of 
the policy in order to avoid poor performance from the start. EIP treatment is 
characterised by long enduring treatment processes with relatively inflexible pathways 
which is why the re-allocation of resources may require a longer period of adaptation. 
Hence, anticipatory behaviour of mental health providers is likely to happen and 
important to explore in order to be considered in the actual evaluation of the policy 
effect itself. The analysis was based on a national cohort of EIP patients from the 
MHLDDS. We investigated whether changes in waiting time were associated with the 
announcement of the EIP target policy (intended effect). Additionally, we explored 
two potentially unintended changes in behaviour providers may have adapted to 
improve target performance. First, we analysed whether changes in waiting time varied 
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by the referral priority or disease severity (re-prioritisation). To explore gaming 
behaviour, we tested whether providers initially focused on improving time from 
referral to EIP caseload acceptance but at the same time took longer to assign patients 
to a care coordinator. Although the care coordinator is crucial to the effective delivery 
of treatment it was announced only later in time as being required in order to stop the 
waiting time clock. We used duration analysis to overcome the challenge of right-
censoring in waiting time studies and account for a patient’s time in study. Our results 
showed that waiting times improved already in the years leading towards the target 
implementation. So, providers may indeed have changed their behaviour already in 
anticipation of the target policy. Providers accepted patients earlier for EIP treatment 
following the first announcement of the EIP target in October 2014. Time until the 
assignment of a care coordinator also improved after the second announcement of the 
care coordinator requirement in February 2015. We found no evidence that providers 
gamed the target and also only little indication of re-prioritisation. 
In chapter 5, we evaluated the effects of the EIP waiting time target for a national 
cohort of first-episode psychosis patients from the MHLDDS. We compared patients 
being treated by EIP services (treatment) with EIP-eligible patients receiving care from 
standard community mental health services (control) pre- and post-policy. Combining 
non-parametric matching with a difference-in-difference approach allowed us to 
account for observed as well as unobserved group differences. We analysed the 
probability of waiting below target at patient level and looked at changes in waiting 
time at different percentiles of the distribution at provider level. We restricted our 
control group to patients with no access to EIP services in the certain travel distance. 
For this, we created a novel dataset which provides information on the number and 
location of EIP and standard care services of each mental health trust across England 
and calculated patients’ travel distances to the nearest EIP service. Our results showed 
that the EIP waiting time target was effective in increasing the likelihood of waiting 
below target for EIP patients compared to standard care patients. However, the waiting 
time distribution did not significantly change post-policy. We found no evidence that 
length of treatment decreased post-policy for EIP patients due to the increased target 
pressure. Also,  providers did not accept fewer EIP patients onto the caseload. 
119 
 
6.2 Implications for research, policy and practice 
6.2.1 The relevance of waiting times for first-episode psychosis 
The research presented in this thesis has implications for a number of stakeholders 
such as policymakers, commissioners, providers, mental health service users and their 
caring families as well as agencies outside the health system. The relevance of waiting 
times for first-episode psychosis patients to specialist services is multi-dimensional. 
First, providing timely and equitable access is not only one of the main corner stones 
in modern health systems in general (Willcox et al., 2007), it also has been particularly 
articulated as a major policy aim in the recent mental health policy initiative in the 
English NHS (Department of Health, 2014a). Especially when waiting times are 
unequally distributed between certain patient groups, as we could show in chapter 2 
for socioeconomically disadvantaged patients, the desired policy aims are threatened. 
Second, previous research has undoubtedly shown that early access to specialist 
services in the case of psychosis is crucial in order to promote treatment engagement 
and recovery as well as the risk of relapse in the long run (Penttilä et al., 2014). In 
chapter 3, we confirmed that the negative impact on treatment outcomes can also be 
shown for patients waiting for a care coordinator even after being accepted onto the 
caseload. Shorter waiting times may therefore contribute to improved health outcomes, 
reduced health service utilisation and associated costs in the future. Hence, EIP waiting 
times are also of interest for commissioners who have to manage limited budgets. 
Third, psychosis has a significant social and economic dimension which makes it of 
relevance for policymakers and agencies outside the health care system. People 
suffering from acute psychotic phases have difficulties to fulfil their family and work 
commitments. Although the prevalence is relatively low, the costs of lost employment 
are tremendous in the case of psychosis (Kirkbride et al., 2012b). The longer patients 
wait for treatment the harder it will be to not only recover in physical terms but also in 
social terms. In chapter 3, we showed that waiting time had the second largest, negative 
impact on the social outcomes sub domain (symptomatic outcome deterioration being 
the first). Re-integrating patients into society demands resources from the social care 
system. If re-integration fails, patients may become homeless or criminal which adds 
interactions with the justice system as well. Last but not least, patients and their caring 
families are interested in short waiting times to adequate services as psychosis is 
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associated with a high degree of disability, anxiety and discomfort particularly when 
untreated.  
 
6.2.2 EIP waiting times and services availability – opening the black box 
The EIP target policy has been introduced without any evidence base of the current 
situation of EIP patients. Information on waiting times was based on a measure of DUP 
drawn from small, regionally limited cohorts within one or two providers. The target 
policy is however based on the referral-to-treatment waiting time concept for which 
no evidence exists in the mental health context. Also, there exists no published 
information on the number of EIP services and their distribution across England. Our 
research opens this black box and makes waiting times and service availability for a 
nationally representative cohort of EIP patients transparent. We show and discuss 
different measures of waiting times which policymakers can compare and draw 
conclusions for future policy initiatives from. Spanning the years immediately before 
the policy introduction until half a year after, our research builds a foundation for 
policymakers to actually evaluate the impact of the EIP target policy by being able to 
observe changes from pre- to post-policy.  
We showed that regardless of the measure used there has been a long tail of very long 
waiting patients. We also found that socioeconomic inequalities are more likely to 
occur for the longest waiting patients and negative impacts on outcome prospects are 
largest for waiting times above three months. Alongside this, our research showed that 
the EIP target helped to increase the proportion of patients waiting below target but 
without improving the waiting time distribution as a whole. This implies, that the very 
long waiting patients did not benefit from this kind of policy. Future policies should 
aim to target the very long waiting patients in order to not further foster already 
existing inequalities along the waiting time distribution. Overall, we found that mean 
waiting times improved over the years towards the policy introduction. Policymakers 
may conclude that the growing awareness created by the ongoing public discussion of 
the importance of early intervention in psychosis in combination with the additional 
resources being made available may have been successful and should be continued in 
the future.  
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In chapter 5, we not only measured referral-to-treatment waiting times for EIP patients 
but also compared them to waiting times for EIP-eligible standard care patients. These 
results contribute to the still ongoing discussion about the superiority of EIP services 
compared to standard care. We showed that despite the national roll-out of EIP services 
since the early 2000’s, still a significant proportion of EIP-eligible patients are 
receiving care from standard care rather than EIP services. However, waiting times are 
on average worse for patients being treated at standard care services even before the 
EIP target policy was introduced. At the same time, we showed that patients face travel 
distances of up to 87 kilometres to the nearest EIP service (11 kilometres on average). 
Therefore, EIP services may not always be available in a manageable travel distance 
for all patients. Our results provide an evidence base for policymakers to decide how 
to shape the future relationship between EIP and standard care. Either it is accepted 
that standard care can compensate EIP treatment in areas where EIP services are not 
available for patients. In this case, they should however underlie the same waiting time 
target to not disadvantage patients using these services. Or if the policy aim is to 
provide EIP treatment for all patients in need of it, service availability clearly has to 
be enriched. At the same time, our findings are of relevance to patients and their caring 
families as they can take better informed decisions about where to seek help. 
 
6.2.3 Different concepts of waiting times and their implications 
Waiting time is one of the most important indicators within the NHS in England to 
measure and quantify access of patients to health care services. However, our research 
showed that there exist plenty of different concepts of waiting time and each has to be 
interpreted in the corresponding context. In the area of psychosis, the concept of DUP 
dominates the existing literature. As it encompasses the patient’s waiting experience 
from the first symptoms onwards, it includes the period of help-seeking which is 
crucial in the case of psychosis. It is this help-seeking period that is most likely 
influenced by factors outside the health care system such as level of education, degree 
of disease insight, knowledge about where to seek help, or the availability of family 
and other support networks. Therefore, implications drawn from DUP studies not only 
address stakeholders within the health system but also other policy areas such as the 
education sector, the justice system, or the social care system as well as patients and 
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their caring families. In chapter 2, for the first time, we showed that it is possible to 
measure DUP using the MHLDDS as an administrative dataset which allowed us to 
draw conclusions from a nationally representative sample. We found that 
socioeconomic deprivation is a contributing factor to a prolonged DUP, independent 
of a number of other patient characteristics. Understanding the factors that contribute 
to a longer DUP can help to develop initiatives for promoting access that target patient 
groups which are at particular risk of being left behind. Education campaigns could be 
launched to improve awareness of professionals which are typically the first point of 
contact for psychotic patients such as general practitioners, social workers, or teachers. 
Improved knowledge about the signs of early psychosis may help identify potential 
patients early and encourage those in contact to refer patients promptly to specialist 
services (Lloyd-Evans et al., 2011). Reducing stigma associated with psychosis 
through information campaigns for young people and their families in schools or in 
mainstream media may further promote early help-seeking (Connor et al., 2016). 
Campaigns should be tailored to target people from socioeconomically deprived areas.  
If the focus of interest lies, however, on the health care system and how health policy 
interventions such as the EIP target should be designed and evaluated, other waiting 
time concepts will be better suited. We developed a way to measure a form of 
“inpatient” waiting time for psychotic patients which has been used pre-dominantly in 
the analysis of the impact of waiting time on outcomes in the past. In chapter 3, we 
showed that the time from caseload acceptance to care coordinator assignment can 
lead to a deterioration in treatment outcomes after adjusting for treatment intensity. On 
the one hand, this is of interest for providers. If they aim to improve patient experience 
and treatment prospects, it is not only sufficient to accept patients quickly onto the 
caseload, but it is also vital to assign a care coordinator who ensures that a tailored 
care plan can be implemented. On the other hand, results are of importance for 
policymakers. The definition of the care coordinator assignment as the endpoint of the 
targeted waiting time appears to be a relevant choice if the policy’s aim is to prevent a 
waiting time induced deterioration of outcomes. However, this concept excludes the 
time from referral to EIP caseload acceptance which is also of relevance particularly 
from a patient perspective. In chapter 4, we provide a comparison between time from 
referral to EIP caseload acceptance and from EIP caseload acceptance to care 
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coordinator assignment. Since the referral may have happened in a different care 
system, i.e. the primary care sector or the justice system, it can be of interest for 
providers as well as for policymakers to see by which proportion each of the 
components contributed to the total waiting time. Based on this information, initiatives 
targeted at reducing waiting times can be better tailored. If waiting times are mainly 
caused by delays from referral to caseload acceptance, providers would rather have to 
focus on improving referral pathways and communication with their referrers rather 
than putting resources into more available care coordinators and vice versa. A 
promising approach could be the increased implementation of single access points 
which serve as a first point of contact for patients seeking help and triage patients to 
the right service according to their needs. 
To conclude, each waiting time concept has its own justification and can provide 
important implications for policy and practice. It depends on the question of interest 
when deciding which measure to prefer. At the same time, we showed that a one-sided 
focus on one concept brings the danger of providers focusing on this part of the 
patient’s waiting experience only to the exclusion of other parts of the waiting 
experience. Transparency through the routine publication of waiting time statistics will 
certainly help to limit such unintended gaming behaviour and give providers the 
opportunity to compare their own performance to others. Also, patients and caring 
families are able to identify good performing providers and choose where to seek help 
accordingly. Fostering transparency requires, however, that data structures improve to 
allow the routine collection of the various waiting time concepts. A first step has 
already been taken as a consequence of the EIP waiting time target. The most recent 
version of the MHLDDS which was not available to be used for this research includes 
a standardised measure of referral-to-treatment waiting time for EIP services. 
 
6.2.4 Intended and unintended effects of waiting time targets 
The research presented provides important evidence for the operation and future 
development of performance targets in the mental health context. The EIP target is the 
first target of its kind that has been introduced for mental health providers. We found 
that mental health providers respond to waiting time targets in a similar way as has 
been shown for the physical health context. This means that targets can also be 
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effective in a setting where services are provided by stand-alone multidisciplinary 
teams within the community; where treatment is delivered in many sessions over a 
period of several years; and where the need for treatment is acute rather than elective. 
Also, target policies in the past have been famous for the tough penalties managers 
had to face when they failed to meet the targets. In contrast, the EIP target was not 
accompanied with aggressive penalties. Hence, our results show that a change in 
provider behaviour can also be incentivised by non-monetary penalties such as 
reputational damage through the publication of performance data. Alongside this, we 
found that the public release of different levels of information about the detailed design 
of the target was associated with a corresponding change in provider behaviour even 
before the actual policy implementation. That is, providers may adapt behaviour 
already in anticipation of a policy change which has to be considered when evaluating 
the actual policy impact.   
One key result of our analysis is that providers seem to respond to targets in the exact 
way as it is defined. That is, the EIP target was effective in increasing the proportion 
of patients waiting below the 14-day target. However, waiting times did not improve 
overall at any part of the distribution. Patients that are waiting above the target may be 
in danger of waiting even longer as resources are used for patients that could still be 
treated within target. Furthermore, we observed differences in waiting times by 
priority and severity without any clear pattern. Mostly, low priority patients seemed to 
have benefitted from improvements in waiting time. One explanation is that providers 
started improving target performance by treating patients which are less severely 
affected and hence may demand fewer resources first. However, we found only little 
evidence that this happened at the expense of more severely affected patients who 
required more resources to be kept engaged in treatment and attend scheduled 
appointments. We found no evidence that providers shifted resources from patients 
already in treatment towards new patients that were about to breach the target by 
reducing length of treatment for EIP patients or accepting fewer EIP patients onto the 
caseload. 
Overall, our results provide important insights for the future development of the 
waiting time target strategy. The target is planned to be increased for EIP patients and 
extended to other mental health services in the next few years. From our research, we 
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conclude that this can be a fruitful strategy to improve access to mental health services. 
However, the exact definition of the target is crucial to its expected effects. Also, other 
non-targeted outcomes should be monitored carefully to assess the extent of potential 
negative effects. Once providers have to respond to different targets for different 
services, the interplay between the performance in these different services will be 
worth investigating in the future as well. 
 
6.3 Limitations and areas for future research 
There are a number of limitations to the work presented in this thesis which will be 
discussed in the following, alongside the outline of opportunities for future research. 
 
6.3.1 Data availability and missingness 
The length of our study periods had to be limited due to data availability. Throughout 
all the chapters, we used MHLDDS data from April 2011 and to November 2015. 
Earlier versions of the dataset were less reliable in terms of data quality which is why 
we decided not to use them for our analysis. Further, data collection stopped 
temporarily in November 2015. A new version of the dataset which also includes 
variables that support the measurement of referral-to-treatment waiting times for EIP 
patients was launched from April 2016 onwards but was not available for this research. 
This was particularly of relevance in chapter 5 where we could only measure the effect 
of the EIP target after the first six months of its implementation which is a short post-
policy period. Once, future releases of the new dataset become available the long-term 
effects of the EIP target policy should be investigated. Similarly, the follow-up period 
in chapter 3 could be increased with more data being available in order to investigate 
the long-term effects of waiting times on patient outcomes. 
Given data availability, one main limitation in working with the MHLDDS is the 
relatively high degree of missing data for some of the variables that were of interest 
for our research. The MHLDDS is designed for the primary purpose of administering 
provider payments. Hence, providers who are responsible for delivering the data will 
focus efforts particularly on data items that are relevant to their payment which are not 
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necessarily the items that are of interest for research. Consequently, coding quality of 
demographic information, diagnoses or the HoNOS is poor. 
If information on the main explanatory variable of interest was missing, we followed 
a complete-case approach by dropping patients with missing values from the analysis. 
The complete-case analysis is generally preferable in dealing with missing data in 
multiple regression analysis as it produces unbiased estimates of the coefficient of 
interest and the residual variance (Jones, 1996). However, exclusions due to data 
missingness become an issue for the interpretation of results if missing information is 
systematically related to the unobserved value itself (missing not at random) (Leurent 
et al., 2018). This may have affected our waiting time measures. Particularly in chapter 
2, the measurement of DUP relied on the psychosis related variables such as the 
emergent psychosis date and the start date of antipsychotic medication which was only 
available for a small proportion of the potential first-episode psychosis cohort. 
Comparisons with similar studies made us believe that we could still generate a 
representative sample that exceeded numbers from any previous studies. If the coding 
quality was, however, systematically different for patients from different 
socioeconomic groups, this may have affected our results. For the other chapters, the 
care coordinator assignment served as our main endpoint in order to measure waiting 
time. If a patient was not assigned to a care coordinator by the end of our data 
availability, we were not able to distinguish whether the patient was still waiting or 
whether the information on the care coordinator assignment of this patient was 
missing. Hence, we had to exclude these patients from the analysis in chapters 3 and 
5 which may have led to an underestimation of the very long waiting times especially 
towards the end of data availability. The extent to which this has happened could be 
followed up once future data releases are available. This would also allow a separate 
analysis of the very long waiters – for example in what characteristics they differ from 
short waiting patients. Policymakers may be interested in this since our research 
showed that the negative impact of waiting time on outcomes is particularly affecting 
the long waiters and also socioeconomic inequalities increase at the higher end of the 
waiting time distribution. 
In chapter 3, our outcome variable of interest was the HoNOS. The poor coding quality 
of HoNOS has been discussed in the literature already (Jacobs, 2009). Hence, we had 
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to exclude patients with missing HoNOS observations which reduced sample size 
considerably. Our strategy to reduce the number of exclusions was to widen the time 
window in which we measure the HoNOS for a patient. That means although we aimed 
to measure follow-up HoNOS scores twelve months after treatment start, we allowed 
for a measurement window of thirty days before and after the end of follow-up to 
increase the number of follow-up HoNOS scores.  
If information was missing on categorical explanatory variables which were not of 
main interest for the analysis, we followed the missing-group approach suggested by 
Cohen and Cohen (1975) to deal with missing information. That is, we created a 
separate group for patients with missing values. This approach has the advantage that 
it uses all the available information and avoids the risk of selection bias by dropping 
subjects for which missing information is not random. Also, a lower power due to the 
considerable reduction in sample size can be prevented by this procedure. The missing-
group method produces unbiased regression parameter estimates as in the case of the 
complete-case analysis. However, it overestimates the residual variance and results in 
considerably larger standard errors (Jones, 1996). 
Missing information also challenged our sample selection procedures. Diagnostic 
information which would usually be used to identify patients relevant to the study is 
poorly coded in the MHLDDS for several reasons which we outlined in section 1.4.3.  
In chapter 2, we identified first-episode patients by the psychosis related date variables 
(emergent and manifest date). Although this was necessary to measure DUP of each 
patient, we noted small patient numbers over the three-year study period which we can 
only explain by poor data quality of the psychosis variables. In the following chapters, 
we therefore used a different strategy to identify relevant patients which resulted in 
larger sample sizes overall. Next to diagnostic information, we used a number of 
additional variables in order to identify patients such as whether they received 
treatment by an EIP team; reported problems with hallucinations and delusions 
(HoNOS item 6 > 0) or were allocated to the first-episode psychosis mental health care 
cluster. This procedure may have, however, led to some inaccuracies in our samples. 
On the one hand, we may have selected patients which were actually not first-episode 
psychosis patients. On the other hand, we may have missed patients which actually 
would have been relevant to our study. We could show that our study samples had a 
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similar composition in terms of demographic characteristics as compared to first-
episode psychosis cohorts in other studies. Also, total patient numbers seemed 
plausible regarding the prevalence of first-episode psychosis in England. Additionally, 
we investigated the recently developed opportunity to link MHLDDS data to Hospital 
Episodes Statistics (HES) which provide data on inpatient admissions within the NHS in 
order to improve diagnostic information. However, this was not fruitful for three reasons. 
First, additional information was limited to patients that had an inpatient admission at 
some point which may be selective for the more severely affected patients or those with 
severe co-morbidities. Second, we found that diagnostic information in HES for the 
relevant patients was not necessarily better coded than in MHLDDS. Third, if a patient 
could be traced in both datasets information on the same variables did not often match 
between the two datasets and decisions would have to be taken on how to deal with 
conflicting data. Nevertheless, the linkage between the two datasets provides a range of 
opportunities to be exploited in the future. For example, HES also provides a linkage to 
general practitioners data as well as mortality statistics which offers opportunities to 
investigate mortality outcomes for EIP patients as well as to enrich analyses of referral 
pathways from primary care. 
Another point to mention is that data missingness may vary between providers which 
may in turn be related to provider performance such as waiting times. By excluding 
patients with missing information from the analysis we may also exclude providers 
with poorer overall performance. The exclusion of patients in our research did however 
never result in a large number of providers being excluded. 
 
6.3.2 Estimating waiting time 
Another main limitation of our research is that the procedures we developed to estimate 
waiting times are based on certain assumptions. In chapter 2, we estimated DUP using the 
recorded emergent date and treatment start date. It is a well discussed limitation of the 
DUP concept in general that the definition of the two points may vary across studies which 
leads to considerably different lengths in DUP (Register-Brown and Hong, 2014; Large 
et al., 2008; Singh, 2007). We chose a conservative approach by using the emergent 
date as the start point compared to the prodrome or manifest date. This may have led 
to an underestimation of DUP and may therefore also explain that our estimates were 
shorter compared to other studies. Results were, however, robust against the change of 
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the start points. It is also recognised in the literature that these dates have to be 
reconstructed once the patient is in contact with services. Unfortunately, the MHLDDS 
provides no more detail on the methods being applied to reconstruct these dates and 
what training the clinical teams received with regard to this. If methods varied between 
providers, we were able to account for this variation through the application of 
provider fixed effects. However, we were not able to capture any variation if clinicians 
within the same provider were recording dates differently. In our case, this would have 
influenced results if clinicians within a provider would record dates for patients from 
socioeconomically more deprived areas differently to those from less deprived areas. 
We cannot rule out that this could have happened not at least because the reliability of 
the reconstructed information relies on the self-report of the patient. It is possible that 
patients from more deprived neighbourhoods may systematically report their symptom 
history differently from others due to lower educational levels or a lack of insight into 
their condition. This may explain why we found the most deprived neighbourhoods to 
have a shorter DUP than the other deprivation quintiles which contradicts findings of 
a clear socioeconomic gradient within the physical health literature. Future research 
could aim to compare waiting time measures that are independent of the patient’s self-
report such as the referral-to-treatment waiting time with DUP by socioeconomic 
status of the patient to see whether there are any systematic differences. 
In chapter 3, we used a variant of inpatient waiting time which we defined as the time 
from acceptance onto the EIP caseload until the assignment of a care coordinator. We 
note some inaccuracies that may have occurred. First, we aimed to look at the patient’s 
first EIP episode as we believe that waiting times for subsequent episodes may be 
different. However, the MHLDDS does not indicate a patient’s first EIP episode which 
may have happened before our data availability. We observed patients that had 
treatment starts before the actual start of the data collection which helped us to exclude 
these. However, we have no means to check the reliability and completeness of this 
information for all patients. We tried to get around this by using one year of data for 
information on the patient’s disease history. This allowed us to ensure that patients did 
not receive EIP treatment within the past twelve months. Second, we assumed that the 
assignment of the care coordinator marks the start of effective treatment. Our approach 
is confirmed by the EIP target guideline which defines the same endpoint to stop the 
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waiting time clock. It is however likely that the patient did receive treatment (at least 
antipsychotic medication) already in advance of the care coordinator assignment. 
Hence, waiting time in our case is not defined as the time until any first treatment but 
rather the implementation of an effective care plan. If any previous treatment 
influenced the patient’s outcomes prospects we would have not been able to account 
for this. At the same time, the simple assignment of the care coordinator does not mean 
that the tailored care plan was indeed implemented. So, the actual waiting time may as 
well have been underestimated. If longer waiting time does indeed have negative 
effects on outcomes, we would have estimated a lower bound of the effect. 
The waiting time concept used in chapter 3 excludes any waiting time that occurred 
between the first service contact (referral) and the specialist’s decision to treat. For the 
analyses in chapters 4 and 5 we developed a procedure to estimate referral-to-treatment 
waiting time as it is also targeted according to the EIP target policy. The challenge lies 
in identifying the referral that was relevant to start the waiting time for the patient for 
acceptance onto the EIP caseload. Patients could have a number of referrals followed 
by a number of different team episodes and other service contacts which may have 
happened simultaneously. Again, we chose a conservative approach in estimating 
waiting times by assuming that the referral closest to the start of the care spell was the 
relevant one. This may have underestimated waiting time if earlier referrals were 
relevant to the EIP episode. Further, we excluded patients from the analysis that were 
in contact with a different mental health service within the same spell before they were 
referred to an EIP service. Since we are the first, to use the MHLDDS to calculate 
referral-to-treatment waiting times we were not able to validate our results in 
comparison to previous studies. Kirkbride et al. (2017) were the first to estimate 
referral-to-treatment waiting times for a regionally limited cohort of EIP patients. We 
found that estimates of both studies were comparable at the 25th percentile. However, 
median waiting time was consistently longer in our sample due to a higher proportion 
of very long waiting patients. The future MHLDDS release will include a measure of 
referral-to-treatment waiting times which allows a comparison of our estimates with 
future waiting times. It will be worthwhile to repeat the analyses presented in this 
thesis once the data are available. 
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6.3.3 The evaluation problem 
Working with observational data to explain causal relationships between any kind of 
treatment on specified outcomes brings the methodological challenge of the so called 
“evaluation problem” with it. The problem is that at any particular point in time only 
one of the potential outcomes (with or without treatment) for an individual can be 
observed (Rubin, 1974). Since the assignment to treatment is usually not random in 
observational studies, treatment and control group may differ in observed or 
unobserved factors which are also correlated with the outcome. We apply a number of 
methods to overcome this challenge but also have to acknowledge each approaches’ 
limitations. 
In chapters 2 to 4, we rely on methods for selection on observables using regression 
analysis. Our results are based on the key assumption that, conditional on the set of 
covariates, selection into treatment is independent of the outcomes of interest 
(Heckman and Robb, 1985). The MHLDDS provides a rich set of covariates to control 
for. In all our models, we include demographic characteristics (age, gender, marital 
status, ethnicity), socioeconomic variables (accommodation and employment status, 
socioeconomic deprivation at neighbourhood level), and disease related variables 
(diagnosis, mental health care cluster, severity of disease measured by HoNOS, 
number of physical and mental co-morbidities, and previous service use). 
Nevertheless, we cannot rule out that any unobserved heterogeneity remained and may 
have confounded our results. In chapter 2, factors such as drug abuse, family history 
of psychosis, or a poor social network are likely to be differently distributed across 
quintiles of socioeconomic deprivation but may also be correlated with help-seeking 
behaviour and hence influence DUP. If these characteristics would be more likely in 
more deprived neighbourhoods and at the same time influence DUP negatively, we 
would have estimated a lower bound of the socioeconomic gradient. In chapter 3, 
waiting time as our covariate of interest may be related to some factors of unobserved 
severity which at the same time may be related to treatment outcomes twelve months after 
treatment start. Although we accounted for pre-treatment HoNOS, previous service use 
and treatment intensity, these measures may have been imperfect. Particularly, our 
measure of treatment intensity was simply a count of several types of service contacts such 
as inpatient stays and outpatient episodes. Our data provide no information on the actual 
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intensity of the service contacts. Treatment intensity will however have played a role in 
the recovery process of the patient. For example, longer waiting patients may have 
developed the need for more intense treatment which helped them to recover better than 
shorter waiting patients. But at the same time, the long waiting could have also impacted 
their ability to benefit from treatment as patients disengaged from treatment during the 
time of waiting. Future research could consider an instrumental variable approach to 
account for the omitted variable bias once a suitable instrument that is correlated with 
waiting time but not with treatment outcomes becomes available. Moscelli, Siciliani 
and Tonei (2016) recently used hospital-level aggregated waiting times to instrument 
patient waiting times when analysing the impact on mortality and readmissions. This 
requires hospital-level waiting times to not be correlated with in-hospital mortality or 
readmission after controlling for patient severity. However, provider-level waiting 
times may be correlated with other quality measures such as the ability to engage 
patients in treatment which in turn may also be related to treatment outcomes. Whereas 
treatment engagement may not play a significant role in coronary bypass surgery as 
investigated by Moscelli and colleagues, it does in the case of psychosis as will be 
discussed in section 6.3.5. Also, future work could consider including a measure of 
priority (as has been used in chapter 4) and interacting it with waiting time to explore 
differential effects of waiting time on outcomes for patients of different priority. 
In chapter 4, we found the announcement of the EIP target policy to be associated with 
changes in waiting time and prioritisation patterns. According to the policy guidelines, 
providers were explicitly encouraged to improve waiting times long before the actual 
implementation of the policy. Visiting an EIP service in York also showed us that 
providers are preparing for the policy introduction long in advance. Nevertheless, we 
cannot conclude from our results that the observed changes are indeed caused by 
providers anticipating the policy change. Other confounders may have contributed to 
a change in waiting time such as the composition of the patient cohort. Although this 
would have been factors which we did not account for in our covariate vector.  
Chapter 5 tried to overcome the weaknesses in chapter 4 by allowing for selection on 
unobservables in a difference-in-difference approach. However, our control group may 
not have been perfect to extract the causal policy effect. The groups were different in 
observed characteristics particularly with regard to the psychosis related variables. 
133 
 
Pre-processing the data through non-parametric matching improved but did not 
achieve perfect balance on observables. Also, there was a chance of spill-overs 
happening between the two service models within one provider. However, our tests 
did not find much evidence that potential spill-overs happened. But these tests can only 
provide an approximation. Future research should aim to investigate the potential 
interactions across services within a provider due to enforced performance targets in 
more detail. Also, other control groups may be identified in the future to enhance the 
analysis. To the best of our knowledge, this is the best possible control group for the 
nationally introduced policy. Should other comparable countries such as Scotland start 
collecting EIP waiting times in the future, a cross-country comparison could be a 
fruitful extension of this research. With a suitable control group, the analysis of 
unintended effects of the target policy according to the research ideas presented in 
chapter 4 could be repeated as well to see to what extent our observed associations are 
indeed caused by the policy anticipation. Unless a better suitable control group 
becomes available, some other alternatives to the difference-in-difference approach as 
applied in this research can be considered in future work to relax the common trends 
assumption. For example, a synthetic control group can be constructed as a weighted 
average of the available control units (O'Neill et al., 2016). The weights are chosen 
based on levels of covariates and outcomes to those of the treated unit prior to the 
intervention. Alternatively, a lagged-dependent-variable approach (LDV) allows one 
to adjust for pre-treatment outcomes and covariates with a parametric regression 
model. This may however lead to bias if the common trends assumption does hold 
(Angrist and Pischke, 2009). 
Despite the advantages of the matching method, it reduces our study sample to those 
patients that could be matched. Hence, our estimated treatment effect is redefined for 
patients under the common support. We cannot conclude from our results to what 
extent the estimated effect is generalizable to the whole population of EIP patients. 
However, using the national administrative database allowed us to draw our estimation 
sample from a nationally representative patient cohort including a large number of 
mental health trusts across England. Alongside this, we estimated an average treatment 
effect which represents the expected gain from the target policy for an individual 
randomly selected from the treated population. In future research, it may be 
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worthwhile to allow for heterogeneity in the treatment effect to see which patient 
groups potentially benefitted more than others form the policy. 
It needs to be noted that for the difference-in-difference approach linearity is central 
(Jones and Rice, 2011) which is challenged by the non-linearity of our outcome 
measure waiting time. We solved this in two ways. First, we looked at the probability 
of waiting below target which allowed us to estimate a linear probability model. 
Second, we aggregated data at provider level to estimate the policy effect on waiting 
times at different percentiles of the distribution including the median which is less 
influenced by a tail of long waiters. However, the aggregation of data may have been 
accompanied by a loss of information. Future research could aim to implement the 
more general changes-in-changes approach proposed by Athey and Imbens (2006) 
which relaxes the additivity assumption.  
 
6.3.4 HoNOS as a routinely collected measure of severity 
Most of our analyses rely on the HONOS as the main measure of disease severity. 
However, the measure comes with its limitations. First, HoNOS is a clinician-rated 
outcome measure and therefore demonstrates the clinician’s judgement of the patient’s 
condition which may not necessarily match the patient’s perception. Also, judgements 
for the same patients may vary between clinicians which we cannot control for since 
we do not know the responsible clinician for a HoNOS record. In the physical health 
context, the analysis of patient-reported outcomes gains increasing importance. 
However, in the context of psychosis this is more difficult as patients may not always 
be able to judge their condition due to the impact of their symptoms or medication and 
the lack of insight into their illness. Also, judgements may differ depending on whether 
the patient is currently experiencing an acute episode or not. To our knowledge, 
patient-reported outcomes for psychotic patients are not available for analysis at the 
moment. 
Second, HoNOS is not specific to psychosis. Although it was developed for the 
outcomes measurement of severe mental illnesses some psychosis specific measures 
such as the Scale for the Assessment of Positive Symptoms (SAPS) or the Scale for 
the Assessment of Negative Symptoms (SANS) (Andreasen, 1984, 1983) may be more 
sensitive in detecting variations in positive and negative psychotic symptoms. These 
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measures are however not routinely collected in administrative data and only used in 
small-scale field studies so far. With increasing opportunities of data linkage, it may 
be possible in future research to link one of these first-episode psychosis cohorts from 
field studies to the MHLDDS in order to enhance outcome measures.  
Third, there are some limitations to the concept of reliable and clinically significant change 
concept as applied to our data in chapter 3. Since the distribution of HoNOS scores is 
unknown in the general population, our reference groups are psychotic patients with higher 
HoNOS scores on average. This leads to cut-off points to define reliable and clinically 
significant changes being quite high and changes will only be evident for observations at 
the extreme ends of the severity distribution. Moreover, there is the danger that our 
measured effect reflects a phenomenon known as “regression to the mean” (Barnett, van 
der Pols and Dobson, 2005). This means that patients who enter mental health services in 
a crisis or acute psychotic phase will record high HoNOS scores. But those patients are 
also more likely to record a lower subsequent rating regardless of the time waited. 
Finally, as mentioned earlier, HoNOS is one of the more poorly coded variables in the 
MHLDDS. This first of all leads to sample size reduction if HoNOS is a main variable 
of analysis as in chapter 3. We found that patients with coded HoNOS scores have 
higher proportions of mental health service contacts in the past. So, the more past 
service contacts, the higher the probability of being in the study sample. This could 
have limited the external validity of our results if past service experience would affect 
the relationship between waiting for treatment and treatment outcomes. If patients 
learned coping strategies during previous service contacts which helped them to 
deteriorate less during the time of waiting, we would have underestimated the negative 
effect of waiting on outcomes. But if patients with more service contacts in the past 
are also the ones for which the condition worsens even more during waiting, we would 
have overestimated the impact of waiting on outcomes. Future work should investigate 
the role of previous service use in the interplay of waiting time and outcomes. Also, 
future research could use multiple imputation to address the problem of missing HoNOS 
data when making inferences about waiting times on treatment outcomes (Leurent et al., 
2018). As additional HoNOS measurements become available for the same patients in 
future data releases, these could be analysed using a repeated measures model. This 
would allow the analysis of changes in outcomes over time whilst taking the 
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correlation between subsequent measures into account (Steele, 2011). This would also 
provide an alternative to the fairly arbitrarily chosen follow-up period of 12-months 
since multiple time points within the defined follow-up period can be investigated. 
Another area for future research could be the investigation of alternative outcome 
measures such as length of treatment, time to first hospitalisation, mortality or costs of 
health care utilisation. The interpretation of these outcomes is however more difficult 
in the case of psychosis. A shorter length of treatment or a longer time to inpatient 
admission may be desirable from a short-term cost perspective. But in very severe 
cases of psychosis, an early hospital treatment can actually help reduce the likelihood 
of the condition worsening or prevent the patient from harming herself or others. A 
cost saving perspective should therefore overlook the long-term effects including 
potential externalities which requires more years of data. Drawing any policy 
implications from such kind of analyses has to consider the complexities that come 
along with it. 
 
6.3.5 The patient as co-producer in the production of mental health 
The final limitation that shall be discussed here is related to the fact that patients are 
co-producers of their health. Psychotic patients experiencing hallucinations and 
delusions often lack insight into their illness, or experience fear of being stigmatised 
and are therefore not able to attend appointments or effectively engage in treatment 
(Gronholm et al., 2017). In chapter 2, this will have influenced help-seeking behaviour 
of patients and hence caused a longer DUP. If the effects of the patient’s engagement 
are related to the socioeconomic background this would have also influenced our 
results. We hope to have accounted for this by controlling for the degree of problems 
with hallucinations and delusions (HoNOS item 6) in combination with the other 
covariates. In a similar way, this may have affected the waiting time measured in 
chapter 3. Although we exclude the help-seeking period in this measure, it is possible 
that the time until the assignment of a care coordinator is also influenced by the degree 
of the patient’s engagement. Before a care coordinator can be assigned, a number of 
assessments have to be done which require the patient to attend and actively take part. 
For less engaged patients this may take longer. If the level of patient engagement in 
turn is related to the changes in outcomes twelve months after treatment start our 
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results would have been affected by this. We accounted for some of the effects through 
our treatment intensity measure which counts the number of service contacts and 
therefore mirrors how many appointments the patient did attend. However, we can 
however not distinguish the quality of the appointments and how engaged the patient 
was. In chapters 4 and 5, we assume that providers are able to manage patient waiting 
times independently from the patient’s engagement in order to respond to targets. For 
example, we observed that low priority patients benefitted more from reductions in 
waiting times then high priority ones. But from our results, we cannot conclude 
whether this was an intentional re-prioritisation by the provider in order to meet targets 
or whether this was an unintentional consequence. It may as well be that providers 
aimed to improve referral pathways for all patients, but certain patient groups took 
better advantage of these changes. For example, providers may have offered rapid 
appointments to all patients, but the more severely affected patients may cancel 
appointments more often and thus cause an increase in waiting time. With the data we 
used it is not possible to retrieve any information on the patient’s level of engagement. 
The best we could do is to control for the level of hallucinations and delusions as well 
as for other patient characteristics which may be correlated with patient engagement. 
It would be fruitful if future work could identify a way to measure patient engagement 
explicitly and analyse its impact on waiting times. The EIP target policy guideline 
states that it lies in the responsibility of the provider to engage the patient in attending 
treatments. The waiting time clock does not stop due to the patient’s non-attendance. 
That means, provider’s performance against the target will also depend on the 
provider’s ability to effectively encourage and proactively manage patients’ 
attendance. 
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Appendices 
A1 Derivation of the study sample from full sample 
 n % 
Patients with recorded psychosis and treatment start in study period 1,441   
with valid psychosis and treatment start* (referred to as full sample) 1,368 94.93 
Excluded due to missing LSOA 6 0.44 
Excluded due to missing HoNOS score 97 7.09 
Excluded due to date of HoNOS more than 30 days after treatment start 356 26.02 
Excluded due to fewer than 3 patients per provider 22 1.61 
Final study sample 887 64.84 
   
Within study sample:   
Number of emergent dates used as psychosis start 696 78.47 
Number of manifest dates used as psychosis start 191 21.53 
Number of prescription dates used as treatment start 784 88.39 
Number of treatment dates used as treatment start 103 11.61 
Number of emergent dates that are equal to manifest dates 192 21.65 
Number of prescription dates that are equal to treatment date 466 52.54 
Mean difference between manifest date and emergent date in days 14.0   
Mean difference between prescription date and treatment date in days 0.3   
Note: * Observations were dropped if treatment start happened before the psychosis start 
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A2 Comparison of covariates between full sample and study sample 
  Study sample 
n = 887 
Full sample 
n = 1,368 
Duration of untreated psychosis (DUP)     
DUP ≤ 2 weeks (%) 44.3 45.8 
DUP > 2 and ≤ 6 weeks (%) 18.8 19.4 
DUP > 6 and ≤ 12 weeks (%) 13.4 12.9 
DUP > 12 weeks (%) 23.5 21.9 
Socioeconomic deprivation     
Least deprived quintile (%) 16.4 16.3 
2nd least deprived quintile (%) 16.0 16.0 
3rd least deprived quintile (%) 20.3 20.6 
4th least deprived quintile (%) 21.5 21.4 
Most deprived quintile (%) 25.8 25.7 
Hallucinations and delusions (HoNOS 6)     
No problems (%) 17.1 22.4 
Minor problems (%) 7.0 8.4 
Mild problems (%) 20.3 20.9 
Moderately problems (%) 36.8 32.8 
Severe problems (%) 18.8 15.7 
Previous mental health related service use     
Zero service contacts 70.4 74.0 
1-10 Service contacts 22.3 19.7 
Zero outpatient episodes 94.7 94.6 
1-3 outpatient episodes 4.5 4.5 
Zero ward stays 93.8 95.3 
1-3 Ward stays 5.4 4.2 
Number of physical comorbidities, mean (SD) 0.014 (0.12) 0.010 (0.11) 
Number of mental comorbidities, mean (SD) 0.016 (0.16) 0.012 (0.13) 
Financial year     
2012/13 (%) 33.2 40.2 
2013/14 (%) 40.0 36.6 
2014/15 (%) 26.8 23.3 
Note: Full sample includes all patients with a valid psychosis start date and a valid prescription start 
date in the financial year 2012/13 - 2014/15. The study sample is based on the full sample and 
excludes observations with missing LSOA, missing HoNOS score (or HoNOS more than 30 days after 
treatment start), and providers where fewer than 3 patients were treated.  
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A3 Distribution of study sample across regions 
Region   Full sample   Study sample 
   n %   n % 
East Midlands   29 2.1%   17 1.9% 
East of England   82 6.0%   52 5.9% 
London   139 10.2%   99 11.2% 
North East   3 0.2%   3 0.3% 
North West   248 18.1%   163 18.4% 
South East   357 26.1%   228 25.7% 
South West   213 15.6%   119 13.4% 
West Midlands   218 15.9%   158 17.8% 
Yorkshire and The Humber   7 0.5%   4 0.5% 
No information on region   72 5.3%   44 5.0% 
Total   1,368 100.0%   887 100.0% 
Note: Regions as defined by the Office for National Statistics. 
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A4 Sensitivity analysis: GLM results for different DUP start and end 
point definitions 
GLM log-gamma regression 
dependent variable: DUP in days (1) Study sample 
(2) Completed 
observations 
(3) Valid treatment 
date only 
Socioeconomic status (ref.cat.: least deprived quintile)  
2nd least deprived quintile 0.335*** 0.214*** 0.412*** 
3rd least deprived quintile 0.414*** 0.351** 0.476*** 
4th least deprived quintile 0.609*** 0.517*** 0.698*** 
Most deprived quintile 0.186* -0.039 0.245 
Severity of hallucinations and delusions (ref.cat.: no problems) 
Minor problems -0.386*** -0.189 -0.217*** 
Mild problems -0.075 0.132 -0.021 
Moderately problems -0.155 -0.009 -0.132 
Severe problems -0.346*** -0.248 -0.295 
Previous mental health service use (ref.cat.: zero service contacts)  
1-10 Service contacts -0.515** -0.566** -0.593** 
>10 Service contacts -0.918*** -0.990* -0.688 
Employment status (ref.cat.: employed) 
Unemployed 0.637** 0.615* 0.628*** 
Student 0.487** 0.435*** 0.598*** 
Provider fixed effects no no no 
Year fixed effects yes yes yes 
Covariates yes yes yes 
Number of patients 887 658 758 
Proportion of total sample 100.00% 74.18% 85.46% 
Note: * p<0.05, ** p<0.01, *** p<0.001. Model (1) includes the full study sample but without controlling 
for provider fixed effects. Model (2) includes only observations for which the emergent date and the 
prescription date have been used to calculate DUP. Model (3) includes only observations from the study 
sample which have a treatment date recorded. Only significant covariates are shown. All models include all 
covariates used in the study sample model and year fixed effects. No provider fixed effects were used due to 
small sample sizes. Robust standard errors clustered at financial year level. 
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A5 Sensitivity analysis: GLM results using treatment date as end point of DUP 
GLM log-gamma regression 
dependent variable: DUP in days 
End point = prescription date   End point = treatment date 
(1) No provider FE (2) With provider FE   (3) No provider FE (4) With provider FE 
Socioeconomic status (ref.cat.: least deprived quintile) 
2nd least deprived quintile 0.335*** 0.459***   0.413** 0.352*** 
3rd least deprived quintile 0.414*** 0.331***   0.502*** 0.308** 
4th least deprived quintile 0.609*** 0.410*   0.630*** 0.390** 
Most deprived quintile 0.186* -0.012   0.227 -0.025 
Severity of hallucinations and delusions (ref.cat.: no problems) 
Minor problems -0.386*** -0.147   -0.341*** -0.079 
Mild problems -0.075 0.011   -0.200* -0.152 
Moderately problems -0.155 -0.169   -0.206*** -0.230 
Severe problems -0.346*** -0.271*   -0.332** -0.214 
Previous mental health service use (ref.cat.: zero service contacts) 
1-10 Service contacts -0.515** -0.526**   -0.496*** -0.471* 
>10 Service contacts -0.918*** -0.929**   -0.773 -0.921** 
1-3 Outpatient episodes -0.881** -0.713   -0.458** -0.419 
> 3 Outpatient episodes -0.776* -0.211   1.124** 1.424 
1-3 Ward stays -0.674 -0.726   -0.777*** -0.680* 
> 3 Ward stays -0.755 -1.417**   -5.065*** -4.725** 
Employment status (ref.cat.: employed) 
Unemployed 0.637** 0.572***   0.525*** 0.540*** 
Student 0.487** 0.456*   0.458* 0.458* 
Number of patients 887 887   784 784 
Note: * p<0.05, ** p<0.01, *** p<0.001. FE = fixed effects. Displayed are only significant covariates. All models include all covariates of the full model and year fixed 
effects. Robust standard errors at financial year level in Models (1) and (3) and at provider level in Models (2) and (4). 
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A6 Sensitivity analysis: GLM results after restricting age and restricting DUP 
GLM log-gamma regression 
dependent variable: DUP in days 
(1) 14-35-year-old (2) DUP > 0 (3) DUP < 2 year (4) DUP < 1.5 year 
Socioeconomic status (ref.cat.: least deprived quintile) 
2nd least deprived quintile 0.543*** 0.358** 0.480*** 0.271 
3rd least deprived quintile 0.442*** 0.472*** 0.298** 0.274** 
4th least deprived quintile 0.565*** 0.523*** 0.412* 0.422* 
Most deprived quintile 0.167 0.084 0.011 0.042 
Severity of hallucinations and delusions (ref.cat.: no problems) 
Minor problems -0.267 -0.104 -0.116 0.018 
Mild problems -0.028 0.137 0.021 0.092 
Moderately problems -0.313 -0.069 -0.150 -0.068 
Severe problems -0.514*** -0.093 -0.278* -0.213 
Previous mental health service use (ref.cat.: zero service contacts) 
1-10 Service contacts -0.545** -0.223 -0.541*** -0.529*** 
>10 Service contacts -0.8480** -0.190 -0.910** -1.127*** 
Employment status (ref.cat.: employed) 
Unemployed 0.546*** 0.439** 0.551*** 0.514*** 
Student 0.469* 0.3600* 0.451* 0.506* 
Number of patients 805 775 883 874 
Proportion of total sample 90.76% 87.37% 99.55% 98.53% 
Note: * p<0.05, ** p<0.01, *** p<0.001. Model (1) includes only 14 to 35-year-old patients. Models (2), (3) and (4) include observations with a DUP greater 
than zero, shorter than 2 years, and shorter than 1.5 years respectively.  Displayed are only significant covariates. All models include all covariates of the full 
model, year and provider effects. Robust standard errors clustered at provider level. 
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A7 Sensitivity analysis: GLM results for different measures of socioeconomic status (SES) 
GLM log-gamma regression 
dependent variable: DUP in days 
  (1) Small-area and patient-level SES   (2) Small-area SES only   (3) Patient-level SES only 
                                 Coeff. Std. Err. dy/dx   Coeff. Std. Err. dy/dx   Coeff. Std. Err. dy/dx 
Socioeconomic status (ref.cat.: least deprived quintile) 
2nd least deprived quintile   0.459*** (0.131) 35.50   0.478*** (0.131) 34.69         
3rd least deprived quintile   0.331*** (0.099) 23.86   0.395** (0.122) 27.44         
4th least deprived quintile   0.410* (0.183) 30.89   0.471** (0.167) 34.07         
Most deprived quintile   -0.012 (0.155) -0.73   0.108 (0.141) 6.44         
Marital status (ref.cat.: single)                     
Married/civil partner   -0.060 (0.136) -4.32           -0.046 (0.123) -3.32 
Divorced/separated   -0.012 (0.314) -0.92           0.055 (0.379) 4.16 
Accommodation (ref.cat.: mainstream housing) 
Homeless    0.011 (0.217) 0.82           -0.032 (0.210) -2.46 
Institutionalised   0.077 (0.247) 6.14           0.049 (0.226) 3.89 
Other accommodation   -1.081*** (0.223) -50.89           -0.956*** (0.240) -47.96 
Not known   -0.058 (0.203) -4.27           0.026 (0.212) 2.07 
Employment (ref.cat.: employed)                     
Unemployed   0.572*** (0.147) 39.98           0.513** (0.173) 36.03 
Student   0.456* (0.203) 29.98           0.402* (0.202) 26.63 
Long-term disabled   0.270 (0.244) 16.07           0.182 (0.247) 10.70 
Other employment   0.193 (0.415) 11.01           0.134 (0.469) 7.68 
Not known   0.721** (0.244) 52.14           0.631*** (0.179) 47.28 
Note: * p<0.05, ** p<0.01, *** p<0.001. All models include year and provider fixed effects. Marginal effects (dy/dx) are average marginal effects in days. For factor 
levels, they present the discrete change from reference category. Robust standard errors (Std. Err.) clustered at provider level. 
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A8 Health of the Nation Outcome Scale (HoNOS) items, sub-domains and 
total score 
HoNOS item HoNOS sub score Total HoNOS score 
1.  Aggression A: Behaviour 
(max. score = 12) 
Total HoNOS score  
(max. score = 48) 2.  Self-harm 
3.  Drug & alcohol use 
4.  Cognitive problems B: Impairment 
(max. score = 8) 5.  Physical illness & disability 
6.  Hallucinations & delusions C: Symptoms 
(max. score = 12) 7.  Depression 
8.  Other symptoms 
9.  Relationships D: Social 
(max. score = 16) 10.  Activities in daily living 
11.  Residential environment 
12.  Day-time activities 
Note: Based on Wing, Curtis and Beevor (1999); Wing et al. (1998). 
 
A9 Reliable and clinically significant change 
For more details, we refer the interested reader to Jacobson and Truax (1991) and 
Parabiaghi et al. (2005). A reliable and clinically significant change satisfies two 
criteria: (1) a clinically significant change would move a person from a score typical 
of the “dysfunctional” population to a score typical of the “functional” population, and 
(2) a reliable change is beyond what could be attributed to measurement error or 
chance.  
(1) Clinically significant change: 
Patients were defined as dysfunctional if they had a score of ≥ 3 in at least two of the 
12 items. All others made up the functional population. The cut-off point where the 
chance of belonging to either population (dysfunctional or functional) is equal is 
calculated as follows: 
cut-off		=	 )meandysfunc	×	SDfunc4	+	)meanfunc	×	SDdysfunc4	)SD6789	×	SD:;<67894 = 	 (17.9×4.5)+(8.9×5.5)	(4.5 + 5.5) = 13.0 
A change of at least 13 score points in HoNOS was considered as clinically significant. 
(2) Reliable change 
We calculated a reliable change index (RCindex) based on the baseline HoNOS score: 
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RCindex=	1.96×SEdiff = 1.96	×5.2	=	10.2	 
where SEdiff is the standard error of measurement of a difference:  
SEdiff = SD1×√2×√1-α = 6.8×√2×√1-0.71 = 5.2 SD1 is the standard deviation of the baseline score and α is Cronbach’s coefficient. A 
change of at least 10 score points in HoNOS was considered as reliable.  
Based on this, we classified patients with a given HoNOS at baseline (score1) and 
follow-up (score2) as improved if score2	≥	RCimprov	,	where	RCimprov=	score1+	RCindex and 
deteriorated if score2	≤	RCdeter	,	where	RCdeter=	score1 −	RCindex. In the study sample, 
77.4% were classified as stable, 18.7% improved, and 3.9% deteriorated.	
A10 Generalised linear model diagnostics – dependent variable: total 
HoNOS score at follow-up 
Test for normality of follow-up HoNOS         
  Obs W V z Prob>z 
Shapiro-Wilk test 8,949 0.98 103.33 12.38 0.000 
Shapiro-Francia test 8,949 0.98 109.33 12.32 0.000 
Within/between provider variance in follow-up HoNOS       
  Mean SD Min Max      Obs 
Overall variance 50.01 74.1 0 365      N = 8,949 
Between provider variance   29.1 0 133.0      n = 48 
Within provider variance   69.5 -82.9 380.7      T-bar = 186.44 
GLM model diagnostics Based on model with independent variable: log waiting time 
Log pseudolikelihood -36006        
Squared correlation btw. y and yhat 0.183         
Linktest yhat P>|t| = 0.000       
Linktest yhat squared P>|t| = 0.051       
Hosmer-Lemeshow test F(10, 8939) = 0.42; Prob>F = 0.9385   
Ramsey RESET test chi2(1) = 5.78; Prob>chi2 = 0.0162   
Park test Gaussian chi2(1) = 26.12; Prob>chi2 = 0.0000 
  Poisson   chi2(1) = 2.20; Prob>chi2 = 0.1376 
  Gamma   chi2(1) = 4.59; Prob>chi2 = 0.0322 
  Inverse Gaussian chi2(1) = 33.26; Prob>chi2 = 0.0000 
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A11 Seemingly Unrelated Regression results – dependent variable: HoNOS sub score at follow-up 
  (1) Behaviour (2) Impairment (3) Symptoms (4) Social 
  Coeff. Std. Err. Coeff. Std. Err. Coeff. Std. Err. Coeff. Std. Err. 
Log waiting time (continuous) 0.040** (0.014) 0.025** (0.009) 0.078*** (0.018) 0.061** (0.021) 
Waiting time quintiles (ref.cat.: shortest quintile)             
2nd shortest quintile -0.084 (0.076) -0.084 (0.049) -0.044 (0.100) -0.157 (0.117) 
3rd shortest quintile -0.111 (0.076) -0.009 (0.048) -0.060 (0.099) -0.218 (0.117) 
4th shortest quintile 0.055 (0.077) 0.076 (0.049) 0.068 (0.100) 0.004 (0.118) 
Longest quintile 0.145 (0.077) 0.053 (0.049) 0.341*** (0.101) 0.198 (0.118) 
Waiting time intervals (ref.cat.: less than 0.5 months)             
Waiting time 0.5 to 3 months 0.066 (0.048) 0.089** (0.031) 0.074 (0.063) 0.045 (0.074) 
Waiting time 3 to 6 months 0.146* (0.074) 0.078 (0.047) 0.295** (0.096) 0.259* (0.114) 
Waiting time 6 to 12 months 0.314*** (0.085) 0.154** (0.054) 0.516*** (0.111) 0.419** (0.130) 
Observations 8,949   8,949   8,949   8,949   
Provider and year fixed effects yes   yes   yes   yes   
Covariates yes   yes   yes   yes   
Note: * p<0.05, ** p<0.01, *** p<0.001. The dependent variable is in model (1) the HoNOS behaviour sub score (items 1-3), in model (2) 
the HoNOS impairment sub score (items 4-5), in model (3) the HoNOS symptoms sub score (items 6-8), in model (4) the HoNOS social 
sub score (items 9-12). 
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A12 Ordered probit estimation results – dependent variable: reliable and clinically significant change in total HoNOS 
score 
  
(1) Study sample (2) Long EIP (3) Short EIP 
Coeff. Std. Err. Coeff. Std. Err. Coeff. Std. Err. 
Log waiting time (continuous) 0.033** (0.012) 0.042** (0.014) 0.029 (0.020) 
Waiting time quintiles (ref.cat.: shortest quintile)    
2nd shortest quintile -0.066 (0.061) -0.052 (0.080) -0.083 (0.109) 
3rd shortest quintile -0.117* (0.058) -0.042 (0.075) -0.312** (0.108) 
4th shortest quintile -0.012 (0.054) -0.020 (0.063) 0.080 (0.127) 
Longest quintile 0.137* (0.064) 0.220** (0.083) 0.042 (0.101) 
Waiting time intervals (ref.cat.: less than 0.5 months) 
Waiting time 0.5 to 3 months -0.023 (0.040) -0.024 (0.046) 0.017 (0.069) 
Waiting time 3 to 6 months 0.122 (0.063) 0.216* (0.084) 0.048 (0.091) 
Waiting time 6 to 12 months 0.253*** (0.077) 0.290** (0.096) 0.239* (0.116) 
Observations 8,949   6,135   2,814   
Provider and year fixed effects yes   yes   yes   
Covariates yes   yes   yes   
Note: * p<0.05, ** p<0.01, *** p<0.001. Models (1) - (3) are ordered probit models with the dependent variable defined as:  1 = clinical 
improvement, 2 = clinical stability, 3 = clinical deterioration. Model (1) includes the complete study sample. Model (2) includes only patients 
that were in EIP care for the whole duration of follow-up. Model (3) includes only patients with an EIP episode shorter than the 12-months 
follow-up.  All models use cluster robust standard errors for 48 provider clusters. 
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A13 Comparison of results using different methods for ties 
  (1) Breslow method (2) Efron's method (3) Exact marginal LL (4) Exact partial LL 
a) Time-to-EIP Coeff. Std. Err. Coeff. Std. Err. Coeff. Std. Err. Coeff. Std. Err. 
Low priority from Apr11-Sept14 ref. cat.   ref. cat.   ref. cat.   ref. cat.   
Low priority from Oct14-Jan15 0.149** (0.050) 0.178** (0.065) 0.414*** (0.113) 0.413** (0.144) 
High priority from Apr11-Sept14 -0.048 (0.052) -0.141* (0.063) -0.219** (0.070) -0.079* (0.091) 
High priority from Oct14-Jan15 -0.084 (0.072) -0.073 (0.090) -0.252 (0.145) -0.277 (0.181) 
  (1) Breslow method (2) Efron's method (3) Exact marginal LL (4) Exact partial LL 
b) Time-to-CCASS Coeff. Std. Err. Coeff. Std. Err. Coeff. Std. Err. Coeff. Std. Err. 
Low priority from Apr11-Jan15 ref. cat.   ref. cat.   ref. cat.   ref. cat.   
Low priority from Feb15-Nov15 0.316*** (0.086) 0.324*** (0.088) 0.331*** (0.088) 0.354*** (0.091) 
High priority from Apr11-Jan15 0.012 (0.074) -0.001 (0.079) -0.006 (0.077) 0.016 (0.082) 
High priority from Feb15-Nov15 -0.145 (0.110) -0.154 (0.114) -0.161 (0.115) -0.176 (0.120) 
Note: * p<0.05, ** p<0.01, *** p<0.001. Robust standard errors (Std. Err.). Stratified by provider. 
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A14 Global score tests and p-values for proportional hazards 
a) Time-to-EIP                   
    g(t) = t g(t) = ln(t) g(t) = S(t) g(t) = rank(t) 
Model specification df chi2 p chi2 p chi2 p chi2 p 
Oct14-Jan15 by priority 36 30.9 0.708 96.1 0.000 102.2 0.000 102.8 0.000 
Oct14-Jan15 by severity 36 30.8 0.710 94.4 0.000 99.6 0.000 100.5 0.000 
Feb15-Nov15 by priority 36 32.2 0.650 97.7 0.000 106.9 0.000 106.6 0.000 
Feb15-Nov15 by severity 36 31.9 0.662 96.1 0.000 104.8 0.000 104.6 0.000 
b) Time-to-CCASS                   
    g(t) = t g(t) = ln(t) g(t) = S(t) g(t) = rank(t) 
Model specification df chi2 p chi2 p chi2 p chi2 p 
Oct14-Jan15 by priority 36 113.1 0.000 136.1 0.000 132.9 0.000 134.5 0.000 
Oct14-Jan15 by severity 36 113.9 0.000 136.9 0.000 133.6 0.000 135.1 0.000 
Feb15-Nov15 by priority 36 120.0 0.000 151.4 0.000 149.4 0.000 150.7 0.000 
Feb15-Nov15 by severity 36 119.9 0.000 158.0 0.000 156.7 0.000 158 0.000 
Note: Reported are degrees of freedom (df), chi2-statistic (chi2) and p-values (p) for score tests of the global 
model including all covariates for different time functions (g(t)). 
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A15 Scatterplot of scaled Schoenfeld residuals for the two policy announcement indicators and their lowess smooth 
versus four different functions of time 
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A16 Log-Log plots of the two policy announcement indicators 
 
 
A17 Extended Cox regression results – main regressors interacted with 
time 
  (1) Time-to-EIP (2) Time-to-CCASS 
  Main effect Time 
interaction 
Main effect Time 
interaction 
a) Priority         
Low priority from Apr11-Sept14 ref.cat.       
Low priority from Oct14-Jan15 0.151* 0.003 -0.946 -0.001 
High priority from Apr11-Sept14 -0.238** 0.005*** 0.027 -0.001* 
High priority from Oct14-Jan15 -0.065 -0.001 0.280 -0.001 
b) Severity     
Low severity from Apr11-Jan15 ref.cat.       
Low severity from Feb15-Nov15 0.114 0.003 0.013 -0.002 
High severity from Apr11-Jan15 0.033 0.005*** 0.159*** -0.001* 
High severity from Feb15-Nov15 -0.002 -0.002 0.128 0.001 
Note: * p<0.05, ** p<0.01, *** p<0.001.  Regression coefficients reported. Robust standard errors. 
Stratified by provider. Referral year is interacted with g(t) = t. 
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A18 Extended Cox regression results – main regressors interacted with 
log of time 
  (1) Time-to-EIP (2) Time-to-CCASS 
  Main effect Time 
interaction 
Main effect Time 
interaction 
a) Priority         
Low priority from Apr11-Sept14 ref.cat.       
Low priority from Oct14-Jan15 0.058 0.147* -0.165 0.009 
High priority from Apr11-Sept14 -0.379*** 0.198*** 0.029 -0.029* 
High priority from Oct14-Jan15 0.060 -0.173* 0.277 -0.015 
b) Severity     
Low severity from Apr11-Jan15 ref.cat.       
Low severity from Feb15-Nov15 0.136* 0.007 -0.054 -0.006 
High severity from Apr11-Jan15 -0.009 0.037* -0.143* 0.114*** 
High severity from Feb15-Nov15 -0.096 0.124 0.209 -0.027 
Note: * p<0.05, ** p<0.01, *** p<0.001.  Regression coefficients reported. Robust standard errors. 
Stratified by provider. Referral year is interacted with g(t) = ln(t). 
 
A19 Comparison of patients with HoNOS score (included) and without 
HoNOS score (excluded) 
  Treated   Controls   
Outcome variable HoNOS No HONOS HoNOS No HONOS 
Proportion below target 0.26 0.18*** 0.18 0.17 
Waiting time in days 50.5 78.9*** 82.9 110.3*** 
Patient characteristic         
HoNOS 6 score (mean) - - - - 
Schizophrenia diagnosis (%) 0.17 0.12*** 0.09 0.08 
First-episode psychosis cluster (%) 0.66 0.45*** 0.13 0.12* 
Age (mean) 22.2 21.9*** 26.3 26.2 
Male (%) 0.62 0.64** 0.47 0.51*** 
Single (%) 0.95 0.97*** 0.88 0.91*** 
Non-white ethnicity (%) 0.36 0.33* 0.31 0.30* 
Least deprived quintile (%) 0.12 0.11* 0.13 0.11* 
Second least deprived quintile (%) 0.14 0.14 0.14 0.13 
Third least deprived quintile (%) 0.17 0.18 0.19 0.18 
Fourth least deprived quintile (%) 0.23 0.23 0.26 0.25 
Most deprived quintile (%) 0.34 0.35 0.28 0.32*** 
Note: * p<0.05, ** p<0.01, *** p<0.001 for p-values of t-tests of mean differences between groups. 
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A20 Comparison of standard care patients with no access to EIP 
(included) and with access to EIP (excluded) 
Outcome variable No access Access 
Proportion below target 0.21 0.19** 
Waiting time in days 81.7 75.4 
Patient characteristic     
HoNOS 6 score (mean) 1.51 1.52 
Schizophrenia diagnosis (%) 0.06 0.08 
First-episode psychosis cluster (%) 0.11 0.11** 
Age (mean) 26.0 26.6*** 
Male (%) 0.48 0.50* 
Single (%) 0.89 0.90 
Non-white ethnicity (%) 0.20 0.33*** 
Least deprived quintile (%) 0.17 0.10*** 
Second least deprived quintile (%) 0.19 0.12*** 
Third least deprived quintile (%) 0.23 0.17*** 
Fourth least deprived quintile (%) 0.22 0.27*** 
Most deprived quintile (%) 0.19 0.34*** 
Note: * p<0.05, ** p<0.01, *** p<0.001 for p-values of t-tests of mean 
differences between groups. 
A21 Observed and predicted probabilities of waiting below target 
  n Mean Std. dev. Min. Max. 
Unmatched sample           
observed probability 8,393 0.263 0.440 0 1 
fitted probability 8,393 0.263 0.202 -0.145 0.972 
Coarsened exact matched           
observed probability 3,712 0.227 0.419 0 1 
fitted probability 3,712 0.218 0.205 -0.214 1.024 
Propensity score matched           
observed probability 6,873 0.269 0.444 0 1 
fitted probability 6,873 0.261 0.211 -0.203 0.951 
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A22 Referral quarter estimates from the test of common trends for 
proportion below target 
 (1) Coarsened exact matching (2) Propensity score matching 
Pre-policy    
 
  
11q3 0.028 (0.070) 0.089 (0.109) 
11q4 0.078 (0.064) 0.024 (0.055) 
12q1 0.042 (0.043) 0.124 (0.065) 
12q2 -0.003 (0.045) 0.095 (0.052) 
12q3 0.018 (0.042) 0.053 (0.063) 
12q4 0.042 (0.046) 0.096 (0.065) 
13q1 0.070 (0.057) 0.087 (0.063) 
13q2 -0.047 (0.044) 0.071 (0.073) 
13q3 0.057 (0.067) 0.134 (0.083) 
13q4 0.057 (0.062) 0.110 (0.068) 
14q1 0.093 (0.071) 0.101 (0.068) 
14q2 -0.048 (0.058) 0.064 (0.070) 
14q3 -0.066 (0.054) -0.026 (0.047) 
Anticipation          
14q4 -0.108 (0.055) -0.014 (0.051) 
15q1 -0.042 (0.042) 0.022 (0.054) 
Post-policy         
15q2 -0.076 (0.041) -0.087 (0.048) 
15q3 -0.03 (0.056) 0.047 (0.054) 
15q4 0.018 (0.083) 0.115 (0.088) 
Pre-policy for EIP         
11q2 for EIP 0.052 (0.041) 0.122 (0.060) 
11q3 for EIP 0.057 (0.073) 0.048 (0.089) 
11q4 for EIP -0.014 (0.066) 0.089 (0.070) 
12q1 for EIP 0.005 (0.044) 0.004 (0.055) 
12q2 for EIP 0.067 (0.051) 0.020 (0.057) 
12q3 for EIP 0.072 (0.052) 0.110 (0.061) 
12q4 for EIP 0.055 (0.060) 0.075 (0.071) 
13q1 for EIP -0.011 (0.068) 0.035 (0.068) 
13q2 for EIP 0.097 (0.063) 0.055 (0.071) 
13q3 for EIP 0.008 (0.066) -0.007 (0.067) 
13q4 for EIP 0.059 (0.060) 0.045 (0.056) 
14q1 for EIP -0.039 (0.073) 0.042 (0.065) 
14q2 for EIP 0.157* (0.061) 0.108 (0.067) 
14q3 for EIP 0.106 (0.063) 0.120* (0.052) 
Anticipation for EIP         
14q4 for EIP 0.153* (0.063) 0.121* (0.050) 
15q1 for EIP 0.118* (0.045) 0.121** (0.042) 
Post-policy for EIP         
15q2 for EIP 0.140** (0.051) 0.221*** (0.050) 
15q3 for EIP 0.193*** (0.067) 0.157** (0.055) 
15q4 for EIP 0.209* (0.093) 0.204* (0.082) 
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Note: * p<0.05, ** p<0.01, *** p<0.001. "11q3" equals quarter 3 in year 2011. Reference category 
is 11q2. Models includes all covariates based on Equation 5.1. Cluster robust standard errors in 
parentheses.  
 
A23 Test of spill-overs from EIP to standard care services 
(1) Treatment = EIP patient (a) Coarsened exact matching (b) Propensity score matching 
Post-policy -0.156 (0.079) -0.279 (0.158) 
EIP patient 0.086 (0.139) 0.247 (0.150) 
Post-policy for EIP 0.217* (0.086) 0.338* (0.162) 
Observations 1,879   5,797   
(2) Treatment = Provider that 
offers EIP and standard care 
(a) Coarsened exact matching (b) Propensity score matching 
Post-policy -0.015 (0.040) -0.083 (0.054) 
Treatment 0.115*** (0.015) 0.066** (0.019) 
Post-policy for treatment -0.055 (0.053) 0.043 (0.063) 
Observations 4,533   10,480 
 
Note: * p<0.05, ** p<0.01, *** p<0.001. Pre-policy: Apr11 to Mar15; post-policy: Apr15-Nov15. 
Oct14-Mar15 omitted. Based on Equation 5.1 but: in model (1) control group limited to providers that 
offer standard care only; in model (2) treatment =1 if patients were with providers that offer EIP services 
additionally to standard care. Cluster robust standard errors in parentheses. 
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Abbreviations 
 
CCASS Care coordinator assignment 
CEM Coarsened exact matching 
Coeff. Coefficient 
Conf. Int. Confidence interval 
df Degrees of freedom 
DUP Duration of untreated psychosis 
EIP Early intervention in psychosis 
GLM Generalised linear model 
HES Hospital Episodes Statistics 
HoNOS Health of the Nation Outcome Scales 
HR Hazard ratio 
ICD-10 International Statistical Classification of Diseases 
and Related Health Problems, 10th version 
IMD Index of Multiple Deprivation 
LSOA Lower super output area 
MHLDDS Mental Health and Learning Disabilities Dataset 
NHS National Health Service 
NICE National Institute for Health and Care Excellence 
PSM Propensity score matching 
RESET test Regression Equation Specification Error Test 
SES Socioeconomic status 
Std. Err. Standard error 
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